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Despite the discovery of the double helical structure of DNA in 1953 by 
Watson and Crick, there are still many aspects of DNA topology that are not well 
understood. DNA catenation arises as a consequence of replication and results in 
the physical interlinking between replicated sister chromatids. Catenanes must be 
resolved prior to chromosome segregation; failure to do so can result in 
chromosome segregation errors and consequent aneuploidy. Type II 
topoisomerases, a highly conserved and essential class of enzymes, are the main 
decatenases in the cell.  
When and where catenation arises along authentic eukaryotic 
chromosomes, where it persists, and when and where it is resolved, is poorly 
understood. This is mainly due to the technical difficulties of visualizing intertwines 
between linear DNA molecules.  We describe here our attempt to study catenation 
of native budding yeast chromosomes by looping out segments of linear 
chromosomes as DNA circles.  
We used site-specific recombination to excise chromosomal regions of 8 to 
18 kb. The topoisomer pattern produced circular monomers that were accompanied 
by slower migrating bands whose behaviour is consistent with that of catenanes. 
They appear during DNA replication, and are resolved by topoisomerase II 
treatment in vitro. We find catenanes at replication termination regions and cohesin 
binding sites, where catenanes are expected to arise and persist, but not to a 
greater extent than elsewhere in the genome. We propose that once formed, 
catenanes distribute freely along chromosomes. Moreover, we provide evidence for 
precatenane formation, as DNA intertwinings between loop outs during replication 
elongation but before termination are detected. This approach allows us to provide 
previously inaccessible insight into the topology of eukaryotic chromosomes. 
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Chapter 1. Introduction 
1.1 Historical perspective 
The proposal of the double helix as the structure for the genetic information 
(Watson & Crick, 1953a) is arguably one of the highest scientific achievements of 
the 20th century. It was radically different to alternative structures proposed at the 
time, and its biological significance was questioned for decades after its publication, 
despite ample evidence that the structure was accurate (Franklin & Gosling, 1953) 
and that it existed in biological systems (Wilkins et al., 1953). Nowadays, the model 
almost seems common sense (Fig.1-1): DNA is composed of two helical chains 
coiled around the same axis, with the chains held together by hydrogen bonds 
between the purine and pyrimidine bases (adenine with thymidine, and guanine 
with cytosine; Watson & Crick, 1953a), Watson and Crick realized the implications 
of the double helical structure: because the two chains are intertwined, they would 
have to untwist if they were to separate, and at the chromosome scale, “a 
considerable amount of uncoiling would be necessary; [...] although it is difficult to 
see how these processes occur without everything getting tangled up, we do not 
feel that this objection will be insuperable” (Watson & Crick, 1953b). It is interesting 
to note that a year later, Delbrück proposed a solution to prevent the predicted 
entanglement problem resulting from unwinding the double helix, namely a 
‘breakage and reunion model’, where a strand of the helix would be broken, the 
intact strand passed through the gap and the break resealed (Delbrück, 1954). 
Delbrück incorporated this idea into a complicated model for DNA replication that 
turned out to be incorrect; however, he inadvertently stumbled nature’s mechanism 
to deal with the topological challenges resulting from the double helical structure of 
DNA. 
DNA topology as a field in its own right formally began with the discovery of 
supercoiled DNA in 1965 (Vinograd et al., 1965). At this time, the focus lay on 
understanding the process of ring formation in phage λ DNA:  the complementary 
sequences at its single-stranded ends allowed their intramolecular joining to form 
rings (intermolecularly, they joined to form oligomers; Hershey et al., 1963; Wang, 
2009). These DNA rings could be converted to covalently closed molecules in the 
presence of E. coli DNA ligase— a reaction product that went on to lead the way to 
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the confirmation that the helical periodicity of DNA, or the number of base pairs 
(bp) per helical turn, was ~10.5, and that it depended on temperature and 
counterions (Wang, 1969; Wang, 1979). Covalently closing DNA rings also enabled 
the measurement of the changes in DNA structure by other molecules, for example, 
how ethidium bromide untwists the DNA helix by approximately 26◦ (Wang, 1974a), 
or how the binding of E. coli RNA polymerases results in unwinding of ~1 turn per 
bound polymerase (Saucier & Wang, 1972). These findings demonstrated that 
protein binding to DNA does not require any drastic change in the double helix, but 
that binding is usually stimulated by negative supercoiling, with examples including 
RNA polymerases (Botchan et al., 1973) and endonucleases (Wang, 1974b). 
An important question at the time was why these λ DNA rings were so 
readily converted to their supercoiled form. As it turned out, serendipity led to one 
of the most important discoveries in the field: instead of supercoiled DNA, most of 
the DNA rings in the lysate of λ infected E. coli cells accidentally left on the bench 
instead of in the fridge were found to be relaxed (Wang, 2009). The enzyme 
responsible for removing supercoils (or relaxing DNA) was isolated and given the 
name of ω protein (ω for the angular velocity that was so heavily used for 
separating supercoiled DNA) (Wang, 1971; Wang, 2009). This enzyme was the first 
of a kind: it was found to transiently break DNA backbone bonds, alter the topology 
of its DNA substrate (i.e. interconvert topological isomers) and subsequently 
religate the break, as predicted by Delbrück; the first topoisomerase to be identified 
(Wang, 1971).   
Topoisomerase biology quickly began to flourish. Apart from the 
aforementioned E. coli ω protein, some of the early topoisomerases to be 
discovered were the mouse “nicking-closing” enzymes (Baase & Wang, 1974; 
Champoux & Dulbecco, 1972), prokaryotic gyrases (Gellert et al., 1976a; Liu & 
Wang, 1978) and the int gene product of bacteriophage λ (Kikuchi & Nash, 1979). 
Gyrases were different from the rest in that they required a cofactor (ATP) to 
catalyse their reaction, which resulted in, surprisingly, the introduction of negative 
supercoils into bacterial DNA (Gellert et al., 1976a). By the end of the decade it 
was already noted that these enzymes played vital roles in DNA metabolism, 
including replication (Champoux & Dulbecco, 1972; Wang, 1971), transcription 
(Wang, 1973), recombination (Kikuchi & Nash, 1979), chromosome condensation 
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(Baase & Wang, 1974), nucleosome assembly (Germond et al., 1979), and virus 
encapsidation (Bauer et al., 1977). 
The 1980s brought a different subclass of topoisomerase, namely type II 
topoisomerases. With the exception of gyrases, the previously discovered enzymes 
belonged to the type I group, characterized by their ability to create (and religate) 
single-stranded breaks (SSB) in DNA. The Alberts group isolated and 
characterized the T4 DNA topoisomerase, different from the aforementioned in that 
it was capable of completely breaking the double helix in a reversible way, which, 
as it subsequently proved to be the case with gyrase, depended on ATP hydrolysis 
(Liu et al., 1980). As proposed in the original study, we now know that type II 
topoisomerases are widespread in nature, and are (as type I topoisomerases) of 
great importance for most genetic processes, including replication, transcription 
and recombination (Liu et al., 1980). 
Since then, research on topoisomerases and DNA topology has branched 
out tremendously. Through X-ray crystallography and single molecule studies, we 
have built a very detailed picture of the mechanism of action of these enzymes. 
Cellular and genetic studies (DiNardo et al., 1984; Goto & Wang, 1982; Goto & 
Wang, 1984; Holm et al., 1985; Morham et al., 1996), on the other hand, have 
shown how topoisomerases act in their biological context, where they localize and 
how they are regulated to maintain the cellular topological homeostasis. Importantly, 
these enzymes have also been established as important targets for anticancer 
therapies, as well as antibiotics (Gellert et al., 1976b; Hsiang & Liu, 1985; Tewey et 
al., 1984). 
Yet, despite all the findings accomplished since 1953 many questions remain 
open. Clear evidence for a model of the topology of the replicon, or unit of 
replication (Jacob et al., 1963; Schvartzman & Stasiak, 2003) is missing: how does 
topology change as replisomes progress and meet one another, to what extent do 
topoisomerases counteract those topological changes? Topoisomerases, through 
their effect on DNA topology, have roles in a myriad of nuclear functions. Indeed, it 
remains enigmatic how such small molecules acting locally can control global, 
genome-wide topology, what takes them to their site of action and ensures the 
completion of their crucial tasks at particular cell cycle stages, and how the cell can 
sense, if at all, topological changes in return. 
  
Chapter 1 Introduction 
18 
 
1.2 DNA topology 
DNA has evolved into a vehicle that transmits genetic information from 
mother to daughter cells, with its functional elegance reflected in its double helical 
structure. The genetic information encoded in DNA is usually considered a one-
dimensional arrangement of bases; however, it is the three-dimensional 
configuration of DNA that directs how the information is accessed. The structure of 
DNA is typically characterized by two complementary polynucleotide chains 
multiply interwound, forming a double helix (Figure 1-1).  
 
Figure 1-1. Primary and secondary structures of DNA 
DNA is composed of repeated units of nucleotides (1 nt= ~3 *10-10 m), themselves 
formed by a phosphate group, a (2’-deoxyribose) pentose sugar and a base (A, C, 
G or T). Two chains (Watson and Crick) of nucleotide strands are intertwined 
around each other, where the phosphate and sugar groups make up the sides of 
the ladder, and the bases form the rungs (From Buck, 2009).  
 
The prevailing conformation, the so-called B-DNA, is a right-handed helix with 
10.5 bp per helical turn, and although locally the shape of DNA may differ from the 
B-DNA, the overall structure of a DNA molecule is accurately described by this 
conformation. The double-helical arrangement confers upon it structural stability; 
however, it also poses a challenge when separation of the strands is required. In 
addition to its double helical nature, DNA is compressed into the dense nuclear 
environment; consequently, three-dimensional relationships in the double helix are 
topological (Deweese et al., 2009). 
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Topology is a field of mathematics that describes relationships that are not 
altered by elastic deformation. Topological aspects of DNA come about by the fact 
that the two strands are interwound, and untangling them— which takes place 
during the majority of genetic processes— proves to be complicated. In the case of 
linear DNA in solution, untangling occurs readily due to the free rotation of the ends 
of the DNA molecule. However, linear DNA has hardly any physiological relevance: 
DNA found in living organisms has effectively no free ends, thus, restricting or 
forbidding its untangling (Clarke, 2009).  
A DNA segment or molecule whose free end rotation is impossible is termed 
a topological domain, the most typical example being circular DNA, characteristic of 
bacterial, mitochondrial, chloroplast and some viral genomes. Eukaryotic genomes, 
despite being overall linear, putatively consist of DNA loops attached to protein 
complexes and/or nuclear matrices, each loop being a domain topologically 
equivalent to covalently closed circular DNA molecules (Mirkin, 2001). 
1.2.1 Measuring DNA topology: linking number, twist and writhe 
The fundamental topological parameter of a topological domain is given by 
the linking number (Lk). Lk describes the number of times the Watson strand wraps 
around the Crick strand in a plane projection (Liu et al., 2009), and thus measures 
the linking between the two strands of DNA— the algebraic sum of all intersections. 
Lk is a topological property of closed systems and is independent of the geometry 
of the DNA (Bates & Maxwell, 2005). Thus, Lk is an integer with a constant value: it 
cannot be altered by local deformations of the DNA strands (i.e. it is a topological 
invariant; Buck, 2009). In other words, the basic strained state of a closed DNA 
molecule cannot be changed: any coiling in that DNA is “locked” into the system 
(Bates & Maxwell, 2005). Changes in Lk can only occur by creating a (transient) 
break in the DNA helix and rotating or passing the strands through each other. 
Lk is described by two properties of DNA, namely twist (Tw) and writhe (Wr), 
the two geometric forms in which the topological state of DNA molecules can 
manifest. Tw is a measure of how the individual strands wind around one another 
(i.e. how tightly the helix is wrapped around its axis), and thus it indicates the 
helical pitch, or number of bp per complete revolution (Bates & Maxwell, 2005). The 
right-handed twist of the Watson-Crick helix is given a positive value by convention. 
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Wr is a property of the spatial course of the double helix, and it describes the 
coiling of the helical axis (i.e. how it is contorted in space; Buck, 2009). It is defined 
as the number of times the double helix crosses itself in a 2D projection. Tw and 
Wr are not topological invariants, and thus may change under deformations of the 
DNA helix (Buck, 2009). The relationship between these three parameters is given 
by: 
𝐿𝑘 = 𝑇𝑤 +  𝑊𝑟 
 
This equation explains that any local changes in Tw are compensated by 
opposite variations in Wr, and vice versa (i.e. Tw and Wr can be interconverted), to 
keep Lk constant in a given topological domain.  
1.2.2 Physiological topoisomers: supercoils, catenanes and knots 
For an N bp long circular DNA molecule: 




where γ describes the number of base pairs per helical turn. The above equation 
describes a relaxed DNA molecule, like the Watson-Crick structure, free of 
torsional stress, i.e. in the lowest free-energy state (Liu et al., 2009).  For relaxed 
DNA molecules, e.g. a planar DNA circle, Wr=0, and the Lk is given by the number 
of double-helical turns around the circle (Bates & Maxwell, 2005). For example, a 
relaxed DNA molecule of 1050 bp should have an Lk0 =1050 bp÷10.5 bp/turn=100 
(under standard conditions, 0.2 M NaCl, pH 7, 37°C; Deweese et al., 2009). 
Conversely, supercoiled molecules are characterized by Lk ≠ Lk0, with the 
difference being quantified by Lk. When Lk is negative, the corresponding DNA 
molecule is referred to as negatively supercoiled; if Lk is positive, the DNA is 
positively supercoiled. The former is underwound relative to a relaxed molecule, 
which can manifest as a relative untwisting of the helix, or an increase in the 
number of base pairs per turn. Conversely, positively supercoiled molecules are 
overwound, with a lower helical repeat than their relaxed counterpart. Supercoiling 
can manifest not only as changes in twist, but also in writhe, or the spatial course of 
the helical axis: underwound and overwound DNA molecules adopt higher order 
helical coiling (hence the name ‘supercoiling’; Figure 1-2a). The most prominent 
supercoiled configurations are plectonemic and solenoidal (Figure 1-2b). 
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Plectonemic or interwound DNA is characteristic of prokaryotes and is 
characterized by the winding of the DNA helix around another part of the same 
molecule (Adrian et al., 1990; Bates & Maxwell, 2005). Solenoidal (or toroidal) DNA 
forms as DNA wraps around the histone octamer in eukaryotic chromosomes 
(Davey et al., 2002).  
To compare supercoiling between different molecules, it is useful to 








Thus, σ measures supercoiling density, and estimates the number of 
supercoils per helical turn. In living cells, σ varies from -0.02 to -0.09. Thus, 
following the previous example, a 1050 bp underwound by 6% (σ= -0.06) would 
have 94 turns of the helix, instead of the 100 expected for its relaxed counterpart, 
and its ΔLk= -6. Supercoiling, which introduces torsional and bending deformations, 
is energetically unfavourable and, conversely, local relaxation favourable.  
 
 
Figure 1-2. Topological relationships in a covalently closed DNA molecule 
(a) (+) and (-) supercoiled molecules adopt higher order helical conformations with 
respect to relaxed DNA. (b) Supercoiling typically adopts a plectonemic or a 
solenoidal shape in the absence and presence of histones, respectively. (c) Knots 
and catenanes are topological invariants, and require breaks in the DNA for their 
resolution. 
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DNA molecules can adopt other conformations apart from supercoiling. 
Knots and catenanes (Figure 1-2c) are two examples of structures detected in 
living cells, where one or more DNA molecules become interlinked, respectively. 
Their formation is facilitated by the fact that the nuclear environment is crowded, 
and the organization of chromosomes as individual entities is challenging. Naturally 
occurring knots have been observed in DNA from bacteriophage capsids, probably 
arising from the joining of the single-stranded extensions at the ends of the phage 
DNA (Liu et al., 1981). Knots can also be generated in vitro, for example, through 
site-specific recombination by the integrase (Azaro & Landy, 2002) and the 
resolvase (Wasserman et al., 1985) families of recombinases. Catenanes, on the 
other hand, are much more common in nature than knots, and their presence has 
been reported in a multitude of biological systems (Bates & Maxwell, 2005; Farcas 
et al., 2011; Sundin & Varshavsky, 1981). They originate during replication and 
impede the segregation of DNA molecules during cell division (Sundin & 
Varshavsky, 1981; diNardo et al., 1984). Unlike supercoils (sc), which can be 
interconverted from twists to writhes, knots and catenanes are constrained as 
writhes. They are topological invariants: the number of crossings for a given knot or 
catenane can only be changed by breaking the DNA strands.  
1.2.3 The physiological relevance of supercoiled genomes 
Topology is an important active player in genome functioning, and 
topological relationships affect virtually any aspect of DNA metabolism. First, 
supercoiling can reduce the overall volume occupied by a DNA molecule, as it 
triggers the formation of plectonemic superhelices with diameters of only a few 
times larger than that of DNA itself, and thus aids in the organization of genomes 
into small cellular/nuclear volumes (Holmes & Cozzarelli, 2000; Vologodskii & 
Cozzarelli, 1994). Moreover, as explained above, in any given topological domain, 
a change in Tw (secondary structure) is compensated by a change in Wr (overall 
shape). For example, unwinding of a stretch in a DNA molecule will be reflected by 
a change in global supercoiling— and vice versa— as long as both strands have no 
breaks. Thus, an immediate benefit of DNA supercoiling is that it could be used as 
a sensor of DNA integrity; the fact that supercoiling is required for replication 
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initiation could mean that replication can only start if both strands are intact, (Mirkin, 
2001) in addition to facilitating duplex unwinding.  
DNA processing is directed not only by specific nucleic acid sequences, but 
also by the energetics of DNA topology (Sissi & Palumbo, 2010). As mentioned 
previously, the genomes of most living organisms are negatively supercoiled, and 
this global underwinding conveys single-stranded character that enables the 
temporary unwinding that takes place during all major genetic processes (Bates & 
Maxwell, 2005). Thus, negative supercoiling supplies the energy for localized 
unwinding of the double helix, which, in turn, facilitates the access to polymerases 
and repair factors. Supercoiling may also assist the synapsis of distant sites of the 
chromosome (Embleton et al., 2004; Vologodskii and Cozzarelli, 1996) because 
high-order folding could put in contact chromosomal regions that would be 
otherwise far apart. Indeed, the importance of negative supercoiling for 
transcription, DNA replication and recombination has been demonstrated, mostly 
for prokaryotic systems. In eukaryotes supercoils accumulate in chromatin, 
constrained by the wrapping of DNA around nucleosomes (which provides the 
major mode of negative supercoiling in eukaryotic chromosomes; Schvartzman & 
Stasiak, 2003). Typically, DNA wrapping around a nucleosome leads to ΔLk =-1; 
however, this decrease in Lk is dependent on the levels of histone acetylation, with 
highly acetylated histones (characteristic of euchromatin) being less able to 
sequester DNA and reducing the linking number only by ΔLk =-0.8 (Norton et al., 
1989; Osborne & Guarente, 1989). In line with this, DNA in silent 
chromatin/heterochromatin has been found to be more negatively supercoiled (Bi & 
Broach, 1997).  
As well as affecting all major genetic processes, DNA topology can, in turn, 
be affected by these processes. Tracking systems that unwind DNA as they travel 
along the DNA seem to move linearly and do not change Lk (as this requires 
breaks in DNA), but compress supercoils into an increasingly shorter region (Bates 
& Maxwell, 2005). This results in progressively more overwinding ahead of the 
tracking system, which makes the unwinding of the helix more difficult, ultimately 
impeding DNA processes. Thus, in contrast to underwinding, positive supercoiling 
tends to inhibit DNA processes, because it opposes local melting of the double 
helix.  
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1.3 DNA topoisomerases 
DNA topoisomerases are enzymes that modify DNA topology and regulate 
the topological state of cellular DNA; they evolved to deal with the topological 
challenges rooted in the double-helical structure of DNA (Wang, 2002).  They 
comprise a ubiquitous family of enzymes whose mechanism of action 
encompasses characteristics of nucleases and ligases: they generate transient 
breaks, rearrange and religate their substrate DNA (Sissi & Palumbo, 2010). 
Topoisomerases are fundamental for the survival of all organisms and have crucial 
roles in DNA replication, transcription, chromosome condensation and segregation, 
and Holliday junction resolution; thus, deficiencies in their activities give rise to 
diseases linked to genome instability (Clarke, 2009). 
1.3.1 Classification & Mechanisms of action 




Figure 1-3. General reaction mechanism of topoisomerases. 
During the topology-remodelling reactions of type IA and II topoisomerases, the 
active tyrosyl group of the enzyme establishes a covalent bond with the 5’-
phosphoryl group of the DNA through a transesterification reaction that breaks the 
DNA backbone bond. In the case of type IB topoisomerases (not depicted), the 
tyrosyl group is linked to a 3’-phosphoryl group (from Wang, 2002; with permission 
from Nature Publishing Group). 
 
They initiate DNA cleavage by nucleophilic attack by their active site tyrosyl 
residues on the phosphate of the DNA backbone (Champoux, 2001). Following a 
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transesterification reaction, a covalent phosphotyrosyl bond forms between 
topoisomerase and the newly created DNA end, and a hydroxy moiety is formed on 
the opposite end of the broken strand. The covalent bond maintains the energy of 
the sugar-phosphate backbone, and it also keeps genomic integrity during the 
reaction. After the topological transaction, ligation proceeds as the reverse of the 
cleavage event, i.e. by nucleophilic attack of the hydroxy moiety on the 
phosphotyrosyl bond, which breaks the protein-DNA bond and reforms the DNA 
backbone link, restoring a chemically identical structure to that of the initial 
substrate (Champoux, 2001).  
Topoisomerases fall into two main groups, type I and type II. Type I 
enzymes make transient breaks on one strand of the DNA at a time, whereas type 
II enzymes act as dimers to temporarily break a pair of strands in the double helix 
(Wang, 2002). 
1.3.1.1 Type I topoisomerases 
Type I topoisomerases, denoted by odd roman numbers, e.g. topo I and 
topo III, are active in their monomeric form and do not require a high-energy 
cofactor. They are further divided into class IA or IB, depending on their 
mechanism of action and the polarity of the covalent linkage between DNA and 
enzyme. 
Type IA topoisomerases bind a negatively supercoiled substrate, leading to 
the unwinding of a short stretch of DNA. They transiently break the single stranded 
region, and attach to the 5’-terminal phosphate of the DNA at the site of the break 
(Kim & Wang, 1992; Wang, 2002). Acting as a bridge that connects the newly 
generated DNA ends, they subsequently pass the opposite strand through the 
break (Figure 1-4a). As relaxation proceeds, and the substrate becomes less (-) 
supercoiled, the enzyme becomes progressively less proficient; thus, overwound or 
(+) supercoiled DNA is not a good substrate for this subclass of topoisomerases 
(Wang, 2002). In the presence of a nick or gap, type IA topoisomerases may also 
pass a double helical segment through a second helix, resulting in 
catenation/decatenation reactions (Tse & Wang, 1980). This subclass requires the 
presence of divalent metal ions for catalysis. Type IA topoisomerases have roles in 
recombination, including Holliday junction resolution (Harmon et al., 1999; Wallis et 
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al., 1989), recombinational DNA repair (Zhu et al., 2001) and the maintenance of 
genome stability (Watt & Hickson, 1994). In most species, topoisomerase III acts 
together with a 3’-5’ helicase of the RecQ family, e.g. RecQ in E. coli, Sgs1 in S. 
cerevisiae, and BLM in human cells (Bachrati & Hickson, 2003; Bocquet et al., 
2014; Duguet, 1997)— and the complex further associates with the major ssDNA 
binding factor in each species (Bachrati & Hickson, 2003; Cejka et al., 2012; 
Sharma et al., 2006) to putatively disentangle homologous recombination 
intermediates containing Holliday junctions. 
 
  
Figure 1-4. Topology modification by type I topoisomerases 
(a) Type IA enzymes, like yeast topoisomerase III (top3), carry out a strand 
passage reaction of an intact strand through a transient single-strand break (SSB). 
(b) Type IB topoisomerases, e.g. yeast topoisomerase I (top1), act through a 
rotation mechanism around the induced SSB (From Vos et al. 2011; with 
permission from Nature Publishing Group). 
 
The type IB subfamily includes most eukaryotic type I enzymes, and, as 
opposed to the bridging mechanism of the type IA enzymes, they probably act 
through DNA rotation. After cleaving one of the DNA strands, the type IB 
topoisomerase assumes a linkage to the 3’ end (upstream) of the DNA: supercoils 
(sc) are relaxed by rotation of the free 5’ end around the intact strand (Figure 1-4b; 
Koster et al., 2005; Krogh & Shuman, 2000). Because the interaction between the 
enzyme and the downstream region of the break is mostly ionic in nature, this 
region is able to rotate. Thus, the segments flanking the nick can turn around one 
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of the single bonds opposing the nick (Champoux, 2001). Type IB topoisomerases 
cleave one strand in a double-stranded DNA (dsDNA) region, and can relax both (-) 
and (+) sc. This subclass of enzymes has been reported to carry out 
catenation/decatenation reactions in vitro, as long as the DNA substrate contains 
nicks and/or gaps (Brown & Cozzarelli, 1981). However, the mechanism of this 
reaction remains unclear, and so does its biological significance since a linear 
dsDNA break intermediate (covalently attached to the enzyme on one end) would 
be expected to form during the reaction (Wang, 2002). Type IB enzymes do not 
require divalent metal ions for catalytic activity. 
 It is worth noting that the integrase (Int) family of site-specific recombinases 
(hereby referred to as tyrosine recombinases) uses a very similar mechanism to 
catalyze the formation and resolution of Holliday junctions (Krogh & Shuman, 2000). 
Tyrosine recombinases, including λ Int, Cre and Flp, share very little sequence 
homology to type IB topoisomerases; however, their catalytic domains are 
structurally very similar (Cheng et al., 1998). The main mechanistic difference is 
that the 5’ hydroxyl formed by topo IB is rejoined to its original strand by a single 
topoisomerase molecule, whereas four recombinase molecules are required to 
rejoin the similarly created 5’-OH moiety to a 3’ phosphate partner in a DNA strand 
of a distant region (Sherratt & Wigley, 1998).  
1.3.1.2 Type II topoisomerases 
Type II topoisomerases, which are designated by even roman numbers, e.g. 
topo II and topo IV, are active as multimers (homodimers, in the case of eukaryotic 
enzymes, and A2B2 structure in prokaryotes) and require ATP and divalent metal 
ions for catalysis (Deweese et al., 2009; Wang, 1996). This subclass has two-fold 
symmetry, and the interface between the two halves consists of three gates, 
namely the N-, DNA-, and C-gates (Schoeffler & Berger, 2008; Yogo et al., 2012). 
The catalytic cycle of type II topoisomerases, the now well-accepted “two-gate 
mechanism” (Roca & Wang, 1994; Roca et al., 1996) has been extensively 
documented through biochemical and structural studies (Figure 1-5a). The strand 
passage reaction starts when the enzyme binds the G (gate) DNA segment at the 
DNA-gate (Deweese & Osheroff, 2009; Laponogov et al., 2013). Although binding 
does not seem to rely strictly on primary sequence, there is probably a preference 
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for certain tertiary structures, i.e. crossovers (Alonso-Sarduy et al., 2011; Roca et 
al., 1993; Watt & Hickson, 1994). On the other hand, DNA binding does not 
necessarily lead to strand passage (Roca et al., 1993). The N-terminal domains, 
closed by ATP binding, act like a clamp to capture a second DNA segment, T 
(transport; Bates & Maxwell, 2007; Laponogov et al., 2013). N-gate closure thus 
precedes DNA-gate opening (Martinez-Garcia et al., 2015), possibly acting as a 
safety mechanism to avoid futile cleavage cycles, and is followed by the transport 
of the T segment towards the DNA-gate. Here, a transient double strand break 
(DSB) is made on the G segment, maintaining a covalent bond between the newly 
formed 5’-ends and the enzyme’s catalytic tyrosines on each side of the DNA gate. 
The scissile bonds on the double helix are staggered and positioned across the 
major groove from one another, with the cleaved DNA molecules containing 4 bp 
5’-ssDNA cohesive ends attached to a protomer of topoisomerase II (Liu et a., 
1983; Sander & Hsieh, 1983; Zechiedrich et al., 1989). ATP hydrolysis powers the 
passage of the T segment through the DSB in the G segment to leave by the C-
gate (Bates & Maxwell, 2007), followed by the religation of the break and N-gate 
reopening to allow enzyme turnover (Martinez-Garcia et al., 2015; Schoeffler & 
Berger, 2008; Yogo et al., 2012). Abortive cycles have also been reported, as has 
ATP hydrolysis in the absence of strand passage (Lindsley & Wang, 1993). The 
biological relevance of these observations is unknown. Conversely, single molecule 
experiments have suggested that multiple T segments can be transported through 
a given DSB (Charvin et al., 2003; Smiley et al., 2007; Strick et al., 2000; Yogo et 
al., 2012), but how this apparent processivity is regulated, especially without 
dissociation of the G segment from the enzyme, is still to be clarified.  
Type II topoisomerases are further divided into type IIA and IIB, ever since 
the discovery of the first type IIB enzyme in the archaeon Sulfolobus shibatae 
(Bergerat et al., 1997), and though both subclasses share a number of mechanistic 
features, there are clear structural differences between the two (Figure 1-5b). The 
IIA subclass includes the bacterial gyrase, which has a characteristic extended C-
terminal domain that wraps ~140 bp of dsDNA around it (Lynn et al., 1986; Liu & 
Wang, 1978; Liu & Wang, 1981), and is thought to underlie the enzyme’s 
preference for (+) supercoiled DNA as substrate (Kampranis et al., 1999) and its 
unique ability to introduce (-) sc in the bacterial chromosome (Gellert et al., 1976a; 
Kirkegaard & Wang, 1981; Kreuzer & Cozzarelli, 1980; Liu & Wang, 1978). As well 
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as gyrases, the type IIA subclass comprises most nonsupercoiling type II 
topoisomerases, such as the bacterial topo IV and the majority of eukaryotic topo II 
enzymes. The topoisomerase IIB subclass, of which topo VI is currently the only 
known example, is found in archaea, plants and a number of bacteria, protists and 
algae. Interestingly, Spo11, identified as a homologue of the DNA-binding subunit 
of topo VI, has been reported as an important factor during meiotic recombination 
in eukaryotes (Keeney et al., 1997). 
 
Figure 1-5. Topology modification by type II topoisomerases. 
(a) Type IIA topoisomerases create a transient DSB and pass an intact duplex 
through it in an ATP-hydrolysis dependent manner. (b) Type IIB enzymes carry out 
a similar reaction, but differ from the type IIA subclass in their tertiary structure 
(From Vos et al., 2011; with permission from Nature Publishing Group). 
 
Topological changes by topoisomerases 
Type I topoisomerases alter topology in steps of ΔLk =±1 (Wang, 1996): 
because they act on twists, they are only able to relax DNA or resolve interlinked 
ssDNA molecules (Champoux, 2001; Lopez et al., 2005). Decatenation and 
unknotting of intact duplexes requires type II enzymes, which can act on DNA 
writhes and change topology in steps of ΔLk =±2 (Liu et al., 1980). Following from 
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the first equation relating Lk, wr and tw, type II topoisomerases can also remove 
two supercoils (Deweese et al., 2009). 
1.3.2 Roles of topoisomerases 
All organisms whose genomes have been sequenced so far encode for at 
least one type I, and one type II topoisomerase. Under laboratory conditions, 
however, it has been shown that budding yeast cells can survive with just a copy of 
type II topoisomerase (i.e. Δtop1, Δtop3), although cells grow poorly (Walls et al., 
1989).  Multicellular organisms have more stringent topoisomerase requirements, 
especially during embryonic development. In mice, all six topoisomerases are 
indispensable to sustain life: knocking out topo Iβ results in death between the 4- 
and 16-cell stage (Morham et al., 1996), topo IIβ deletion allows embryonic 
development but leads to death at birth (Yang et al., 2000) and inactivating topo IIIα 
impedes proper implantation (Li & Wang, 1998). TopIIIβ-/- mice have a decreased 
lifespan and fertility problems (Kwan & Wang, 2001), and topo IIα disruption leads 
to lethality, even in cultured cell lines (Wang, 2002).  
The differential requirements of these topoisomerases imply that, although 
the enzymes perform similar reactions in vitro, their roles in vivo are not redundant. 
Therefore, the main DNA transactions in the cell, namely DNA replication, DNA 
transcription, chromosome segregation, chromosome condensation and 
recombination1, create topological challenges that require the specific action of a 
given topoisomerase. 
1.3.3 Topoisomerases and replication 
Early stages of replication  
Topoisomerases play an important role in DNA replication: their regulation 
of the local topology around a replication origin can affect its firing. Examples 
include gyrase, which is required for activation of oriC in E. coli (Kornberg, 1984), 
topoisomerases I and II for activation of viral DNA origins in Simian virus 40 
(Halmer et al., 1998), Epstein-Barr virus (Kawanishi, 1993) and Bovine 
papillomavirus (Hu et al., 2006), and topo I for in vitro DNA synthesis in budding 
                                              
1 The role of topoisomerases in recombination is beyond the scope of this thesis, 
and will not be further discussed. 
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yeast nuclear extracts (Mitkova et al., 2005). It has also been reported that origin 
recognition complex (ORC) binding to replication origins requires negative 
supercoiling in Drosophila (Remus et al., 2004), and that topo I is required for 
replication initiation close to the lamin B2 gene in human cells (Abdurashidova et 
al., 2007).  
 
Late stages of replication 
The replication of topologically constrained DNA molecules leads to a 
number of topological problems (Postow et al., 1999). Perhaps most remarkably, 
as helicases at the replication fork unwind the parental strands to make them 
accessible to polymerases, the reduction in Lk caused by unwinding is 
compensated by formation of (+) sc—or overwinding— ahead of the fork 
(Champoux & Been, 1980; Postow et al., 2001), which must be dealt with by 
topoisomerases for replication to progress. In eukaryotes, both IB and IIA relax this 
torsional strain, with topo IB perhaps having a more significant role (Tuduri et al., 
2014); in prokaryotes, gyrase is the main effector in removing these (+) sc 
(Zechiedrich et al., 1994). As forks travel from their origin, the unreplicated region 
becomes progressively smaller, with (+) sc eventually occupying a stretch of DNA 
that is not long enough for topoisomerases to act upon (Postow et al., 1999). How 
do cells then manage to complete replication and resolve the leftover topological 
problems? Two models have been postulated to explain how cells resolve DNA 
replication-induced topological challenges, namely the termination and the 
precatenane models. 
 
The termination model 
The termination model postulates that sister chromatid intertwinings 
originate at replication termination regions (Figure 1-6; Murray & Szostak, 1985; 
Sundin and Varshavsky, 1980). It provides an explanation of how DNA replication 
can be completed without immediate topoisomerase action (Fields-Berry & de 
Pamphilis, 1989; Spell & Holm, 1994). This model was proposed in the early 1980s 
and was supported by a number of experiments using the Simian virus 40 (SV40) 
replication model, which provided the first formal record that replication products 
appear as catenanes (Sundin & Varshavsky, 1980). 




Figure 1-6. The termination model for DNA catenation 
The termination model predicts that catenanes form at the regions of replication 
fork convergence. Topoisomerases cannot act on the (+) sc ahead of the forks in 
this region due to steric hindrance. To complete replication of the last few turns of 
the parental strands, replisomes must rotate, which leads to the intertwining of 
replicated DNA duplexes (From Murray & Szostak, 1985). 
 
When converging replication forks are proximal, with approximately 200 
nucleotides of unreplicated parental duplex in between them (Sundin & Varshavsky, 
1981), they stall due to the accumulation of (+) sc in the region between the forks 
that cannot be removed due to steric exclusion of a swivelase (i.e. topoisomerase I 
and/or topoisomerase II). Catenation results from the unwinding and replication of 
this last DNA stretch: fork rotation converts each helical turn that gets replicated 
into a duplex intertwining (DiNardo et al., 1984). Both the virus (Sundin and 
Varshavsky, 1980) and early yeast studies using minichromosomes (DiNardo et al., 
1984) found an average of 20-30 intertwinings after replication in the absence of a 
functional type II topoisomerase, indicating that the constraints imposed by 
replication forks may be similar in yeast and mammalian systems.  
However, it has been recently reported that DNA synthesis does not 
significantly slow down upon fork convergence in Xenopus egg extracts, 
suggesting that leading strands simply pass each other before undergoing ligation 
to lagging strands (Dewar et al., 2015), as opposed to the fork stalling predicted by 
Sundin & Varshavsky. Moreover, the replisome dissociates after ligation (Dewar et 
al., 2015), unlike during the replication of the SV40 genome, where the helicase 
large T antigen is removed before unwinding of the last parental DNA stretch (Tack 
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& de Pamphilis, 1983). Similarly, genome-wide replication termination seems solely 
determined by origin position, timing and efficiency and does not correlate with 
pausing elements (McGuffee et al., 2013). Although higher temporal resolution 
might be required (e.g. to compare the replisome speed during the elongation and 
termination stages), this studies argues against major stalling events during 
termination, raises doubts on the presence of major topological constraints during 
this the last step of DNA replication. 
 
The precatenane model 
In contrast, the precatenane or elongation model postulates that, to 
counteract the supercoiling accumulated in the unreplicated region between the 
converging forks, some of the torsional stress can diffuse across the fork and take 
the form of intertwined replicated DNA behind the replication fork (Figure 1-7; 
Champoux & Been, 1980).  
It assumes that, in order for (+) sc to be converted into precatenanes, 
replication forks must be able to rotate (Champoux & Been, 1980). Fork rotation 
would alleviate some of the stress ahead of the fork: while (+) sc can interfere with 
replisome progression, precatenanes do not oppose further helicase unwinding 
(Bermejo et al., 2008). However, precatenanes, which become catenanes after S 
phase is completed, need to be removed prior to chromosome segregation 
(Bermejo et al., 2008). 
 
Figure 1-7. The precatenane model for DNA catenation. 
Fork rotation during the elongation step of replication enables the transmission of 
(+) sc ahead of the fork into precatenanes at its wake (adapted from Postow et al., 
2001). 
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In support of this model, replication of a plasmid in vitro using purified E. coli 
topoisomerases showed that unlinking occurred both in front of and behind the fork 
(Hiasa & Marians, 1994; Peng & Marians, 1993). Moreover, electron microscopy 
(EM) analysis of replication intermediates indicates that precatenanes do form as 
replication intermediates (Peter et al., 1998). In vivo, topological analyses of 
replicating molecules also support the precatenane model. In E. coli, replication 
intermediates of a plasmid with two opposing unidirectional ColE1 origins become 
knotted (maybe as a by-product of topo II activity on replication bubbles, rather 
than a biologically relevant structure during replication). Analysis of the knots 
through RecA coating and EM has provided further evidence for the precatenane 
model (Postow et al., 1999; Sogo et al., 1999). Moreover, partially replicated 
plasmids are more torsionally constrained in the absence of topo IV than in 
wildtype cells, suggesting that this enzyme is required during replication to remove 
precatenanes behind the replication fork (Cebrian et al., 2015). Further studies 
have obtained consistent results in Xenopus egg extracts, where it was shown that 
topo II acts behind the fork during replication (Lucas et al., 2001).  
Despite these results, evidence for precatenane formation during replication 
elongation remains contested. The use of stalled replication forks is problematic 
because it may affect the behaviour and structure of the replication intermediates 
and create differences from actively replicating molecules, for example, due to 
continuing gyrase activity in the absence of replication fork progression (Postow et 
al., 1999; Schvartzman & Stasiak, 2003). 
 
Replication fork rotation 
A key requirement for precatenane formation is that the replisome can freely 
rotate, but it is yet unclear whether this is the case: while rotation is simple to 
imagine if replisomes travel independent of one another (Breier et al., 2005; Reyes-
Lamothe et al., 2008), it seems almost impossible if the replisomes remain 
associated as proposed by the fixed double-replisome model (Dingman, 1974; 
Falaschi, 2000; Levine et al., 1998). In fact, evidence from a number of systems 
suggests that replisomes are largely immobile (Cook, 1991; Jackson & Cook, 1986, 
Nakamura et al., 1986). In summary, how catenanes originate in vivo in eukaryotic 
cells remains an open question. 
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Replisome components could have an indirect role in modulating catenane 
levels through controlling the degree of fork rotation and thereby the diffusion of (+) 
sc to the region behind the fork, i.e. their conversion into precatenanes. For 
example, in E. coli, it has been observed that overexpression of the replisome 
clamp loader γ requires the action of topo IV during S phase (Espeli et al., 2003; 
Levine & Marians, 1998). In budding yeast, deletion of specific replisome-
associated factors Tof1 (Timeless) and Csm3 (Tipin) leads to higher catenation 
levels in plasmid DNA, which can be interpreted to mean that these proteins 
usually prevent fork rotation (and thus precatenane formation; Schalbetter et al., 
2015). However, the direct role of fork rotation in topology remains to be tested; 
Schalbetter and colleagues studied a genetic interaction between replisome 
components and topological outcomes but were unable to define the origin of the 
catenanes. 
1.3.4 Topoisomerases and transcription-induced torsional stress 
Transcription-induced topological challenges probably resemble those that 
arise during the elongation step of DNA replication. The transcriptional machinery, 
as the replication machinery, locally alters DNA topology producing (+) sc ahead of 
the elongating RNA polymerase (Pol I, II or III) and (-) sc in its wake (Liu & Wang, 
1987; Mondal & Parvin, 2001).  
If not dealt with, this accumulation of superhelical tension inhibits further 
transcription. Experimentally, this is supported by the fact that in the absence of 
topo I and topo II activities, transcription of E. coli β-galactosidase from a plasmid is 
repressed, suggesting that DNA topology can locally affect transcription (Caron et 
al., 1994; Gartenberg & Wang, 1992).  
In bacterial systems, gyrase is probably the most important effector in 
removing transcription-induced (+) sc, while type IA topoisomerases relax the (-) sc 
(Nitiss, 1998; Wang, 2002; Drolet et al., 1995). The absence of topo IA in some 
prokaryotes, e.g. Shigella flexneri, is perhaps compensated for by the expression of 
topo IV (or other topoisomerases; Bhriain & Dorman, 1993; Kato et al., 1990). 
In eukaryotes, the division of labour between the different topoisomerase 
enzymes is more elusive as studies often have contradictory results depending on 
the system used. In particular, the relative efficiencies of the different 
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topoisomerases in relaxing supercoils differ if the substrate is naked or 
chromatinized DNA (Salceda et al., 2006). In budding yeast, the presence of at 
least one topoisomerase (topo IB or topo IIA) is sufficient to support transcription 
(Kim & Wang, 1989a). The absence of both enzymes, however, inhibits RNA Pol I 
and Pol III (Brill et al., 1987; Schultz et al., 1992) and interferes with rDNA and 
polyA+ RNA synthesis (Brill et al., 1987; Yamagishi & Nomura, 1988). This could 
be due to differences in processivity and/or translocation between RNA Pol I and 
Pol II (responsible for transcribing rRNA and mRNA, respectively) in the presence 
of torsional stress or due to differential localization of the template DNA in the 
nucleus (Matera, 1999; Misteli, 2001). Overall transcription is reduced by a global 
increase in (+) sc, as it occurs in double topoisomerase mutants (top1Δ, top2-4 ts) 
ectopically expressing bacterial type I topoisomerase that preferentially removes (-) 
sc (Gartenberg & Wang, 1992), suggesting that there is a threshold in torsional 
tension after which transcription and possibly other DNA processes are precluded 
(Joshi et al., 2010). On the other hand, closer inspection of how the inactivation of 
topoisomerases affects transcription revealed that the transcription of long (>3 kb) 
genes was precluded in topo II mutant cells (but not in topo I mutants; Joshi et al., 
2012). Inactivation of topo II precluded Pol II elongation, rather than initiation, 
indicating that the overaccumulation of (+) sc as the transcriptional machinery 
travels along the chromosome is usually removed by topo II and not topo I (Joshi et 
al., 2012). 
1.3.5 Topoisomerases and chromosome segregation 
Effective segregation of sister chromatids requires the removal of all 
interlinks between the two strands of DNA (Watson & Crick 1953). For relatively 
small genomes, like the E. coli chromosome (~4.7*106 bp), this comes down to 
~4.5*105 links per generation (Nolivos et al., 2016), for small eukaryotic genomes, 
like the budding yeast (1.25*107 bp), it would be in the order of 1.2*106 links per 
generation, whereas for large mammalian genomes, e.g. human cell (3.3*109 bp), 
the task is more daunting, with over 3.2*108 links requiring removal. 
Topoisomerases are very effective at performing this unlinking, considering the 
astounding efficiency in sister chromatid segregation, e.g. with only 1 in 105 mitotic 
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and 1 in 104 meiotic divisions experiencing loss of a chromosome in budding yeast 
(Murray & Szostak, 1985).  
While most interlinks are removed before mitosis, and most probably ahead 
of the fork during DNA replication, an important proportion of the unlinking revolves 
around the removal of sister chromatid intertwinings. Being the main decatenase in 
the cell, the most obviously expected consequence of improper topo II activity is 
defective chromosome segregation, which is the case in bacteria (Wang et al., 
2008) and eukaryotes, both during mitosis (diNardo et al., 1984; Holm et al., 1985; 
Holm et al., 1989; Uemura et al., 1987; Spell & Holm, 1994) and meiosis (Rose et 
al., 1990). Historically, the first phenotype characterized in fission yeast topo II 
mutants, namely the so-called cut (Cell Untimely Torn) phenotype, was described 
by cells attempting cytokinesis without the genome being segregated (Hirano et al., 
1986; Uemura et al., 1987). In contrast to the cut phenotype, inactivation of topo II 
in mammalian cells can lead to a wide variety of phenotypes, each resulting from 
the specific time in the cell cycle when the enzyme is inhibited. This is probably due 
to the sheer size of mammalian chromosomes, which makes it easier to visualize 
changes in their morphologies. Topo II inactivation in metaphase blocks sister 
chromosome segregation; its inactivation in G2/M prevents segregation as well as 
chromosome resolution. In addition to these two phenotypes, mammalian cells in 
which topo II has been inactivated in G2 also fail to achieve chromosome 
individualization (Clarke et al., 2009). 
 
DNA Catenation and Sister Chromatid Cohesion 
Sister chromatid cohesion (SCC) is integral for chromosome integrity, not 
only it is necessary for correct chromosome segregation in mitosis (Nasmyth, 2005), 
but it also seems to be required for DSB repair through homologous recombination 
(Ledesma & Aguilera, 2006). The current view is that the conserved cohesin 
complex tethers sister duplexes together by embracing them within its ring-shaped 
structure (Haering et al., 2008). The cohesin complex, formed by the Structural 
Maintenance of Chromosomes (SMC) proteins Smc1 and Scm3, the kleisin subunit 
Scc1 and Scc3 (Figure 7-1), mediates sister chromatid cohesion from S phase until 
the metaphase to anaphase transition, when the protease separase cleaves Scc1 
(Uhlmann et al., 1999; Uhlmann et al., 2000). Two main lines of research support a 
major role of the cohesin complex in establishing and maintaining SCC: cohesin 
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mutants display increased distance between sister loci (Guacci et al., 1997; 
Michaelis et al., 1997), and cohesin binding to chromatin mirrors the SCC cycle 
(Michaelis et al., 1997), with non-cleavable cohesin preventing sister chromatid 
segregation (Uhlmann et al., 1999) and inducing cleavage of the cohesin complex 
early resulting in premature segregation (Uhlmann et al., 2000). However, it is 
becoming increasingly clear that other pathways contribute to SCC, especially 
considering the fact that the penetrance of the phenotype of cohesin mutants is 
locus dependent (Figure 1-9; Antoniacci & Skibbens, 2006; Ciosk et al., 2000; 
Diaz-Martinez et al., 2008; Guacci et al., 1997; Michaelis et al., 1997; Sullivan et al., 
2004; Toth et al., 1999). 
 
Figure 1-8. Penetrance of cohesin mutants is locus dependent in budding yeast 
Tet and lac operators can be introduced into a given locus along budding yeast 
chromosomes, and SCC can be assessed using Tet- or lacR-GFP fusions. The 
absence of functional cohesin complexes affects SCC differently among the distinct 
loci studied so far. For example, SCC at the rDNA locus is hardly disturbed upon 
cohesin inactivation (only 10% of the cells show SCC defects), whereas telomeric 
SCC is almost completely dependent on an active cohesin complex (86% of the 
cells show premature sister chromatid separation; (1) Antoniacci & Skibbens, 2006; 
(2) Lam et al., 2006, (3) D’Amours et al., 2004). 
 
In fact, the first formally proposed mechanism of SCC suggested that 
cohesion was provided by topological intertwinings (Tschumper & Carbon, 1983; 
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Murray & Szostak, 1985; Holm, 1994; Koshland & Hartwell, 1987; Spell & Holm, 
1994). This idea was supported by studies that reported the presence of intertwines 
before anaphase (Uemura & Yanagida, 1986; Holm et al., 1985). Because 
catenation occurs as a by-product of DNA replication (Sundin & Varshavsky, 1980), 
it physically couples replication to cohesion. In contrast, cohesin couples replication 
to SCC biochemically, and replication can proceed to completion in the absence of 
the cohesin complex (Diaz-Martinez et al., 2008). The levels of chromosomal DNA 
catenation are controlled by topo II and it has been proposed that this enzyme 
could reinforce cohesin–based SCC (Bachant et al., 2002). In fact, a number of 
studies suggest that both catenation and the cohesin complex are required for 
sister chromatid cohesion, and both need to be removed to achieve complete and 
correct segregation (Deehan-Kenney & Heald 2006; Diaz-Martinez et al., 2006; 
Toyoda & Yanagida, 2006). In budding yeast, it has been proposed that the 
contribution of sister chromatid intertwining towards cohesion also is locus-specific 
(Diaz-Martinez et al., 2008). Indeed, while the segregation of the majority of the 
genome is marked by cohesin removal, underscoring the role of the cohesin 
complex, the rDNA locus segregates later (Koshland & Guacci, 2000). Introducing 
an ectopic decatenase that cannot be subjected to endogenous regulation speeds 
up the rDNA segregation, suggesting that catenanes at least partly mediate 
cohesion at this locus (D’Ambrosio et al., 2008a). Moreover, topo II seems to play a 
role in modulating the levels of tension between sister kinetochores at mitosis 
(Porter & Farr, 2004): topo II inactivation in DT40 cells arrested in prometaphase 
due to cohesin depletion restores biorientation of chromosomes at the metaphase 
plate and deactivates the spindle assembly checkpoint (Vagnarelli et al., 2004). 
Similar observations have been reported in budding yeast (Dewar et al., 2004). 
Depletion of condensin has analogous effects after cohesin removal in Drosophila 
(i.e. cells progress through prometaphase; Coehlo et al., 2003), perhaps by 
interfering with topo II–mediated resolution of sister chromatids. These 
observations together suggest that the residual catenation could contribute to sister 
chromatid cohesion (Porter & Farr, 2004). 
On the other hand, it was shown in budding yeast that ≤5% of a 14 kb 
minichromosome population is catenated prior to anaphase, which argues for a 
transient nature of intertwinings as well as their dispensability for SCC (Koshland & 
Hartwell, 1987). However, later studies have shown a size dependency effect on 
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the levels of detectable catenation in minichromosomes: while very small plasmids 
(i.e. <5 kb) are hardly detected as catenated topoisomers in wildtype cells (Ivanov 
& Nasmyth, 2007; Farcas et al., 2011), at least 20% of minichromosomes that are 
>20 kb are catenated in cells arrested in metaphase (Farcas et al., 2011; Charbin 
et al., 2014). Furthermore, it is known that minichromosomes are up to two orders 
of magnitude less efficiently segregated than endogenous chromosomes (Koshland 
& Hartwell, 1987), and it can be argued that the reduction in faithful segregation 
may be due to lower SCC levels in the absence of intertwinings.  
In bacteria, the intertwining of sister DNA duplexes is, at least partly, 
responsible for chromatid cohesion (Wang et al., 2008). Topo IV inactivation 
inhibits locus separation; conversely, increasing the levels of the decatenase 
reduces cohesion substantially, suggesting that catenanes mediate sister 
chromatid cohesion in this system (Wang et al., 2008). Nevertheless, cohesion by 
physical DNA intertwining could be a peculiarity of systems where there is hardly 
any temporal separation between DNA replication and chromosome segregation, 
with strictly controlled, dedicated cohesion mechanisms playing a more prominent 
role in organisms with distinct S phase and mitosis. It would be interesting to find 
out the relative contribution of precatenation to sister chromatid cohesion in 
bacteria and archaea that experience clearly separated DNA replication and 
segregation (Wang et al., 2008).  
The complete picture regarding the interplay between cohesin–mediated SCC 
and topo II–driven decatenation is far from being elucidated. Theoretically, using a 
protein structure to maintain SCC would facilitate efficient and simple chromatid 
segregation— the forces keeping the protein complex together are probably 
weaker than those holding a catenane, and alternative ways to disengage the 
complex would still be attainable. If intertwinings contribute towards SCC, 
decatenation should be controlled in time (ensuring complete removal of 
intertwines by anaphase) and also in space, especially if catenanes are mobile 
along chromosomes (Bermejo et al., 2008). Up to very recently, it was very difficult 
to foresee how such temporal and spatial control could be achieved. On the other 
hand, it is becoming progressively more evident that topo II is subject to regulation 
(See section 1.5). Thus, it is plausible that proper SCC results from a balance 
between cohesin, catenation and possibly other mechanisms, and that their relative 
contributions vary across genomic loci. 
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1.3.6 Topoisomerases and chromosome condensation 
Prior to sister chromatid segregation, cohesed sisters undergo condensation 
or protein–mediated packaging of the DNA (Hirano, 2010). Condensation is thought 
to be crucial for two processes, namely sister chromatid resolution and axial 
compaction, i.e. reduction of the length of chromosomal arms to prevent potential 
damage by cytokinesis (Hirano, 2000). Condensation, which is indispensable for 
accurate chromosome segregation, involves a highly coordinated folding of 
chromatin, yet is a poorly understood process at the molecular level (Cuvier & 
Hirano, 2003).  
It is now well established that the evolutionarily conserved condensin 
complex determines mitotic chromosome architecture and stability through its role 
in chromosome condensation (Thadani et al., 2012). It is composed of the SMC 
ATPase subunits Smc2 and Smc4, as well as a kleisin subunit (CAP-H/Brn1 in 
budding yeast) and two HEAT-repeat subunits CAP-D2 and CAP-G (Ycs4 and 
Ycg1; Figure 7-1; Cuvier & Hirano, 2003; D’Ambrosio et al., 2008b). Interestingly, 
condensin purified from mitotic Xenopus extracts can introduce (+) sc on plasmid 
DNA in the presence of topo I in vitro, an activity that requires ATP hydrolysis and 
involves the wrapping of two oriented gyres of DNA around the complex (Bazzett-
Jones et al., 2002; Cuvier & Hirano, 2003; Kimura & Hirano, 1997). In the presence 
of type II topoisomerase, purified Smc2/4 promotes knotting of supercoiled plasmid 
DNA (Stray & Lindsley, 2003), and this behaviour is also observed in the presence 
of an ATP hydrolysis defective Smc2/4 dimer (Stray et al., 2005). However, how 
this in vitro activity translates into the condensation process in the cell remains 
largely unknown (Cuvier & Hirano, 2003). In vivo, condensin has been found to 
promote chromosome recoiling during budding yeast anaphase, which in turn 
triggers sister chromatid separation (Renshaw et al., 2010). 
Topo II, on the other hand, is also essential for chromosome condensation 
(Uemura et al., 1987), but again the mechanism through which it contributes to 
mitotic chromosome organization is unclear, with both structural and enzymatic 
roles having been suggested as important towards this means (Cuvier & Hirano, 
2003). Strikingly, the failed chromosome segregation phenotypes of topo II 
(Uemura et al., 1987) and condensin (Bhalla et al., 2002; Saka et al., 1994; 
Strunnikov et al., 1995) mutants are very similar, which has pointed to the 
Chapter 1 Introduction 
42 
 
hypothesis that chromosome condensation may drive topo II–mediated 
decatenation in mitosis (Hirano, 2000; Holmes & Cozzarelli, 2000). In Xenopus egg 
extracts, chromosome assembly after DNA replication takes place in two 
temporally distinct steps: first, topo II binds chromatin forming a topo II axis, 
followed by condensin–mediated compaction (Cuvier & Hirano, 2003). 
In E. coli, the functional analogues of the SMCs are the Muk proteins, MukB, 
MukE and MukF (from the Japanese word for anucleate, mukaku).  It has been 
established that both MukB and topo IV are required for efficient chromosome 
segregation (Hirano, 2010), and the interaction between the two complexes has 
been inferred from live-cell imaging (Nicolas et al., 2014) and shown in vitro 
(Hayama & Marians, 2010; Li et al., 2010). The C-terminal domain of ParC 
(Hayama & Marians, 2010), a region predicted to act as the geometry sensor of 
topo IV (Hirano, 2010; Corbett et al., 2005), interacts with the hinge of MukB 
(Hayama & Marians, 2010; Li et al., 2010). This interaction substantially stimulates 
topo IV–mediated relaxation, and, to a lesser extent, decatenation (Hayama & 
Marians, 2010; Li et al., 2010). However, why the interaction stimulates relaxation 
over decatenation, and what the influence of the whole MukBEF complex (rather 
than MukB-hinge or MukB alone) on topo IV function is, are still not understood. 
How do these in vitro results translate into the cellular processes that drive 
condensation and segregation? The MukBEF complex normally associates with the 
origin region of the bacterial chromosome (Nicolas et al., 2014), presumably to 
position it, and is displaced from the termination region by MatP (Nolivos et al., 
2016). One possibility is that MukBEF recruits topo IV through a physical 
interaction (Hayama & Marians, 2010) and directs its activity to decatenate different 
regions of the chromosome in a timely manner (Nolivos et al., 2016). Alternatively, 
MukBEF binding to DNA may alter its topology and make it a preferred substrate 
for topo IV catalysis (Zechiedrich et al., 1997). This hypothesis has also been 
proposed for eukaryotic condensin, from experiments using centromeric 
minichromosomes in the absence of topo II (Baxter et al., 2011; Baxter & Aragon, 
2012), although whether this scenario represents the situation of native 
chromosomes in unchallenged cells is questionable. 
In eukaryotes, it is yet unclear whether there is a physical interaction 
between condensin and topoisomerase II. Both the condensin complex and topo II 
colocalize to the axial region of mitotic chromosomes and cofractionate into the 
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chromosome scaffold (Farnshaw et al., 1985; Hirano, 2010; Maeshima & Laemmli, 
2003). Genetic analyses suggest that there is a functional interaction (Coehlo et al., 
2003); nevertheless, evidence for direct interaction is mostly lacking (Bhalla et al., 
2002; Charbin et al., 2014; Lavoie et al., 2002), with the only exception reported in 
Drosophila melanogaster embryos (Bhat et al., 1996). In budding yeast, there is a 
statistically significant degree of colocalization, as determined by immunostaining 
on spread chromosomes and ChIP-on-chip (D’Ambrosio et al., 2008b), although 
these do not necessarily imply direct interaction. 
Nevertheless, there seems to be an evolutionarily conserved functional 
interaction between condensins and type II topoisomerases that is of particular 
significance for mitotic chromosome organization and overall chromosome 
architecture. 
1.3.7 Topoisomerases as cellular toxins 
Despite being essential enzymes, type II topoisomerases can be intrinsically 
dangerous due to their ability to create DSBs in the genome (Deweese & Osheroff, 
2009). They form covalent bonds between their active site tyrosyl residues and 
DNA’s terminal phosphates to maintain genome integrity; this DNA-protein 
intermediate is referred to as a cleavage complex (Champoux, 2001; Clarke, 2009). 
Cleavage complexes are transient intermediates in the enzyme’s catalytic cycle, 
and are usually are kept at low levels (and therefore are tolerated by the cell) 
because the cleavage-ligation equilibrium leans toward ligation (Wang, 1996). If 
their concentration is increased significantly, it results in the generation of 
permanent breaks, which ultimately induce illegitimate recombination and 
chromosomal aberrations (Fortune & Osheroff, 2000). In line with this, it is also 
established that high expression levels of wild type DNA topo II in budding yeast 
are known to be cytotoxic (Goto & Wang, 1984; Worland & Wang, 1989). This is 
possibly due to DSBs arising from DNA-tracking machineries colliding into topo II–
DNA intermediate complexes, although other explanations, like aberrantly low 
levels of catenation that could result in insufficient sister chromatid cohesion, have 
not been ruled out. 
To maintain genome integrity, covalently bound topo II–DNA cleavage 
complexes are usually short-lived (Fortune & Osheroff, 2000; McClendon & 
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Osheroff, 2007) and the reaction equilibrium typically favours ligation (McClendon 
& Osheroff, 2007; Schoeffler & Berger, 2008; Wang, 1998), with only 0.5-1% of the 
enzyme being part of such a complex in a reaction mixture (Deweese & Osheroff, 
2009; Liu et al., 1983; Zechiedrich et al., 1989). Moreover, the relatively low 
abundance of single-stranded breaks— about 1/4-1/2 of the active complexes—
suggests that there must be a high degree of coordination between the two active 
sites of the topoisomerase II dimer (Bromberg et al., 2003); once the first break is 
created, the second strand is usually cleaved ~20-fold faster (Mueller-Planitz & 
Herschlag, 2008). 
The levels of topoisomerase II activity and cleavage complexes must be 
tightly regulated: too low levels may result in residual torsional stress and 
intertwining that will hinder chromosome segregation, too high levels may give rise 
to permanent DSBs (Bender & Osheroff, 2008; D’Arpa et al., 1980; McClendon & 
Osheroff, 2007; Pommier & Marchand, 2005; Wu & Liu, 1997). In mammalian cells, 
these DSBs are recognized and turn on signalling pathways involving Ataxia 
Telangiectasia Mutated (ATM), Ataxia Telangiectasia and Rad3-related protein 
(ATR) or DNA-dependent Protein Kinase (DNA-PK), eventually leading to 
extensive phosphorylation of histone H2AX (Rogakou et al., 1998) within a 
megabase of DNA around the DSBs (Rogakou et al., 1999). Eventually, genomic 
stability might be compromised, as the ensuing DNA damage might lead to 
mutations, chromosomal translocations, and, eventually, cell death (D’Arpa et al., 
1980; Deweese & Osheroff, 2009; Kaufmann, 1998; McClendon & Osheroff, 2007). 
Similarly, type I topoisomerases can pose a threat to genome stability, when the 
enzyme fails to complete the reaction cycle and instead remains as a covalent 
DNA-protein intermediate, which constitutes a bulky DNA lesion that can interfere 
with DNA metabolism (Leppard & Champoux, 2005). 
On the other hand, a number of pharmacological agents have been 
developed in the last few decades to exploit the genome-threatening property of 
topoisomerases. They are typically classified into two classes, namely catalytic 
inhibitors and poisons. Catalytic inhibitors decrease the overall activity of 
topoisomerases, while topoisomerase poisons alter the reaction equilibrium 
towards cleavage, thereby increasing the levels of cleavage complexes, which, as 
described above, can result in permanent strand breaks as DNA-tracking systems 
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collide with the covalently bound topoisomerase (D’Arpa et al., 1980; McClendon & 
Osheroff, 2007; Pommier et al., 1998). 
Topoisomerase poisons are amongst the most widely prescribed anticancer 
drugs, with treatments against most types of cancer deemed curable by 
chemotherapy employing drugs against topo II (Baldwin & Osheroff, 2005; 
Deweese & Osheroff, 2009; Hande, 1998; Martincic & Hande, 2005). Interestingly, 
a number of these compounds are low-toxicity derivatives of natural products that 
have been used as folk remedies for centuries (Deweese & Osheroff, 2009). For 
example, etoposide is a synthetic analogue of Podophyllotoxin, from the mandrake 
plant (Hande, 1998). Topoisomerase-targeted drugs have also been used as 
powerful antibacterials, like the quinolone group (topo II poisons) and the coumarin 
family (gyrase inhibitors; Sissi & Palumbo, 2010). 
1.4 How does topo II act globally? 
DNA relaxation is an energetically favourable reaction. It can be carried out in 
the absence of ATP hydrolysis by type I topoisomerases. The fact that 
nonsupercoiling type II enzymes employ ATP hydrolysis seemed puzzling, until it 
was shown that the reaction carried out by these enzymes simplifies the topology 
of the products beyond the level of equilibrium, i.e. in the presence of ATP and topo 
II, a steady-state distribution narrower than the Bolztmann equilibrium distribution 
achieved by topo I is produced (consistent with the free energy associated with 
supercoiling; Rybenkov et al., 1997). Thus, at least locally, there is no 
thermodynamic mystery: the energy derived from ATP hydrolysis drives the 
reaction away from equilibrium. However, at a global scale, we still cannot explain 
how a small enzyme can alter the topology of the cell’s genome (Stuchinskaya et 
al., 2009; Timsit, 2011), and ensure that, for example, all catenanes are resolved 
prior to anaphase. This is a particularly complex conundrum, considering that the 
complexity of a large DNA molecule is a global property of the assembly and is 
insufficiently described by local protein-DNA interactions (Sissi & Palumbo, 2010).  
Despite the fact that topo II acts on a global scale, it has been suggested to 
cleave DNA at preferred sequences (Capranico & Binaschi, 1998); however, the 
consensus sequence is weak and prediction of scission sites is nearly impossible 
(Capranico & Binaschi, 1998; Deweese & Osheroff, 2009). This suggests that other 
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factors, possibly including local structure, accessibility, and/or flexibility determine 
cleavage (Velez-Cruz et al., 2005). 
A number of models have been put forward to explain how global topology 
simplification occurs, and address the concept of a particular T segment being 
preferred over others in the strand passage reaction (Timsit, 2011). This would 
occur through either geometric or kinetic selection (Figure 1-10). 
 
Figure 1-9. Models for topo II topology simplification 
a) In the kinking model, topo II binding bends the G segment and repositions the 
enzyme with respect to other DNA regions, creating a preference over a particular 
T segment. b) According to the hooked juxtaposition model, the geometry of 
supercoils, catenanes and knots is favoured for recognition by topo II. c) Topo II 
creates a corral effect by tracking along a DNA stretch, progressively making this 
stretch shorter and facilitating the capture of a given T segment. d) Proofreading 
models propose that topo II initially traps a T segment, and an irreversible ATP-
dependent step changes the enzyme-DNA conformation, which in turn favours T 
segment passage over loss. (Adapted from Bates & Maxwell, 2007) 
 
Geometric models propose that the differential probability of the enzyme–T 
segment interaction comes from the local curvature of a given DNA segment. This 
curvature can be introduced by the enzyme, which by “kinking” the DNA creates a 
preferred orientation with respect to the global topology of DNA (Figure 1-10a; 
Vologodskii et al., 2001). Alternatively, geometric selection could come from the 
topoisomer curvature alone (rather than the DNA-enzyme complex), as in the 
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“hooked juxtaposition” model (Figure 1-10b; Buck & Zechiedrich, 2004). Type II 
topoisomerases preferentially associate with DNA crossovers or juxtapositions 
(Zechiedrich & Osheroff, 1990; Roca et al., 1993; Charvin et al., 2003; Charvin et 
al., 2005; Alonso-Sarduy et al., 2011), which can explain why the enzyme would 
preferably bind (+) sc, knotted and catenated DNA, (Stuchinskaya et al., 2009). 
Monte Carlo simulations (Vologodskii et al., 2001) and X-ray crystallography (Dong 
& Berger, 2007) studies support geometric models. 
In contrast, kinetic tracking models propose that the enzyme recognizes a 
third site on DNA, tracks along it reducing the apparent DNA length, and eventually 
traps a T segment in a small loop (thus also called “corral effect”; Figure 1-10c; 
Rybenkov et al., 1997). The trapped segments are more likely to correspond to 
supercoiled knotted or catenated DNA, thereby explaining the eventual global 
topology simplification. While there is some experimental support for topo II binding 
to three sites on DNA (Trigueros et al., 2004), as kinetic tracking requires, 
circumstantial evidence argues against tracking, as the presence of protein 
roadblocks does not affect the topology simplification effect by topo II 
(Stuchinskaya et al., 2009). Finally, kinetic proofreading models have been put 
forward (Figure 1-10d; Yan et al., 1999; Yan et al., 2001) that postulate that the T 
segment preferences may be driven by geometric selection, but amplified through 
an irreversible ATP-dependent step. Experimentally, it has been shown that gyrase 
can capture and release the same T segment without passage (Bates et al., 1996; 
Kampranis et al., 1999). For decatenases, like yeast topo II, it has been reported 
that the rate of ATP hydrolysis can exceed the rate of the strand passage reaction 
(Lindsley & Wang, 1993), however, this does not directly show a proofreading 
effect. 
Overall, there is no consensus to explain topo II topology simplification, and 
the models put forward so far cannot fully account for this effect. Understanding 
topology simplification will require more studies on the properties of different DNA 
crossovers, and how they differentially affect topo II–mediated recognition and 
processing.  
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1.5 Regulation of topoisomerases 
Topology simplification is typically studied in vitro, often with the minimal set 
of components required for topoisomerase function. The main caveat is that these 
experiments largely exclude the potential effects of cellular components that may 
affect topo II-mediated topology simplification, through for example regulating the 
enzyme’s subcellular localization and/or activity (i.e. processivity, reaction rate, 
etc.) or by altering the conformation of the DNA substrate.  
Topoisomerases are abundant proteins in the cell, perhaps unsurprisingly, 
given the huge topological challenges that the cell has to overcome. There are 
many instances when topoisomerase action is necessary: every time a gene is 
transcribed, but most notably when catenanes need to be disentangled during 
mitosis. Several lines of evidence suggest that the activity of these enzymes is 
subject to regulation, activatory or inhibitory. One important example is the 
stimulation of topo I during the transcription pause-release cycle, whereby BRD4–
mediated phosphorylation of the C-terminal domain (CTD) of paused RNAPII 
(which itself triggers release from the pause) enhances topo IB processivity to clear 
out (+) sc as the polymerase starts the elongation step (Baranello et al., 2016). 
Thus, key cell cycle events may fine-tune topoisomerase activities and/or 
localization to coordinate topological rearrangements required for DNA metabolism.  
1.5.1 Regulation of topo II 
Topoisomerase II is the main cellular decatenase, and, due to the potential 
problems that incomplete decatenation can lead to, one might naively assume its 
activity to be constitutive throughout the cell cycle and the genome. However, it is 
becoming progressively clear that many factors may affect topo II catalytic activity. 
First, the CTD of topo II is subject to post-translational modifications, with 
phosphorylation and sumoylation being the two most studied examples (Porter & 
Farr, 2004). Acetylation and ubiquitination of topo II have also been reported, but 
their effects on the enzyme’s functions are more controversial. Moreover, an 
increasing number of factors seem to enhance the catalytic activity of topo II 
through protein-protein interations. Understanding how the function of topo II is 
modulated will help elucidate how topological challenges come about in the cell, 
and whether there are mechanisms that sense them prior to their resolution. 
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1.5.2 C-terminal domain (CTD) of type II topoisomerases 
Intriguingly, the domains that confer topo II catalytic activity are not sufficient 
for its localization to mitotic chromosomes (Linka et al., 2007); instead, it has been 
suggested that the non-conserved C-terminal domain (CTD) has a role in directing 
topo II to chromosomes (Lane et al., 2013). This region is a disordered and poorly 
conserved stretch of 200-300 amino acids (aa), dispensable for the topo II catalytic 
activity (Edgerton et al., 2016) and completely absent in the viral enzymes. Up to 
date, it has been refractory to crystallization, and studies on its function have not 
led to a uniform picture.   
Budding yeast topo II CTD comprises a 250 aa region that has little 
homology with other eukaryotic type II topoisomerases. Deletion of most of the 
CTD (the most C-terminal 209 aa) has no noticeable effect on the enzyme’s 
function in vivo or in vitro (Caron et al., 1994; Jensen et al., 1996). Leaky 
transcription of mutants lacking this fragment (i.e. driven by the repressed GAL1 
promoter, in the presence of glucose) complemented the lethality of the 
temperature sensitive allele top2-4 at restrictive temperature, underscoring the fact 
that low levels of topo II are sufficient to attain viability.  Interestingly, the adjacent 
approximately 40 aa are important for topo II’s in vivo functions, but not its in vitro 
activities (Caron et al., 1994). One possibility is that this stretch is important for 
protein-protein interactions with other cellular entities, as evidenced by the reduced 
nuclear localization of some of truncated topo II proteins (Caron et al., 1994).  
In higher eukaryotes, topo II’s CTD has been implicated in the enzyme’s 
dynamics on chromosomes (Lane et al., 2013; Linka et al., 2007). Deletion of the 
most C-terminal 31 aa of human topo IIα— referred to as Chromatin Tether (ChT) 
domain because it binds DNA and histone H3 in vitro— precluded the stable 
interaction between the enzyme and chromosomes and affected mitotic 
chromosome formation and segregation (Lane et al., 2013). Fluorescence recovery 
after photobleaching (FRAP) analysis showed deletion of the ChT domain resulted 
in an increased mobility of the enzyme on chromosomes (t1/2 of 6.4 s versus 10.3 s 
for wildtype topo IIα; Lane et al., 2013). Given that the activity of topo II is excluded 
from nucleosome-rich regions in vitro (Galande and Muniyappa, 1997), ChT 
binding to histones could present a mechanism to help the enzyme position itself 
along the DNA (Lane et al., 2013).  
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1.5.3 Sumoylation and phosphorylation 
Post-translational modification by SUMO (Small Ubiquitin-like MOdifier) is a 
major, highly conserved protein modification system with a wide impact on cellular 
functions. Vertebrates have three SUMO isoforms, all around 50% identical to the 
budding yeast single SUMO orthologue, Smt3 (Dasso, 2008). The SUMO 
conjugation process resembles that of ubiquitin, with three sequential enzymes (E1, 
E2 and E3), and it can be reversed by highly active SUMO proteases (Dasso, 
2008). Budding yeast topo II modification by SUMO revealed a novel regulation 
mechanism on mitotic chromosomes (Takahashi et al., 2006), shown to also be the 
case in mammalian cells (Mao et al., 2000) and Xenopus egg extracts, where 
inability to properly sumoylate topo II in mitosis affects the enzyme’s association 
with chromosomes and causes aberrant sister chromatid separation (Azuma et al., 
2003). 
Interfering with topo II sumoylation has been reported to hinder chromatid 
separation, ultimately inducing mitotic checkpoint arrests (Diaz-Martinez et al., 
2006) or leading to anaphase bridging (Dawlaty et al., 2008). Because sumoylation 
has been suggested to control topo II localization to centromeres and the axis of 
mitotic chromosomes in vertebrates (Dawlaty et al., 2008; Ratner et al., 1996), it 
has been proposed that this post-translational modification may direct the enzyme 
to sites of residual catenation, as cells transition into anaphase (Diaz-Martinez et 
al., 2006). However, due to the inability to observe catenanes along eukaryotic 
chromosomes, this hypothesis has not been formally confirmed. In yeast, topo II-
SUMO fusion proteins crosslink to centromeric DNA (Takahashi et al., 2006) and 
can accumulate in the nucleolus (Takahashi & Strunnikov 2008). In addition, topo II 
mutants that cannot be sumoylated (top2-SM) exhibit incomplete centromere 
compaction (Bachant et al., 2002). In line with these observations, Smt4 
isopeptidase (which removes the Smt3/SUMO-1 posttranslational modification) is 
required to maintain chromatid cohesion in metaphase (in a cohesin-independent 
manner) at centromeres and centromere proximal regions but not at chromosome 
arms, as determined by separation of GFP-labelled lac operator arrays (Bachant et 
al., 2002).  
More recently, sumoylation of budding yeast topo II CTD has been reported 
to be essential for the recruitment of Ipl1 (Aurora B) to inner centromeres, 
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independently of the Shugoshin-H2A pathway (Edgerton et al., 2016). This finding 
has been complemented with the observation that topo II CTD sumoylation triggers 
the formation of Haspin kinase–topo II complexes in Xenopus egg extracts, and 
Haspin–mediated phosphorylation of H3 in turn promotes Aurora B recruitment to 
centromeres (Yoshida et al., 2016). Together, these observations indicate that 
sumoylation of topo II is required for organization of mitotic chromosomes. 
The topo II CTD also contains sites for cell-cycle dependent phosphorylation 
which putatively modulates the enzyme’s activity and localization, e.g. 
phosphorylation of serine 1212 seems to relocalize topo IIα from the arms to the 
centromeric region of mitotic chromosomes (Ishida et al., 2001; Porter & Farr, 
2004). Moreover, in vitro experiments have shown that topo II can be 
phosphorylated by Aurora B, indicative of mitotic activity (Morrison et al., 2002). 
Protein Kinase C and casein Kinase II have been reported to phosphorylate 
topoisomerase II in vitro in Drosophila (Ackerman et al., 1988; deVore et al., 1992), 
human cells (Sahyoun et al., 1986), budding yeast (Cardenas et al., 1992) and the 
sponge Geodia cydonium (Rottmann et al., 1987), which, in turn, stimulates the 
enzyme’s catalysis 2-3 fold through an increase in the enzyme’s rate of ATP 
hydrolysis (Ackerman et al., 1988; DeVore et al., 1992). Additional lines of research 
are required to fully understand the relevance of topo II CTD phosphorylation and 
its putative effect on the enzyme’s activity during mitosis. 
1.5.4 Protein-protein interactions 
A number of recent studies have identified a number of protein-protein 
interactions between topo II and different cellular factors that affect the enzyme’s 
activity and/or stability. One such interaction is promoted by ATM, which interacts 
with and phosphorylates topo IIα at Serine 1512 (S1512; Tamaichi et al., 2013). 
Interestingly, this phosphorylation seems important for regulating the enzyme’s 
cellular levels, and S1512A mutants display higher protein stability (Tamaichi et al., 
2013). Mitogen-Activated Protein (MAP) kinases have also been reported to 
interact with topo II; for example, phosphorylated Extracellular Signal-Regulated 
Kinase 2 (ERK2) binds to and stimulates topo IIα catalytic activity in vitro and in 
vivo (Shapiro et al., 1999). Other than kinases, chromatin-binding proteins have 
also been reported to regulate topo II. For instance, the chromatin-associated 
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protein High Mobility Group Box1 (HMGB1, from the HMG-box protein family) 
enhances topo IIα–mediated DNA cleavage, which in turn stimulates its catalytic 
activity (Stros et al., 2007). Similarly, the chromatin remodelling BRG1-Associated 
Factors (BAF) complex has been shown to interact with topo IIα, which greatly 
stimulates the enzyme’s activity on chromosomes (Dykhuizen et al., 2013).  
Tumour suppressor proteins have been recently linked to type II 
topoisomerases. In mammalian cells, BRCA1 was found to interact with topo IIα 
during S phase, and affects its ubiquitination (Lou et al., 2005). Strikingly, extracts 
from cells lacking BRCA1 were inefficient at kDNA decatenation in vitro. This 
activity could be rescued by reconstituting BRCA1 in these cells, suggesting a link 
between this tumour suppressor in regulating topo II–mediated decatenation (Lou 
et al., 2005). In line with these observations, it has been recently noted that 
Drosophila topo II interacts with Mus101/TopBP1 (a BRCA1 C-Terminus domain-
containing protein), and abrogation of this interaction results in chromosome 
segregation defects (Chen et al., 2016).  
Although the relevance of these interactions needs to be fully elucidated, a 
picture of complex regulatory networks to control DNA topology is starting to 
emerge. 
 
1.6 Complexities in chromosome organization 
A second caveat of topology simplication assays is that, for simplicity, they 
often use DNA substrates that are possibly different from the endogenous 
substrates. Thus, these assays could be overlooking aspects of DNA topology 
influenced by particular sequences (e.g. protein binding sites) that could in turn 
affect their recognition by topoisomerases. 
Our understanding of chromosome topology is based on findings using 
exogenous plasmids or minichromosomes. Molecular cloning allowed the 
introduction of replicators (Struhl et al., 1979), telomeres (Szostak & Blackburn, 
1982; Szostak, 1982) and centromeres (Clarke & Carbon, 1980; Stinchcomb et al., 
1982) into DNA molecules in order to approach the structure and behaviour of 
natural chromosomes (Murray & Szostak, 1985).  While the mechanisms of 
replication, organization and segregation may be similar for minichromosomes and 
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chromosomes, it has never been directly tested because detailed analysis of 
endogenous chromosome behaviour is technically very difficult. One noticeable 
difference is in stability: linear artificial chromosomes and circular centromeric 
plasmids are at least ~100-fold more prone to mitotic loss with respect to 
endogenous chromosomes, an effect that seems to be dependent on the length of 
the DNA molecule (Murray & Szostak, 1983; Murray & Szostak, 1985). 
Minichromosomes can probably be pictured as small, independent topological 
domains, and, in many aspects, their topological behaviour may not exactly 
emulate that of endogenous chromosomes. Differences in size (typically, 5-40kb in 
minichromosomes versus 230 kb for the smallest budding yeast chromosome (Chr. 
I), protein binding, DNA/chromosomal elements and nuclear localization might 
account for possible differences in their topological states between the two.  
 
1.6.1 Topological domains 
Topological stresses generated by cellular machineries that track along 
DNA are probably confined to closed topological domains and physical barriers 
restrict their diffusion to other chromosomal regions (Postow et al., 2004). 
This idea comes from the widespread view that eukaryotic chromosomes 
are intricately organised, starting with the wrapping of DNA into nucleosomes and 
10 nm chromatin fibres (Kawamura et al., 2010). At larger scales, chromatin 
organisation is thought to involve chromatin-chromatin interactions, as well as 
chromatin tethering to nuclear membranes, possibly mediated by protein factors 
but still incompletely understood (Kawamura et al., 2010). Moreover, it has been 
suggested that entire chromosomes, or chromosomal elements— such as 
centromeres and telomeres— occupy specific positions in the nucleus, as 
evidenced by in situ hybridization and immunofluorescence (Chung et al., 1990; 
Ferguson & Ward 1992; Gartenberg & Wang, 1993). Electron microscopy has 
allowed the visualization of supercoiled loops ranging from 1-300 kb that protrude 
from the amorphous, globular mass in both eukaryotic and bacterial chromosomal 
preparations (Delius & Worcel, 1974; Paulson & Laemmli, 1977). Furthermore, a 
genome-wide study of helical tension in budding yeast using psoralen photobinding 
followed by hybridization of the crosslinked DNA to arrays concluded that different 
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chromosome compartments confined varying levels of torsional stress (Bermudez 
et al., 2010). Together, these results support a view of DNA arranged into 
topological domains, through attachment to chromosomal anchors. 
Micromanipulation experiments have been used to determine which factors 
contribute to the stable and well-characterized elasticity of isolated native 
chromosomes (Marko, 2008). For example, applying a force of 500 pN to newt 
mitotic chromosomes extended them to double their native length; treatment with 
restriction nucleases completely dissolved these chromosomes, pointing at a 
network organization with approximately 15 kb stretches of chromatin strung 
between crosslinks (Poirier & Marko, 2002; Pope et al., 2006). Protease treatment, 
on the other hand, only partially decondenses mitotic chromosomes (Pope et al., 
2006) and, while reducing chromosome stiffness, protease-treated chromosomes 
remain elastic. A role for RNA in stability has been discarded, since experiments 
using RNase showed no relaxation of mitotic chromosomes (Almagro et al., 2004). 
Alternatively, DNA entanglements (i.e. catenation and/or knotting) could be partially 
responsible for organizing chromosome architecture (Kawamura et al., 2010). 
Addition of recombinant topo IIα reduces the native chromosome spring constant 
(i.e. stiffness) by 35% without detectably altering chromosome morphology, in a 
manner that depends on hydrolysable ATP and DNA cleavage by topo II (i.e. the 
effect is abolished in the presence of topoisomerase inhibitors). Because the same 
effect is not observed with topo I or topo III, it suggests that DNA intertwinings and 
knots, but not supercoils or hemicatenanes, contribute to mitotic chromosome 
mechanical stability (Kawamura et al., 2010). Moreover, the 35% decrease 
suggests that the densities of entanglements and of protein cross-linkers should be 
similar: if the former was much larger than the latter, spraying topo II on the 
chromosomes would almost entirely eliminate chromosome elasticity, whereas if 
the opposite was the case, topo II addition would have no significant effect on the 
spring constant (Kawamura et al., 2010). 
The topo II strand passage reaction can also result in catenation and knot 
formation (i.e. entangling activities), which are thermodynamically favoured in 
tightly packed polymers (Arsuaga et al., 2002). Condensing mitotic chromosomes 
are rigidified through ATP dependent cross-linking (Gerlich et al., 2003), which in 
turn could stimulate topo II to add intrachromosomal links (Marko & Siggia, 1997). 
At the end of mitosis, the cross-linkers are removed from chromatin (e.g. 
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condensin), potentially offering a driving force for topo II towards its disentangling 
activities. 
However, few methods are available to investigate intact nuclear 
architecture directly. Most of the aforementioned experiments disrupt the nuclear 
structures and thus may create artificial readouts. In situ hybridization, electron 
microscopy and psoralen binding, which depends not only on superhelical tension, 
but also nucleoprotein structure, must be interpreted with caution. 
Conversely, recent evidence suggests that chromosomal ends may partly 
be able to rotate. Budding yeast cells whose only relaxation activity comes from 
ectopic expression of the bacterial topo I, which acts solely on (-) sc (top1Δ, top2-4, 
pGDP E. coli topA; Gartenberg & Wang, 1993) accumulate (+) sc (ΔLk= +4% with 
respect to wild type), and their overall transcription is largely precluded (Salceda et 
al., 2006). Interestingly, there seems to be a positional dependence of 
transcriptional inhibition, as genes within ~100kb of a telomere are normally 
transcribed, whereas genes in more internal parts of the chromosome experience a 
reduction in transcript levels (Joshi et al., 2010). This effect is observed in all 32 
telomeric regions and is independent of subtelomeric chromatin structure (i.e. it is 
observed in the presence and in the absence of the SIR complexes that organize 
heterochromatin-like structures at subtelomeric regions; Joshi et al., 2010). Thus, it 
seems that torsional stress can dissipate through chromosome ends, suggesting 
that even if telomeres are tethered and confined within a restricted volume (Hediger 
et al., 2002), they are still able to rotate, at least temporarily (Joshi et al., 2010). 
Moreover, the transcriptional stall seen in the chromosomes of these cells is 
gradual, arguing against the presence of barriers delimiting strict topological 
domains, and instead, suggestive of torsional stress slowly diffusing throughout the 
chromosome. 
1.6.2 Chromosome size 
Experimental evidence from minichromosome studies suggests that the 
length of a DNA molecule affects its mitotic stability. For example, linear 
minichromosomes of 55 kb are lost in 1 in 100 mitoses (Murray & Szostak, 1983), 
whereas 100 kb minichromosomes increases the stability by a factor of five; linear 
minichromosomes of 15 kb or less seem to undertake random segregation at 
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mitosis and are much more frequently lost (Murray & Szostak, 1985). The idea that 
chromosome size affects its behaviour is not a new one: it was first suggested by 
Spell & Holm, when they analysed chromosome breakage by PFGE, and noticed 
that in the absence of functional topo II, small chromosome arms were hardly ever 
broken, whereas 1/3 of long chromosome arms, usually at a region centred around 
200 kb from the centromere, exhibited breakage (Spell & Holm, 1994). 
Densitometry quantifications of the smear of breakage products showed that the 
longest chromosome arms exhibited 40% breakage, and that artificial 
circularization of chromosomes did not significantly increase it when compared to 
telocentric chromosomes of sufficient arm length (>320 kb; Spell and Holm, 1994). 
More recently, chromosome length has been reported to influence topological 
stress during replication, as topo I inactivation in budding yeast cells results in a 
late replication phenotype in longer, but not shorter, chromosomes (Kegel et al., 
2011).  
1.6.3 Composition 
Topoisomerases are highly conserved and necessary for genome 
functioning, replication and segregation in all organisms. However, it is less clear 
whether they act uniformly across the whole genome. Recent studies have 
suggested that chromosomes have specialized elements or regions with special 
topological properties and ensuing differential topoisomerase activity requirements.  
 
rDNA locus 
The budding yeast rDNA locus lies on the long arm of chromosome XII, and 
consists of a tandem array of 100-200 copies of a 9.1 kb repeat that contains the 
ribosomal genes. The rDNA array localizes to the nucleolus, where ribosomal rDNA 
is mainly synthesized, and it sequesters Cdc14, an essential phosphatase key in 
regulating mitotic exit (Visintin et al., 1999). This locus reaches full condensation in 
anaphase, later than the rest of the genome, in a manner that depends on the 
recruitment of condensin, which in turn promotes both rDNA sister chromatid 
resolution and subsequent hypercompaction (Guacci, et al., 1994; Sullivan et al., 
2004; D’Amours et al., 2004; Machin et al., 2005; D’Ambrosio et al., 2008a). 
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Why this unique locus requires more than cohesin removal to achieve 
chromatid segregation seems to relate to the high levels of transcription occurring 
at this locus, because interfering with rDNA transcription abrogates the need for 
Cdc14 for rDNA segregation, and partially suppresses the locus segregation 
defects in condensin mutants (Tomson et al., 2006). Inactivation of condensin in 
metaphase (i.e. when all the genome except for the rDNA locus has been 
condensed) prevents correct nucleolar segregation; however, the defect can be 
rescued by ectopic expression of Paramecium bursaria chlorella virus (PBCV-1) 
topo II, but not endogenous yeast topo II (D’Ambrosio et al., 2008a). The 1061 aa 
long PBCV-1 topo II has been described as the minimal type II enzyme because it 
lacks the putatively regulatory C-terminal 260 aa (when compared to the budding 
yeast counterpart) but possesses the properties of eukaryotic topo II and has 45% 
amino acid identity to Drosophila and human topo II (Lavrukhin et al., 2000). 
Interestingly, overexpression of PBCV topo II in wildtype cells sped up rDNA 
segregation, which suggests that anaphase bridging and late segregation of this 
locus is due to persistent sister chromatid intertwinings, and that perhaps the 
regulation of decatenation of this locus could determine segregation timing and 
subsequently its positioning in the daughter nuclei (D’Ambrosio et al., 2008a; 
Gerlich et al., 2003). Altogether, these findings indicate that the rDNA locus might 
have different topological constraints than the majority of the genome, arising both 
from DNA replication and transcription machineries, implying that the roles of 
topoisomerases may be of particular significance at this locus. 
 
Centromeres 
The centromere is the chromosomal locus that organizes the kinetochore, 
where spindle microtubules attach during cell division (Diaz-Ingelmo et al., 2015). 
Centromeres differ across eukaryotes: they are mostly confined long, epigenetically 
defined regions, with a few notable exceptions, like the budding yeast point 
centromere, which is formed by a short, 150-200 bp sequence (Bloom & Carbon, 
1982). Topological analysis of budding yeast centromeres (inserted into 
minichromosomes) revealed that each centromere stabilizes a Lk= +0.6 (Diaz-
Ingelmo et al., 2015). This singular, positively supercoiled, topology, which is 
established through specialized centromeric nucleosomes (Furuyama & Henikoff, 
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2009), could be important for resisting spindle forces and/or during bipolar 
orientation at mitosis (Diaz-Ingelmo et al., 2015). 
Several observations indicate that yeast centromeres (CEN) have 
specialized cohesion properties (Bachant et al., 2002), including the enrichment of 
cohesin complexes at these loci (Blat & Kleckner 1999), the fact that ectopic 
insertion of CEN sequences results in cohesin deposition at those places (Tanaka 
et al., 1999), and that removal of CEN sequences from minichromosomes affects 
their cohesion (Megee & Koshland, 1999). Strikingly, indirect immunofluorescence 
analysis shows that mammalian topo II (particularly the α isoform) accumulates at 
centromeres from prometaphase until anaphase (Taagepera et al., 1993; Gorbsky, 
1994; Rattner et al., 1996; Porter & Farr, 2004). Experiments using GFP-tagged 
topo IIα have shown similar localization patterns, with the enzyme enriched at 
centromeres as well as along axial regions of metaphase chromosomes 
(Tavormina et al., 2002). 
The high mobility of the enzyme in its association with chromosomes, i.e. 
the quick exchange between cytosolic and chromosome-bound topo II depends on 
catalytic activity, as it is inhibited in the presence of inhibitors that trap topo II as a 
closed clamp (Porter & Farr, 2004; Tavormina et al., 2002).  Indeed, methods that 
detect catalytic activity instead of simply the presence of topo II by using poisons 
(e.g. Self Primed in situ labelling, SPRINS, and Differential Retention of 
Topoisomerase, DRT) have shown that “active” topo II accumulates at centromeres 
with a centromere/chromosome arm ratio of ~2.5 in metaphase, and that this 
particular topo II accumulation depends on the heterochromatin structure of the 
centromeric region (Andersen et al., 2002; Agostinho et al., 2004; Porter & Farr, 
2004). Molecular mapping using PFGE has also tracked etoposide-immobilized 
topo II–mediated DNA breaks near centromeres in human and chicken cells 
(Floridia et al., 2000; Spence et al., 2002). The preferential activity of topo II at 
centromeres has also been detected using cleavage assays in Drosophila (Kas & 
Laemmli, 1992), as well as using microscopy in mouse cells treated with etoposide 
(Marchetti et al., 2001). The centromere-specific activity of topo II has not been well 
documented in the yeast systems, although there is some evidence that S. pombe 
topo II interacts with the outer centromere repeats (Murakami et al., 1992), and that 
S. cerevisiae sumoylation of topo II CTD triggers Aurora B recruitment to 
centromeres (Edgerton et al., 2016). Put together, these results suggest that the 
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centromeric region is a preferred substrate for topo II’s catalytic activity during 
mitosis; however, it does seem like there is no role for topo II in kinetochore 
assembly and/or organization, as cells organize functional kinetochores 
irrespective of whether topo II is active or not (Porter & Farr, 2004). The most 
striking centromeric defect of topo II mutants is observed in cells where 
sumoylation is blocked: centromeric fibres acquire an abnormally elongated shape 
in budding yeast cells where the SUMO-machinery is compromised (Bachant et al., 
2002). Similar lines of evidence have been reported in higher eukaryotes (Azuma 
et al., 2003, Mao et al., 2000), although sister chromatid cohesion dynamics is 
slightly different in this case. SUMO-modification of topo II has no detectable effect 
in topo II other than its relocalization to centromeres; however, whether the 
centromeric effect observed in these conditions is a direct consequence of topo II 
or other substrates (e.g. Pds5 is also a sumo-substrate; Stead et al., 2003), is yet 
to be clarified (Porter & Farr, 2004). 
Thus, topo II seems to be preferentially associated with mitotic centromeres. 
However, for now how its activity at this locus is different from the rest of the 
genome is just speculation. 
 
 SMC5/6 binding regions 
Smc5/6 complex has been linked to catenanes and/or DNA replication–
associated torsional stress. This poorly understood SMC complex is formed by 
Smc5/6 and the non-SMC Nse1-6 subunits (Fig. 7-1). Nse1 contains a RING finger 
domain, usually found in ubiquitin ligases, and Nse2 has SUMO ligase activity 
(Gallego-Paez et al., 2014). Smc5/6 has mostly been associated with homologous 
recombination–mediated repair of double-strand breaks, particularly due to 
epistasis with Rad51 (McDonald et al., 2004; De Piccoli et al., 2006). The complex 
associates with chromatin in interphase and largely comes off chromosomes during 
mitosis, a pattern reminiscent of cohesin (Gallego-Paez et al., 2014; Jeppsson et 
al., 2014). Outside its repair function, the role of Smc5/6 remains unclear. A 
number of studies have implicated the complex in chromosome organization, in 
particular in the resolution of DNA linkages arising from replication (Bermudez-
Lopez et al., 2010), replisome progression and rotation (Kegel et al., 2011) and 
organization of repetitive chromosomal regions (Torres-Rosell et al., 2007). 
Interestingly, the number of Smc5/6 peaks increases substantially along 
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chromosome arms— correlating with cohesin-binding sites— when budding yeast 
cells undergo S phase in the absence of functional topo II, suggesting that this 
SMC complex might recognize catenation events (Kegel et al., 2011) In human 
cells, depletion of Smc5/6 retards S-phase progression and affects chromosomal 
structural integrity and topo IIα mitotic localization, indicating that Smc5/6 might be 
important to organize chromosomes during or right after DNA replication (Gallego-
Paez et al., 2014). 
 
1.7  Open Questions  
Topo II is inarguably required to decatenate chromosome intertwinings that 
result from DNA replication. However, there are many questions that remain 
unanswered. We still fail to understand the nature and “life cycle” of catenanes: 
how catenation arises and where along the chromosomes it originates is still to be 
clarified. Moreover, we know little about their distribution: are they stationary or 
mobile along chromosomes? Recent experiments have suggested that while most 
catenanes are resolved by topo II during or shortly after S phase, a small 
proportion of the intertwinings remains until mitosis (Charbin et al., 2014); further 
insights into how and why these interlinks are not immediately removed are 
required. Finally, we do not know what, if any, molecular mechanism coordinates 
decatenation through topo II’s timely activation in anaphase (Haering et al., 2008). 
Insights into the enzyme’s regulation will shed light into its ability to decatenate 
intertwinings at appropriate stages of the cell cycle. Future lines of research need 
to look into these questions in order to understand some of the most basic, 
conserved and intriguing aspects of cellular biology. 
 
1.8 Aim and outline of this thesis 
This project aims to tackle a number of unresolved questions regarding DNA 
catenation. Using budding yeast as a model organism, and taking advantage of its 
powerful genetics, we will try to clarify key aspects of chromosome topology and 
sister chromatid intertwining.  
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The first part of the project investigates the local topologies of native 
budding yeast chromosomes. We will use site-specific recombination to loop out 
specific chromosomal regions and analyse their topologies. We will validate this 
system, and use it to convey previously unavailable information on (1) the 
distribution of catenanes along chromosomes and (2) their formation.  
The second part of the project has a more protein-centric approach, and 
investigates when and where topoisomerases act along chromosomes. For this, we 
will perform ChIP-on-chip in the presence of topoisomerase poisons, which will 
enable us to map the active population of these enzymes.  
We will then attempt to assess the contribution of catenation towards sister 
chromatid cohesion. We will use an ectopic topo II that does not respond to 
putative budding yeast regulation, and measure what effect its decatenating activity 
has on sister chromatid cohesion. 
Finally, the results of this thesis will be discussed and put into perspective in 
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Chapter 2. Materials & Methods 
2.1 Yeast techniques 
2.1.1 Yeast strains 
The genotypes of the yeast strains (of the W303 background) used in this 
work are shown in Table1. 
Table 1. List of strains used in this study  
Strain No.  Genotype 
CSL72 MATa, ade2-1 can1-100 scc1-73::TRP1, ura3::3xURA3::tetO112 
his3::HIS3::tetR-GFP PGAL1- SCC1 (R180D, R268D)-HA3::LEU2, 
CSL141 MATa, ade2-1 trp1-1 can1-100 leu2-3, 112 his3-11,15 ura3-1 GAL 
psi+ (w303 wildtype) 
CSL1397 MATa, ade2-1 trp1-1 can1-100 leu2-3,112 ura3-1 GAL psi+ TOP2-
HA6::HIS3 
AM1 MATa ade2-1 trp1-1 can1-100 his3-11,15 ura3-1, psi+ PGAL1-
Cre::LEU2 loxP::ARS508:: loxP 
AM2 MATa ade2-1 can1-100 leu2-3, 112 his3-11,15 ura3-1 GAL, psi+, 
CRE-EBD78::TRP1 loxP::ARS508:: loxP 
AM3 MATa ade2-1 can1-100 his3-11,15 ura3-1 psi+ PGAL1-Cre::LEU2 
loxP::ARS508:: loxP, top2-4::TRP1 




MATa ade2-1 trp1-1 can1-100 ura3-1 psi+ PGAL1-Cre::LEU2 PADH1-
hENT1-TK(1X)::HIS3 loxP::ARS508:: loxP 
AM6 MATa ade2-1 trp1-1 can1-100 ura3-1 psi+ PGAL1-Cre::LEU2 
loxP::TER501::loxP 
AM7 MATa ade2-1 trp1-1 can1-100 ura3-1 psi+ PGAL1-Cre::LEU2 
loxP::TER301::loxP 
AM8 MATa ade2-1 trp1-1 can1-100 ura3-1 psi+ PGAL1-Cre::LEU2 
loxP::TER301b::loxP 
AM9 MATa ade2-1 trp1-1 can1-100 ura3-1 psi+ PGAL1-Cre::LEU2 
loxP::TER404::loxP 
AM10 MATa ade2-1 trp1-1 can1-100 ura3-1 psi+ PGAL1-Cre::LEU2 
loxP::ARS702::loxP 
AM11 MATa ade2-1 trp1-1 can1-100 ura3-1 psi+ PGAL1-Cre::LEU2 
loxP::TER/CEN1004::loxP 
AM12 MATa ade2-1 trp1-1 can1-100 ura3-1 psi+ PGAL1-Cre::LEU2 
loxP::TER/CEN1004::loxP PMET3-CDC20::TRP1 
AM13 MATa ade2-1 trp1-1 can1-100 ura3-1 psi+ PGAL1-Cre::LEU2 
loxP::TER1004::loxP 
AM14 MATa ade2-1 trp1-1 can1-100 ura3-1 psi+ PGAL1-Cre::LEU2 
loxP::TER603::loxP 




AM15 MATa ade2-1 trp1-1 can1-100 his3-11,15 psi+ PGAL1- PK3- 
ϕ31C::LEU2 attB::klURA3-ARS508-attP::KanMX 
AM16 MATa ade2-1 trp1-1 can1-100 his3-11,15 psi+ + PGAL1- PK3- 
ϕ31C::LEU2 attB::klURA3-TER603-attP::KanMX  
AM17 MATa ade2-1 trp1-1 can1-100 his3-11,15 psi+ PGAL1- PK3- 
ϕ31C::LEU2 attB::klURA3-TELO1R-attP::KanMX 
AM18 MATa ade2-1 trp1-1 can1-100 his3-11,15 psi+ PGAL1- PK3- 
ϕ31C::LEU2 attB::klURA3- TER1004-attP::KanMX 
AM19 MATa ade2-1 trp1-1 can1-100 his3-11,15 psi+ PGAL1- PK3- 
ϕ31C::LEU2 attB::klURA3-TER1417-attP::KanMX 
AM21 MATa ade2-1 trp1-1 can1-100 his3-11,15 psi+ leu2-3,112::PGAL1-Cre-
LEU2 RFB::klURA3 loxP::TER301::loxP 
AM22 MATa MATa ade2-1 trp1-1 can1-100 ura3-1 psi+ PGAL1-Cre::LEU2 
loxP::TER501::loxP 
AM24 MATa RS::HMRE-a2a1-HMRI-TRP1-lacO256::RS PGAL1-R::LEU2  
ade2::ADE2::lacR-GFP 
AM32 MATa trp1-1 leu2-3,112 can1-100 psi+ ura3::3xURA3::tetO112 
his3::HIS3::tetR-GFP PGAL1-CVTOP2-PK3::ADE2 
AM33 MATa ade2-1 trp1-1 can1-100 psi+, ura3::URA3::tetO112 
his3::HIS3::tetR-GFP PGAL1-TOP2-PK3::LEU2 
AM34 MATa ade2-1 trp1-1 can1-100 GAL psi+ ura3::URA3::tetO112, 
his3::HIS3::tetR-GFP PTOP2-TOP2- PK3::LEU2 
AM35 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 psi MnC 
prsrDNA(URA3) 
AM36 MATa trp1-1 can1-100 leu2-3,112 his3-11,15 psi+ MnC 
prsrDNA(URA3) PGAL1-CVTOP2-PK3::ADE2 
AM37 MATa ade2-1 trp1-1 can1-100 ura3-1 psi+ TOP2-HA6::HIS3 
PADH1PDR1(DBD)-CYC8::LEU2 
AM38 MATa ade2-1 trp1-1 can1-100 ura3-1 psi+ TOP2-HA6::HIS3 
PADH1PDR1(DBD)-CYC8::LEU2 ΔPDR5::KanMX 
AM41 MATa ade2-1 trp1-1 can1-100 psi+ TOP2-HA6::HIS3 
PADH1PDR1(DBD)-CYC8::LEU2 ΔPDR5::KanMX ΔPDR3::URA3 
AM42 MATa trp1-1 can1-100 psi+ TOP2-HA6::HIS3 PADH1PDR1(DBD)-
CYC8::LEU2 ΔPDR5::KanMX ΔPDR3::URA3 PGAL1-CVTOP2-
PK3::ADE2 
AM43 MATa ade2-1 can1-100 psi+ TOP2-HA6::HIS3 PADH1PDR1(DBD)-
CYC8::LEU2 ΔPDR5::KanMX ΔPDR3::URA3 TOP1- PK3::TRP1 
AM44 MATa ade2-1 trp1-1 can1-100 psi+ his3-11,15 PADH1PDR1(DBD)-
Cyc8::LEU2 ΔPDR5::KanMX ΔPDR3::URA3 
 
2.1.2 Yeast growth 
Cells were grown in YP (Yeast Peptone; 1.1% w/v yeast extract, 2.2% w/v 
bacto-peptone and 0.0055% w/v adenine) supplemented with 2% w/v glucose 
(YPD) or 2% raffinose/galactose (YPRaff/Gal). Cells carrying constructs of Cre 




recombinase, ϕ31C integrase, Saccharomyces cerevisiae topo II (topo II) and 
Paramecium bursaria chlorella virus topo II (CV topo II) were grown in YPRaff, and 
expression of the respective proteins was induced upon addition of galactose (2% 
final). 
Cells expressing Cdc20 under the control of the MET3 methionine 
repressible promoter were grown in YNB (Yeast Nitrogen Base; 0.8% w/v yeast 
nitrogen base) supplemented with CSM (Complete Supplement Mixture, 
Formedium) minus methionine and with 2% Raff/ Gal.  
For the selection of transformants, YNB agar plates lacking the appropriate 
auxotrophic amino acid were used. In the case of selection of Kanamycin resistant 
colonies, cells were plated on YPD and replica-plated in YPD + geneticin G418 (50 
μg/ml). Sporulation was carried out on sporulation media (100 mM CH3COONa, 20 
mM NaCl, 25 M KCl, 1.5 mM MgSO4, 1.5% w/v agar). 
2.1.3 Cell cycle arrests 
Cell cycle arrests used in this study are summarized in Table 2.  
Table 2. List of cell cycle arrests used in this study 
Arrest From Addition of Construct 
G1 Cycling cells 10 μg/ml α factor N/A 
HU G1 release 0.1 M HU N/A 





G2/M (+spindles) G1 release Methionine PMET3-Cdc20 
 
Mid-log phase (OD600= 0.15) cells of the a-mating type were arrested in G1 
upon addition of the pheromone α factor (1:1000 of a 5 mg/ml stock in MeOH, 
added twice; O’Reilly et al., 2012). Unless G1 arrest was terminal, cells were 
released by washing the α factor with at least seven times the volume of the culture. 
S-phase arrest was achieved by G1 release into YPD/ Raff containing 0.1 M 
hydroxyurea (HU; Sigma). G2/M arrest was induced upon addition of 10 μg/ml 
Nocodazole (Sigma). Cells carrying the construct PMET3-Cdc20 were arrested in 
G2/M by G1-release into rich medium (YPRaff/Gal).  




2.1.4 Yeast Transformation 
Cells were transformed using the standard LiAc procedure. Briefly, ~10 
OD600 units of mid-log phase were spun down (3 krpm 4°C 5 min), washed with 
water and pelleted again (6 krpm RT 2 min). Pellets were washed in 1x TEL (10 
mM Tris-HCl pH 7.5, 0.1 mM EDTA, 100 mM LiAc). 50μl of cells were added to 8 μl 
of DNA (~1 μg) +2 μl 10 mg/ml ssDNA, and mixed with 300 μl TELP (1x TEL 40% 
PEG 3350) by vortexing. Cells were incubated at 25°C for 2-4 h, and heatshocked 
at 42°C for 15 min, after which they were washed with 1 M Sorbitol and plated on 
the appropriate selective plates. 
2.1.5 Mating and tetrad dissection 
MATa and MATα strains were mated by mixing onto YPD plates and 
incubating overnight at RT. Diploids were selected upon restreaking onto double 
selection plates, replated onto sporulation plates and incubated for 5-7 days. Asci 
were treated with 1 M Sorbitol containing lyticase for 10 min at 30°C, after which 
tetrads were dissected onto YPD plates using the MSM400 Dissection Microscope 
(Singer Instruments). Plates were replica-plated onto the appropriate auxotrophic 
plates to enable selection of the correct genotype.   
2.1.6 Spot Dilution assay 
Logarithmically growing cells were diluted to OD600 =0.3, and 10-fold serial 
dilutions were spotted onto YPD plates with or without etoposide. Plates were 
incubated for 2 days at 30°C and photographed. 
2.1 General molecular biology methods 
2.1.1 Cloning 
Cloning was carried out using the In-Fusion® HD cloning kit (Clontech) 
according to the manufacturer’s instructions.  The respective vector and insert 
sequences were amplified using CloneAmp HiFi premix (Clonetech) in a thermal 
cycler under the following conditions: initial denaturation of 98°C 2 min, followed by 
35 cycles of 98°C 10 sec, 55°C 10 sec, 72°C 10 sec/kb, and a final step of 72°C 2 




min. Reaction products were separated on a 1% agarose gel in 1x TAE (40 mM 
Tris pH 7.5, 20 mM CH3COOH, 1 mM EDTA) and purified using the NucleoSpin ® 
Gel and PCR Clean-up (Macherey-Nagel) kit according to the manufacturer’s 
manual. 
2.1.1.1  Plasmids used for strain construction 
LoxP cassette vector 
Evt’I+II, containing the loxP -Kluyveromyces lactis (K. l.) URA3- loxP 
cassette was obtained from T. Kuilmann. Removal of the CYC8 terminator was 
achieved by cutting the vector with NotI and BglII (New England Biolabs, NEB), 
treatment with Klenow (NEB) for 10 min at 37°C and ligation with T4 ligase (NEB) 
overnight at 16°C. Diagnostic restriction digest and sequencing were used to 
confirm the final construct “loxP cassette vector” (Fig 2-1).  
This plasmid was used as template for PCR to introduce the loxP -K. l. 
URA3- loxP cassette in S. cerevisiae cells. The primers used for this PCR had an 
overhang of 50-70 nt homologous to the genomic locus of interest followed by a 
short sequence that annealed to the vector (FWD primer 5’-
…CCGTTGAGTCACTGTCGA-3’; REV primer 5’-… CCATACTTCTTCGGACAT-3’). 
 
Figure 2-1. Schematic representation of the vector containing the loxP cassette. 
The loxP cassette (loxP -K. l. URA3- loxP) was amplified by PCR from this vector, 
with primers annealing immediately upstream and downstream (indicated in purple) 
of the loxP sequences. 
  





We amplified the replication fork barrier (RFB) sequence element (130 bp) 
from S. cerevisiae genomic DNA and cloned it into a plasmid containing the K.l 
URA3 gene using the In-Fusion® HD cloning kit (Figure 2-2). For integration into 
the genome, we amplified the K.l. URA3-RFB cassette with the primers shown in 
Table 3. Integration was confirmed by genotyping and sequencing PCRs. 
Table 3. Primers for integrating the RFB sequence in the genome 












Figure 2-2. Schematic representation of the RFB cassette vector 
This vector contains the RFB sequence from the rDNA repeats for amplification 
and integration of the RFB-K. l. URA3 cassette into the chromosome. 
 
AttB and attP cassette vectors 
For the unidirectional ϕ31C system, the attB-K. l. URA3-attP cassette was 
ordered from and synthesized by geneART © and cloned into the LoxP cassette 
vector backbone using the In-Fusion® HD cloning kit (Fig. 2-3). The primers used 




for this PCR had an overhang of 50-70 nt homologous to the genomic locus of 
interest followed by a short sequenced that annealed to the vector (FWD primer 5’- 
GAATTCCGTTGAGTCACTGTCG…3’, REV primer 5’ 
GAGGCCTCCAATGCAGGTGG…3’). 
 
Figure 2-3. Schematic representation of the attB-K.l URA3-attP cassette vector.  
 
We also constructed a vector containing attP-KanMX, by PCR amplification 
of the vector pFA6-KanMX4 and the attP insert (from attB-K.l. URA3-attP) using the 
primers and In-Fusion® HD cloning kit (See Table 4). 
Table 4. Primers used to clone the attP-KanMX cassette 










The coding sequence of C31 Integrase (codon-optimized for S. cerevisiae 
expression, ordered from and synthesized by GeneART ®) was cloned using the 




In-Fusion® HD cloning kit into p1064, a centromeric plasmid containing the LEU2 
marker and the galactose inducible GAL1 promoter (Figure 2-4).  
 
Figure 2-4. Schematic representation of the PGAL1-Φ31C construct 
PK3-PGAL1-Φ31C was obtained by replacing the Cre ORF in p1064by the Φ31C 




As a reporter plasmid for assessing the catenation levels in the CV topo II 
strains, a centromeric plasmid containing an rDNA repeat was constructed using 
In-Fusion® HD cloning kit. Briefly, the centromeric vector prs316 was linearized 
with SalI (NEB) for 2 h at 37°C, and the 9.1 kb rDNA repeat was amplified from S. 
cerevisiae genomic DNA using primers  (FWD) 5’-
TATCGATACCGTCGACCTCATGTTTGCCGCTCTGATG-3’ and (REV) 5’-
CCCCCTCGAGGTCGACCCAAGAAAGATGTAAGAGACAAGTG-3’. Fragments 
were fused with the In-Fusion® HD cloning kit, and the final construct was isolated, 
confirmed (Section 7.6) and amplified in E. coli (Figure 2-5). 





Figure 2-5 Schematic representation of the minichromosome prs-rDNA 
An rDNA repeat was cloned into prs316, a centromeric 4.9 kb plasmid. The 
difference rDNA elements (RFB, 5S, ARS1200 and 35S), as well as the prs316 
backbone are shown. 
 
2.1.2 Protein analysis 
2.1.2.1 TCA 
2 OD600 units of mid-log phase cells were spun down at (3 krpm 4°C 5 min) 
and pellets were resuspended in 1 ml 20% TCA. Pellets were washed with 1 ml 
Tris-Base and resuspended in 2x SDS loading buffer containing 0.2 M DTT. Glass 
beads were added and cells were broken using a fast-prep at 4°C. Cell debris was 
discarded and samples were boiled at 95°C and spun down.  
 
SDS-polyacrylamide gel electrophoresis (PAGE) and western blotting 
10 μg of TCA extracts (estimated by Bradford analysis) were loaded on a 4-
12% Bis-Tris or 3-8% Tris-Acetate precast gel (Thermo Fisher) and run according 
to the manufacturer’s instructions. Proteins were then transferred to a nitrocellulose 
membrane using the TE 70 PWR semi-dry transfer unit (GE Healthcare) at 25 V 90 
mA for 3 h. Membranes were then rinsed in PBS and blocked in 5% Milk PBS 0.2% 
Tween. 





Table 5. List of primary antibodies used in this work. 
Antibody Source Dilution 
Mouse Anti-V5 (Pk) Serotec (MCA1360) 1:5000 
Mouse anti-HA  (12CA5) Cell services CRUK 1:5000 
Rabbit Anti-Rad53 Abcam 1:1000 
Mouse anti-Myc (9E10) Cell services CRUK 1:2000 
Mouse anti-Tubulin (TAT-1) Cell services, CRUK 1:5000 
Mouse anti-Cre Millipore 1:1000 
Mouse anti-BrdU MBL 1:1000 
 
As secondary antibodies, we used the HRP anti-mouse (sheep; 926-32280) and 
HRP anti-rabbit (sheep; NA934), purchased from Amersham and used at a 
1:15000 dilution. 
2.1.3  DNA analysis 
2.1.3.1 Genomic DNA preparation for Southern Blotting 
10-15 OD600 units of mid-log phase cells were spun down (3 krpm 4°C 5 
min), and pellets were resuspended in 50% EtOH, and kept on ice. Samples were 
pelleted and washed with 1 M Sorbitol, 0.1 M EDTA. Cells were spheroblasted in 1 
M Sorbitol, 0.1 M EDTA, 0.05 mg/ml zymolyase 100T (MP Biomedicals) and 8 μl/ml 
β-Mercaptoethanol for 45 min at 37°C. Spheroblasts were pelleted and incubated in 
0.5 ml 50 mM Tris-HCl pH 7.5, 10 mM EDTA 1% SDS for 30 min at 65°C. 0.2 ml 5 
M KAc was added, and samples were incubated on ice for 1 h. Samples were spun 
down (14 krpm 4°C 10 min) and supernatant was transferred to a new tube, left on 
ice for 1 h and spun down again. Supernatants were again collected in a fresh tube, 
added 1 ml EtOH 100% and left for 10 min at RT. Samples were spun down (14 
krpm RT 3 min), and pellets were subsequently washed with 70% EtOH and air-
dried. 0.3 ml TE buffer containing 1 mg/ml RNase A was added and samples were 
incubated for 1 h at 37°C. Ethanol precipitation (using 200 mM NaCl) was 
performed, and pellets were washed with 70% EtOH and air-dried, before 
resuspending in 0.1 ml TE buffer. 




2.1.3.2 Quantification of DNA concentration 
To determine the DNA concentration in the genomic DNA samples, 
PicoGreen® dsDNA quantitation assay (Invitrogen) was performed using the 
manufacturer’s instructions. Briefly, 1 μl of DNA sample was mixed with 199 μl 
PicoGreen reagent 1:200 diluted in TE buffer on a 96-well plate. After a 5 min 
incubation at RT, the sample fluorescence was measured using a microplate 
reader (wavelengths: excitation ~480 nm, emission~520 nm). Sample 
concentration was calculated from a standards curve obtained using serial dilutions 
of a DNA sample of known concentration (commercial genomic DNA from S. 
cerevisiae, Amsbio; Figure 2-4) 
 
Figure 2-6. PicoGreen standards 
Commercial budding yeast DNA (Amsbio) was serially diluted (1 ng to 1 μg, 1:10 
dilution factor) and mixed with the PicoGreen solution. Sample fluorescence was 
measured and standards calculated averaging the values from three technical 
replicates. 
2.1.3.3 In vitro assays 
2.1.3.3.1 kDNA 
0.2 μg of catenated kinetoplast DNA (kDNA; Topogen) was treated with 
topo II (topo II purified from S. cerevisiae –gifted by C. Bouchoux- or human topo 
IIα, Topogen) in 50 mM Tris-HCl, pH 8.0, 120 mM KCl, 10 mM MgCl2. 0.5 mM ATP, 
0.5 mM DTT for 30 min at 37°C. Reactions were run in 1% agarose in 1x TAE 
buffer. 




2.1.3.3.2 Enzymatic Treatments 
Restriction digest of ~1 μg of genomic DNA with NEB enzymes was set up 
in 20 μl reactions for 2 h at 37°C. Nicking reaction was carried out with Nt.Bpu10I 
(Thermo Fisher) in R buffer (10 mM Tris-HCl pH 8.5, 10 mM MgCl2, 100 mM KCl, 
0.1 mg/mL BSA) for 30 min at 37°C. Topoisomerase II treatment of 1 μg of 
genomic DNA was performed in 50 mM Tris-HCl pH 8.0, 120 mM KCl, 10 mM 
MgCl2, 0.5 mM DTT, supplemented with 0.5 mM ATP using human topoisomerase 
IIα (Topogen) in a 20 μl final volume for 1h at 37°C. 
  Topoisomerase IV (E. coli, Topogen) treatment was carried out as for topo II, 
but in 40 mM Tris-HCl pH7.5, 6 mM MgCl2, 10 mM DTT, 100 mM C5H8KNO4, 50 μg 
BSA/ml and 40 μM ATP. Topoisomerase I (E. coli; NEB) treatment was performed 
as for topo II, but in 50 mM CH3COOK, 20 mM Tris-CH3COOH, 10 mM 
Mg(CH3COOH)2, 100 μg/ml BSA. 
2.1.3.4 1D Gel Electrophoresis  
~1 μg of genomic DNA was loaded on a 0.5% 1x TAE agarose gel and run 
for 12-24 h at 1.5 V/cm on a B3 Self Recirculation System (Thermo Fisher) at RT. 
Gels were subsequently stained with 1:1000 GelRedTM (Biotium Inc.) in 1x TAE 
buffer for 1 h, and a picture was taken to assess the migration of the genomic 
bands and efficiency of digests. 
2.1.3.5 Capillary transfer 
Gels were depurinated with 0.125 M HCl for 15 min, rinsed with water and 
incubated with denaturing solution (0.5 M NaOH, 1.5 M NaCl) shaking at RT for 30 
min. They were rinsed with water and incubated with neutralizing solution (0.5 M 
Tris-HCl pH 7.5, 1.5 M NaCl) for 20 min, followed by a 5 min incubation in 20x SSC 
(0.3 M NaCl, 0.3 M Na3C6H5O7 pH 7.0). DNA was transferred to N+ Hybond 
nitrocellulose membrane (GE Healthcare) through capillary action using absorbent 
paper to soak 20x SSC through the gel and the membrane for 16 h. DNA was 
crosslinked to the membranes using the Stratalinker 1800 UV  (120000μJ).  




2.1.3.6 Southern blotting 
Membranes were prehybridized with QuickHyb Hybridization Solution 
(Agilent) for 1 h at 68°C. Labelled probes were generated using the Prime-It II 
Random Primer Labeling Kit (Agilent), following the manufacturer’s instructions. 
50ng of template DNA in 23 μl volume were mixed with 10 μl random 
oligonucleotide primers, and boiled at 95°C for 5 min. 10 μl of 5x *dATP primer 
buffer (0.1 mM dCTP, 0.1 mM dGTP, 0.1 mM dTTP), 5 μl [α-32P] dATP at 3000 
Ci/mmol, Perkin Elmer) and 1 μl Exo(-)Klenow enzyme (5 U/μl) were added to the 
DNA and incubated for 30 min at 37°C. The reaction was interrupted upon addition 
of 2 μl of stop mix (0.5 M EDTA), and purified using Illustra Microspin G50 column 
(GE Healthcare). Freshly prepared probes were then added to the membranes. 
Hybridization was allowed for 4 h at 68°C. Membranes were then washed twice in 
2x SSC 0.1% SDS for 15 min at RT, and twice in 0.5x SSC 0.1% SDS, rinsed 
briefly in 50 mM Tris-HCl pH 7.5 and exposed overnight using Phosphor screen 
and cassette (Amersham biosciences), prior to scanning on Typhoon 9400 Imager. 
2.1.3.7 Pulsed-field gel electrophoresis (PFGE) 
20 OD600 units of mid-log phase cells were spun down (3 krpm 4°C 3 min). 
Pellets were washed twice in 1 ml SP1 buffer (50 mM citrate/phosphate pH 5.6, 40 
mM EDTA, 1.2 M Sorbitol), and spheroblasted with 0.6 mg/ml zymolyase-100T at 
37°C for 40 min. Spheroblasts were spun down and resuspended in low melting 
point agarose in TSE (10 mM Tris-HCl pH 7.5, 0.9 M Sorbitol, 45 mM EDTA) to a 
final concentration of 108 cells in 100 μl per plug (estimated using a 
haemocytometer). Plugs were solidified at 4°C for 10 min and transferred to 12 ml 
tubes, where they were covered with 3 ml 0.25 M EDTA, 50 mM Tris-HCl pH 7.5, 
1% SDS and incubated at 55°C for 90 min. The solution was replaced with 0.5 M 
EDTA, 10 mM Tris-HCl pH 9.5, 1% lauryl sarcosine, 1 mg/ml proteinase K, and 
plugs were incubated at 55°C for 48 h. Plugs were then washed twice with T10xE 
(10 mM EDTA, 10 mM Tris-HCl pH 7.5) and incubated with T10xE with 0.04 mg/ml 
PMSF at 55°C for 1 h, after which they were washed twice with T10xE. 
Running was performed in a 1% agarose gel (PFGE-grade, Bio-Rad) in 0.5x 
TBE (44.5 mM Tris-HCl pH 7.5, 44.5 mM Boric Acid, 1 mM EDTA) with the 
following conditions: 60-120 sec switch time, 120 angle, 6 V/cm, 14°C for 24 h. The 




gel was subsequently stained with 1x Gel Red for 1 h and destained in distilled 
water overnight, before imaging, capillary transfer and southern blotting, as 
described previously. 
2.1.3.8 Quick genomic prep for PCR 
Genotyping PCRs were performed on DNA extracted using the following 
protocol. A toothpick of cells was resuspended in 0.1 ml lysis Buffer (0.2 M LiAc, 
1% SDS) and incubated at 70°C for 10 min. 0.3 ml 100% EtOH was added, and the 
sample was centrifuged for 3 min at 14 krpm. Pellets were washed with 70% EtOH, 
dried and resuspended in 50 μl EB. 1 μl was used as template for genotyping PCR. 
2.1.3.9 Genotyping PCR 
1 μl quick genomic prep was added to the following reaction: 6 μl Q solution, 
3 μl 10x PCR buffer, 0.5 μl dNTP mixture (25 μM each dNTP), 0.5 μl 10 μM 
Forward primer, 0.5 μl 10 μM Reverse primer, 0.5 μl 5 mM MgCl2, 17.5 μl DW and 
0.5 μl Taq polymerase (NEB), and incubated in a thermal cycler under the following 
conditions: initial denaturation of 96°C 2 min, followed by 35 cycles of 96°C 15 sec, 
50-55°C 20 sec, 72°C 2 min, and a final step of 72°C 5 min. Reaction products 
were separated on a 1% agarose gel in 1x TAE. 5 μl of PCR reaction were treated 
with 2 μl ExoSAP-IT (Affymetrix), and incubated at 37°C for 15 min, followed by 15 
min incubation at 80°C. 3 μl was used as template for PCR Sequencing reaction. 
2.1.3.10 Chromatin Immunoprecipitation (ChIP)-on-chip analysis 
40 OD600 units of mid-log phase cells were collected. For TOP2-HA6, 
CVTOP2-PK3 and TOP1-PK3 analysis, cells were crosslinked with formaldehyde 
(FA; 1.8% final) for 30 min at RT, added glycine (0.125 M final) and incubated for 5 
min at RT. Etoposide- and Camptothecin-treated cells (0.5 mg/ml and 0.1 mg/ml, 
respectively, for 60 min) were not treated with FA. For BrdU incorporation, cells 
were added 200 g/ml 20 min before release from G1 arrest and released into 
YPRaff/Gal containing 0.1 M HU and 200 g/ml BrdU. Cells were added 0.5 M 
EDTA 0.1% NaN3 and kept on ice for 10 min, followed by 3 washes in 0.1 M EDTA 
10 mM Tris-HCl pH 7.5 0.1% NaN3. 




Cells were washed 2x with ice-cold 1x Tris-buffered saline (TBS), and 
resuspended in lysis buffer (50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1 mM 
EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 1 mM PMSF 1x Complete Protein 
Inhibitors), added 1.2 ml glass beads and broken in the cell breaker (Multi-beads 
shocker Yasui Kikai; 14 cycles 30 sec on 30 sec off 2500 rpm). Samples were then 
sonicated (20 cycles, 30 sec on 30 sec off). Cell debris was discarded after 
spinning (15 krpm 4°C 5min) and cell extracts were incubated with antibody (anti-
PK or -HA)-coupled Dynabeads ® Protein A (Thermo Fisher) for 4 h at 4°C. Anti-
BrdU antibody-coupled Dynabeads were prepared using the Dynabeads ® 
antibody coupling kit (Thermo Fisher) according to the manufacturer’s instructions. 
After the incubation, beads were washed twice in each of the following: lysis buffer, 
lysis buffer containing 200mM NaCl and wash buffer (10 mM Tris-HCl pH 8.0, 250 
mM LiCl, 0.5% NP-40, 0.5% Na-deoxycholate, 1 mM EDTA), and once in TE pH 
8.0 DNA was eluted upon incubating the beads with elution buffer (50 mM Tris pH 
8.0, 1% SDS, 10 mM EDTA) at 65°C for 15 min, and crosslinking was reversed 
upon addition of 95 l (input samples) and 120 l (IP samples) TE 0.1% SDS and 
incubation at 65°C overnight. Samples were treated with Proteinase K (37°C, 2 h), 
purified using the Qiagen PCR purification kit, treated with RNase A (37°C, 1 h) 
and cleaned up by PCI extraction and NaCl/ethanol precipitation. Library 
preparation and amplification were carried out using the Sigma® GenomePlex ® 
WGA kit. 7 g of DNA were fragmented with human apurinic/apyrimidinic (AP) 
endonuclease (APE1) in APE1 buffer containing 8 units (U) UDG/reaction. 
Samples were then labelled with Biotin-11-dXTP by rTdT (60 U/reaction), and 
added Oligo B2 (0.05 mM), Eukaryotic Hybridization controls, herring sperm DNA 
(0.1 mg/ml), SSPE (6.25X), Triton-X (0.005%). Mixtures were boiled for 10 min, 
cooled on iced and used to hybridize GeneChip S. cerevisiae Tiling 1.0R arrays for 
16 h at 42°C. Chips were processed with the GeneChip® fluidics station 450 and 
scanned using the GeneChip ® 3000 7G scanner. Analysis was carried out using 
the R package Ringo. 




2.2 Cell biology and Microscopy 
2.2.1 Flow cytometry  
1 ml of culture (OD600 ≥0.15) was spun down and resuspended in 1 ml 70% 
EtOH. After at least 2 h, cells were spun down, resuspended in 50 mM Tris-HCl pH 
7.5 containing 0.1 mg/ml RNase A, and incubated at 37°C for at least 2 h. Cells 
were then pelleted, resuspended in 0.4 ml FACS buffer (200 mM Tris-HCl pH 7.5, 
211 mM NaCl, 78 mM MgCl2, 50 μg/ml propidium iodide) and sonicated for 5 sec. 
100 μl cells were transferred to 500 μl 50 mM Tris-HCl pH 7.5, vortexed and 
processed using the Becton Dickinson FACSCalibur with settings in linear mode 
(FSC threshold: 52, detector: E01, amplifier: 1.4; SCC: detector: 400, amplifier: 1; 
FL2 detector: 750, amplifier: 7).  Data analysis and plots were done using FlowJo 
V.10.1. 
2.2.2 URA3-GFP cohesion assay  
2 ml of mid-log phase cells (OD600 ≥0.15) arrested in G2/M (nocodazole). 
1ml culture was spun down (3 krpm 4°C 2 min), resuspended in 1 ml ice-cold 100% 
EtOH and sonicated for 5 sec. 30 μl melted 1% agarose was loaded onto a slide 
and a second slide was pressed on top, to flatten the agarose. Once solidified, 5 μl 
of cells was added onto the agarose layer and covered with a coverslip. 100 cells 



























Chapter 3. Local DNA topology of budding yeast 
chromosomes 
The aim of this part of the project was to construct a system that would enable 
the investigation of local topologies, in particular catenation events, along native S. 
cerevisiae chromosomes. 
3.1 How to study chromosomal topology: site specific 
recombinases and integrases 
Investigating the topology of linear eukaryotic chromosomes poses a 
technical challenge. Topological information is only retained in topologically closed 
systems, and while in living cells protein factors might act as topological barriers, 
isolation of nucleic acids would ultimately render long linear molecules topologically 
unconstrained. Only circular prokaryotic chromosomes and plasmids retain the 
topological relationships established in vivo, which is probably the reason why they 
have been the preferred substrates for topology assays. Moreover, eukaryotic 
chromosomes are usually orders of magnitude longer than their prokaryotic 
counterparts, making them even more challenging to study. Nevertheless, directly 
understanding the different topologies that occur in eukaryotic chromosomes would 
enhance our understanding of chromosome organization through replication, 
transcription, repair and segregation, and it seems that extrapolating from plasmid 
observations has its limitations.  
Site-specific recombination could provide a powerful tool to study 
chromosome topology, by induction of a recombination reaction that results in 
excision of a covalently closed circle or “loop out”. This experimental set-up would 
require three elements, namely, an inducible recombinase (e.g. expressed under 
the control of an inducible promoter), and two recombinase target sites in tandem 
orientation, placed in the chromosome surrounding a region of interest to be 
excised (Figure 3-1).  
A system like the aforementioned would provide a relatively simple tool to 
study the topology of different genomic loci, with their particular chromosomal 
elements, and would not necessarily lose substantial topological information 




because recombination would be triggered after the locus of interest has 
undergone topological changes in the context of the whole chromosomes.   
 
Figure 3-1. Site-specific recombination to study the local topology of 
chromosomal regions. 
Two recombinase target sites (Rec site) are first inserted in the chromosome. 
Following replication, the sister chromatids may be catenated (upper panel) or not 
(lower panel). Induction of site-specific recombination, or loop out, would produce 
two interlinked circles or two free monomers, respectively. The reaction would also 
leave a recombinase target site in the remaining (linear) chromosome (not shown). 
 
In order to study chromosome topology, we decided to use the Cre/loxP 
system, because it has been well characterized and previously used in budding 
yeast. The Cre protein of phage P1 is a member of the large tyrosine recombinase 
family (see Section 1.3.1), which also comprises the λ Int protein and the yeast Flp 
recombinase (Grainge & Jayaram, 1999). Their active site motif contains an RHR 
triad and a tyrosine nucleophile, similarly to the RKRH motif from type IB 
topoisomerases, and they perform a recombination reaction that involves formation 
and resolution of a Holliday junction by a tetramer of the recombinase (Grainge & 




Jayaram, 1999). Tyrosine recombinases act on a pair of identical recombination 
sites, and thus their reaction can be bidirectional.  
We will use Cre recombinase–mediated excision of chromosomal loci 
surrounded by loxP sites, hereby referred to as “loop out”. Similar loop out 
approaches have been previously taken with R recombinase (Chang et al., 2005; 
Gartenberg et al., 1993; Raghuraman et al., 1997) and Flp recombinase (Bi and 
Broach, 1997), although these were performed to study heterochromatin 
establishment. These previous loop out sizes were small (2-7 kb) and possibly their 
size precluded the maintenance of certain topologies. Based on previous 
minichromosome experiments showing a correlation between DNA molecule size 
and catenane accumulation (Charbin et al., 2014), we reasoned that loop out sizes 
between 7.5-18 kb would offer a good trade-off between efficient recombination 
and retention of meaningful topologic information.  
3.2 Establishing a Loop Out system 
3.2.1 Construction of strains 
A number of regions of interest were identified for loop out, pertaining to 
what we divided into three groups of chromosomal features: replication, SMC 
complexes and sequence elements (although in most cases, there is an overlap 
between at least two groups). Replicon loop outs contained either an efficient 
replication origin or a replication fork merge zone, where replication is expected to 
terminate with relatively high frequency (based on genome-wide analysis of 
Okazaki fragments from McGuffee et al., 2013). This first group was designed with 
the purpose of testing the termination model for catenation (introduced in Section 
1.3.3). SMC loop outs were designed to investigate topological differences between 
regions of cohesin and/or condensin enrichment and regions where these 
complexes are not substantially detected. Cohesin and condensin binding sites 
were identified by ChIP-on-chip analysis of Scc1 (Ocampo-Hafalla et al., 2007) and 
of Brn1 (D’Ambrosio et al., 2008b), respectively. Finally, the sequence element 
loop outs contained endogenous sequences that have unique features in terms of 
chromosome replication and/or organization, such as centromeres and 
ribosomal/tRNA genes. A list of the strains, the positions of their respective loxP 
sites, and predicted loop out sizes, is shown in Table 6. 














TER501 (V) TER, CH, CN -0.499 69508 86765 17257 
ARS508 (V) ARS, CH, CN, 
tRNA 
0.919 84667 102414 
17747 
TER301 (III) TER, CH -0.404 48222 66258 18036 
TER301b (III) TER, CH, -0.404 54930 66258 11328 
TER603 (VI) TER, CN -0.642 176871 184501 7630 
TER701 (VII) TER -0.453 859733 870128 10395 
TER404 (IV) TER, CH, CN, 
ribosomal gene 
-0.580 489031 500957 
11926 
TER1004 (X) TER, CEN, 
CHBS 
-0.504 425102 436770 
11668 
TER: termination region; ARS: autonomous replication sequence; CEN: 
centromere; CH: cohesin binding site; CN: condensing binding site; LO: loop out. 
Efficiency is an estimate of the proportion of a cell population that fires a given 
replication origin (Efficiency: from 0 to 1; McGuffee et al., 2013), or experiences 
fork convergence at a given termination region (Efficiency: from -1 to 0; McGuffee 
et al., 2013). 
 
All loop out loci contain at least one essential gene (according to the 
Saccharomyces Genome Database www.yeastgenome.org) between the loxP sites 
in order to counterselect for spontaneous recombinants prior to Cre induction. 
Strain construction consisted of five steps: (1) integration of the cassette upstream, 
(2) excision of K. lactis URA3-loxP through URA3 counterselection on 5-Fluoorotic 
Acid (5-FOA) plates, (3) integration of the cassette downstream, (4) excision of K. 
lactis URA3-loxP on 5-FOA plates (Figure 3-2) and (5) introduction of the 
recombinase Cre. Genotyping PCR and sequencing were used to confirm that 
each step occurred successfully. Lists of tagging and sequencing primers are 
provided in the appendix (Section 7.3, Tables 9 & 10). 





Figure 3-2. Schematic of the loop out strain construction strategy 
To target loxP-K. lactis URA3- loxP cassettes to the genomic site of interest, the 
cassette was amplified using integration primers that contain 60 bp of homologous 
sequence (H) to the regions flanking the target site and transformed into WT cells. 
Positive transformants were grown on 5-Fluoroorotic acid (5-FOA) plates, to select 
for URA3- loxP excision events that yielded a single loxP in the chromosome. The 
same procedure was used to integrate a second loxP at a downstream genomic 
location (not depicted). PCR and sequencing confirmed the integrations of loxP 
sites. R.O.E: Region of excision; Chr: chromosome; K.l: Kluyveromyces lactis. 
 
3.3 Technical optimization of the topological analysis of 
chromosomal loop outs 
Initial experiments revealed that topological analysis of looped out 
chromosomal regions is more difficult than studying minichromosomes. Separation 
from the rest of the genomic DNA and detection with specific probes are simpler in 
the case of minichromosomes, probably because of their putative topological 
independence from the genome and the fact that they carry unique sequences, like 
the bacterial ampicillin resistance gene.  




3.3.1 Optimization of topological analysis through southern blotting 
Trial runs were performed to determine the right conditions to resolve the 
different loop out topoisomers, testing the length of the electrophoretic run and the 
voltage (not shown). To obtain high quality genomic DNA samples, we also tried a 
number of precipitation steps (Figure 3-3). This was driven by the observation that 
the migration of some of the samples was probably affected by salt and/or protein 
contaminants (not shown), and we therefore looked for additional DNA purification 
steps that could improve the quality of the samples. Using a strain where the 
predicted TER501 was surrounded by two loxP sites, we arrested cells in G2/M by 
adding the microtubule depolymerizing drug nocodazole, and induced Cre 
expression from the GAL1 promoter by adding galactose. We collected samples 
every 30 min for 2 hr, and extracted genomic DNA as described in Section 2.1.3.1. 
The last timepoint (120 min) was divided into six samples: one was left as a control 
and the rest (a-e) were further purified through five different procedures (Figure 3-
3a).  
 
Figure 3-3. Optimization of genomic DNA extraction.  
Cells were arrested in G2/M, Cre expression was induced and samples were 
collected every 30 min for DNA isolation. a) The 120 min timepoint was split into 6 
samples, 5 of which were further processed as follows: (a) CH3COONa/ethanol 
precipitation, (b) magnetic beads clean up (chemagic SEQ Pure20, Perkin Elmer), 
(c) column based purification (Microcon YM10, Millipore) (d) 
CH3COONH4/isopropanol precipitation (e) 4% (w/v) PEG 8000/30 mM MgCl2. b) 
Southern blot analysis of the aforementioned samples. *: looped out species, Non-
LO: non-looped out. 




However, it seemed like these extra steps led to loss of some species 
(Figure 3-3 lanes a-e, bottom band), and in some cases, to the artefactual 
enrichment of others (Figure 3-3 lane c). Thus, we did not include these purification 
steps in our protocol. 
In addition, we noticed that some of the enzymatic treatments were not 
robust (i.e. not removing their expected substrates), particularly treatment with topo 
II to ascertain the identity of catenated topoisomers. To identify the enzymatic 
inhibitors, we performed kinetoplast DNA (kDNA) decatenation reactions in the 
presence of some potential contaminants that could have been carried over from 
the genomic DNA preparations (Figure 3-4). In this assay, we use kDNA from the 
trypanosome Crithidia fasciculata (Topogen), which is formed by a network of 
catenated 2.5 kb circular DNA molecules. During electrophoresis, catenated kDNA 
remains in the well of the gel, whereas decatenated circles are able to enter the gel 
and migrate through the agarose.  
  
Figure 3-4. kDNA decatenation assay to determine which steps in the genomic 
DNA preparation protocol might inhibit topo II activity 
The ability of topo II to decatenate kDNA in the presence of various reagents used 
for the genomic DNA preparation was assessed. (a) SDS had an inhibitory effect 
that could be ameliorated by addition of Triton X-100. (b) Acetate and EDTA also 
had an inhibitory effect on topo II activity. 
 
Both acetate and SDS inhibit topo II activity, but this effect can be overcome 
by using NaCl (instead of CH3COONa or CH3COONH4) in the precipitation steps of 
DNA), and triton, which neutralizes the effect of SDS. 




Finally, to detect the different loop out molecules, we designed a number of 
probes that aligned to unique genomic regions (as determined by single hits upon 
BLAST analysis with default parameters; Altschul et al., 1990). Preliminary 
experiments were conducted to determine the sensitivity and stringency of the 
probes, and showed that some probes hybridized non-specifically (Figure 3-5). To 
select appropriate probe for each loop out, we arrested cells in G2/M (nocodazole), 
induced Cre expression and collected samples for DNA isolation after 90 min. We 
either ran the sample untreated, or treated it with restriction enzymes. Restriction 
digest would allow us to easily distinguish between excised loop outs and non-
recombined chromosomal regions, by producing two differently sized bands. Figure 
3.5 shows a representative example of this procedure: before recombination, the 
17.8 kb region around the predicted termination site TER501 is detected as a 2.9 
kb after Bglll digest or as an 8.5 kb band following BamHI treatment. Conversely, 
after recombination these digests would yield bands of 5.8 kb and 13.2 kb, 
respectively (Figure 3-5a).  
 
Figure 3-5. Probe optimization 
For each loop out region, a number of probes were designed and tested using 
genomic DNA samples taken 90 min after Cre induction. For this particular 
termination region, TER501, DNA was ran untreated, digested with BglII or with 
BamHI. (a) Schematic representation of the expected band sizes after the 
respective digests before and after recombination. (b) A number of probes were 
used for hybridization, and those that showed less non-specificity were selected for 
further experiments. For this particular region, probe B was chosen. TER: 
termination region; Chr: chromosome. 
 




Figure 3-5b shows two different probes we tested to detect this region, with 
both Probe A and B detecting the expected bands, but A also detecting additional 
bands. Closer analysis, by BLAST alignments of smaller regions within the probe 
sequence, confirmed additional hits of this probe against genomic loci other than 
the region in the TER501 loop out, explaining the unexpected bands. 
 
3.3.2 Optimization of Cre Recombination 
A potential drawback of our system is that recombination by Cre might not 
be efficient enough to allow the detection of infrequent topoisomers. It is effectively 
the local concentration of recombinogenic sequences that determines how efficient 
the recombination reaction will be (Burgess & Kleckner, 1999). In addition, a 
number of factors can affect site-specific recombinases like Cre, including (1) 
distance between target sites: reaction rate decreases with increasing distance, (2) 
accessibility of target sites: reaction rate decreases if the chromatin target is 
repressed, and (3) recombinase copy number: reaction rate increases with 
increasing copy number (M. Gartenberg, personal communication). 
We also used two different versions of Cre recombinase. First, we tried Cre 
recombinase fused to the human oestrogen-binding domain (EBD), which is 
constitutively expressed from the strong TDH3 promoter (PTDH3), sequestered by 
heat-shock proteins (HSP) and inactive. It is released from HSP following β-
estradiol addition ready to be relocated to the nucleus (Verzijlbergen et al., 2009). 
This system would enable a fast and synchronous loop out. However, 
recombination levels were not very high, because modification of Cre renders the 
enzyme less robust (M. Gartenberg, personal communication), and excision could 
sometimes be detected in the absence of β-estradiol. Therefore, we turned to 
unmodified Cre driven by the inducible galactose promoter (PGAL1). Although 
recombination does take longer, it is more efficient (Figure 3-6) and less leaky (not 
shown). As Figure 3-6b shows, expression of PTDH3-Cre-EBD is higher than PGAL1-
Cre. In terms of activity, however, we observed more efficient recombination by the 
unmodified Cre (Figure 3-6c). Quantification of the looped out species showed that 
excision by Cre was around 3 times more efficient than Cre-EBD (with 40% and 




15% of the DNA corresponding to excised DNA molecules, respectively; Figure 3-
6d). 
 
Figure 3-6. Comparison between the two Cre constructs. 
A region centred at a predicted replication termination region (TER) in Chr. III was 
looped out either using PGAL1-Cre or constitutively expressed PTDH3-CreEBD. a) 
Schematic representation of the two different Cre constructs. b) Western blot 
showing the expression of the two constructs after 1 h in medium without 
galactose. c) Southern blot showing recombination triggered by the two Cre 
versions, PGAL1-Cre and PTDH3-Cre-EBD, which were induced by addition of 
galactose or β-estradiol, respectively. d) Quantification of excised DNA molecules. 
Recombination by Cre-EBD is not as efficient as unmodified Cre. 
 
3.4 Validation of the loop out 
Once optimized, we set out to determine the loop out kinetics by Cre. For this, 
we used a strain where a 17 kb region centred around the predicted TER501 
region in chromosome V was surrounded by two loxP sites. We arrested cells in 
G2/M by nocodazole addition, induced Cre expression and collected samples for 
DNA isolation every 30 min. Loop out was confirmed by restriction digest (Figure 3-
7), genotyping PCR and sequencing (not shown). 





Figure 3-7. Validation of the loop out. 
Cre–mediated recombination of a 17kb chromosomal region centered around 
TER501 was investigated in G2/M arrested cells (nocodazole). Cre was induced 
upon addition of galactose and samples taken every 30 min. (a) Schematic 
showing the expected sizes of looped out and non-looped out bands after BamHI 
digestion. (b) Southern blot of time-course samples treated with BamHI (upper 
panel). (c) Western blot showing Cre levels during the time-course. 
 
We estimated the proportion of cells that had undergone recombination by 
quantifying the two bands after digest using the Typhoon 9400 Imager and ImageJ. 
Loop out efficiency reached 70-75% 120 min after Cre induction. Recombination 
usually plateaued around 90 min, with no marked increase in loop out levels after 
this time point. Smaller loop outs (<12 kb) had similar recombination kinetics but 
showed slightly higher efficiencies, of around 80-85% (not shown). 
3.5 Topology of a chromosomal region  
We then set out to investigate the pattern of topoisomers. We used the 
samples from the previous experiment, but instead of digesting them with BamHI, 
we ran them untreated (Figure 3-8). Before Cre induction, the single band observed 
corresponds to the unrecombined, or non-looped out (Non-LO) DNA. This band 
persists throughout the time-course because Cre–mediated recombination does 
not reach completion. From 60’ onwards, we see the accumulation of 4 additional 
bands. 





Figure 3-8. Topoisomer pattern of a 17 kb TER loop out in G2/M-arrested cells. 
a) Time-course of Cre-mediated looping out of a chromosomal region in 
nocodazole-arrested cells. The identity of the bands was extrapolated from 
minichromosome studies, and is indicated to the right of the gel. From top to 
bottom: open catenanes, open monomers, supercoiled catenanes, non-looped out, 
and supercoiled monomers. b) Quantification of the different topoisomers. Non-LO: 
non-looped out.  
 
.Extrapolating from minichromosome experiments (Charbin et al., 2014), we 
propose that the two most abundant topoisomers correspond to the monomeric 
loop outs (open/nicked for the slower-migrating band, and supercoiled for the 
faster-migrating one), and that the two less abundant species might correspond to 
the catenated forms of the loop out (the slower migrating band representing the 
open/nicked catenanes, and the faster migrating band representing the supercoiled 
catenanes). Cellular genomic DNA bound by histones would expectedly appear 
negatively supercoiled once deproteinised. However, during the DNA isolation 
process nicking often happens, which is the likely reason why we detect the 
open/nicked conformations of the loop out. The bands that might correspond to 
catenanes constitute about 15% of the looped out species, whereas about 85% of 
the loop out is present as monomeric species. 




3.5.1 Determination of the topoisomer identity 
To confirm the identity of the bands observed, we took two approaches 
(Figure 3-9). We first performed the loop out in different cell cycle stages with the 
underlying reasoning that catenane bands would only appear after DNA replication. 
Secondly, we performed in vitro treatments with a number of enzymes that alter 
DNA topology. 
 
Figure 3-9. Identification of topoisomers produced after Cre–mediated 
recombination. 
Cell cycle synchronization (lanes 1-3) and enzymatic treatments of the recovered 
DNA (lanes 4-7) help identify the topoisomers. Lane 1: genomic DNA before 
recombination; Lane 2: loop out induced in G1-arrested cells; Lane 3: Loop out in 
nocodazole-arrested cells. Lane 4: genomic DNA before Cre induction (sample 1) 
treated with XhoI. Sample 3 was treated with XhoI (lane 5), to reveal the linear form 
of the loop out, with nicking enzyme (lane 6) to reveal open topoisomers, and with 
human topo IIα (lane 7) that removes catenanes and relaxes supercoils. 
 
As predicted from the minichromosome pattern, the less abundant 
topoisomers accumulate only after DNA replication, and are removed by topo II 
treatment in vitro, consistent with what would be expected from catenated species. 
Thus, with this experiment, we confirm that using our site-specific recombination 
system, we can detect catenanes in a TER region in G2/M-arrested cells. 




3.5.2 G1-arrested diploids do not present catenated species 
An important question at this point is whether the topoisomer pattern we 
observe is a reflection of the local chromosomal topology, or rather an artefact of 
our recombination system. One possibility could be that after recombination of a 
non-catenated region after S phase, which would produce two monomeric loop 
outs, endogenous topo II mediates their catenation. To test this, we created a 
diploid strain that can be arrested in G1 (MATa/MATa). We first obtained MATα 
haploids of our loxP::TER501::loxP strain, mated it to the original MATa strain, and 
performed a second mating type switch in the MATα locus in the heterozygous 
diploid. We reasoned that in the scenario where this strain is arrested in G1 there 
should be no catenanes (since DNA replication has not occurred yet), but there 
would still be two monomeric loop outs that could be catenated by topo II (Figure 3-
10a). 
 
Figure 3-10. Induction of the loop out in diploid cells arrested in G1 does not 
produce catenanes and/or unwanted recombination products 
a) Scheme showing how catenanes could be generated by topo II that do not 
reflect the topology of the local chromosome b) Southern blot comparing the loop 
outs performed in haploid and diploid strains in G1 and G2/M (nocodazole) arrests. 
c) FACS showing the arrests in which the respective loop outs were induced. 




When we performed the topological analysis of the diploids, we could see 
that, as in the case of the haploid, diploids only present catenanes after S phase 
(Figure 3-10b & c). The lack of catenated species in the G1-arrested cells suggests 
that the topoisomer distribution we observed is not an artefact of our method, but 
rather a representation of the actual topology of the chromosomal region. 
 
3.5.3 Effect of the spindle on a centromeric Loop out  
Spindle forces affect the topology of minichromosomes; namely, in the 
presence of a spindle, the population of catenated centromeric minichromosomes 
is markedly reduced, compared to a similar arrest in the absence of mitotic spindle 
forces (Farcas et al., 2011; Charbin et al., 2014). It has been proposed that the 
tension exerted by the spindle stimulates topo II–mediated decatenation (Figure 3-
11a). On authentic chromosomes, the spindle effect is expected only around the 
centromere, which is known to undergo pre-anaphase breathing (Ocampo-Hafalla 
et al., 2007). 
We constructed a strain in which the centromeric region of Chr. X (CEN10) 
was surrounded by two loxP sites, and observed that catenanes were readily 
detectable following loop out in nocodazole-arrested cells (Figure 3-11b). To 
assess the impact of the spindle on these catenanes, we first arrested cells in 
metaphase by depletion of the Anaphase Promoting Complex (APC) activator 
Cdc20, and split the culture into two. One half was treated with nocodazole, which 
depolymerizes the mitotic spindle, whereas the other half was mock-treated, 
maintaining its spindle. Figure 3-11c shows that in the absence of the spindle, the 
catenated species are readily visible. In contrast, the presence of the spindle leads 
to a great reduction in these species: quantification revealed a significant (~3-fold) 
decrease in the population of open catenanes (Figure 3-11d). The low number of 
catenanes observed is probably due to the low recombination efficiency (possibly 
as a result of growing the cells in minimal medium to prior to depleting Cdc20). 
Recombination efficiencies in this experiment (3 biological replicates) reached 
about 25%. However, the proportion of catenanes are consistent with previous 
experiments (Figure 3-8): around 15% of the LO species are catenated 
(0.25*0.15=3.75% catenanes in nocodazole-arrested cells). Therefore, like in the 
case of centromeric minichromosomes, spindle forces cause a reduction in the 




catenated loop out population, probably by stimulating topo II–mediated 
decatenation of this chromosomal region. 
 
 
Figure 3-11. Loop out of CEN region in G2/M in the absence or presence of the 
mitotic spindle 
a) Schematic representation depicting the effect that spindle forces have on 
centromeric catenanes, putatively stimulating topo II–mediated decatenation at this 
region. Centromeres are represented by pink circles. b) Southern blot of a 
centromeric loop out (CEN10) in G2/M arrested cells, and the respective in vitro 
treatments to confirm the identities of the topoisomers. c) Effect of the mitotic 
spindle on the topoisomer distribution of a centromeric loop out: cells arrested in 
G2/M with the spindle present exhibit a reduction in the catenated species (left 
lane) compared to cells arrested in the same cell cycle stage in the absence of 
spindles (right lane). d) Quantification of the open catenane population from (c). 
 
3.6 Chromosomal elements & topology 
Together, the experiments described so far suggested that our loop out 
method is able to capture the local topologies of native budding yeast 
chromosomes. So far, we have detected catenaned loop outs of a predicted TER 
site in G2/M arrested cells. We then turned to our research questions. We first 




decided to study the distribution of DNA catenation: where do we find catenanes 
along chromosomes? 
3.6.1 Topologies of replication origins and termination regions 
According to the termination model, catenanes will form at replication 
termination regions (TER) as replisomes converge. In contrast, stable catenanes 
would not be generated at or near replication origins (ARS) if replisome rotation 
during elongation is limited or prohibited. If catenanes were not able to translocate 
along chromosomes, we would expect to find them around TER but not ARS 
regions (Figure 3-12a).  
 
Figure 3-12. Assessing the local topologies of an ARS and a TER loop outs. 
a) Schematic representation of the expected topologies, according to the 
termination model, of TER (top) and ARS (bottom) regions after S phase. b) 
Southern blotting of TER and ARS loop outs (left and right, respectively) from G1 
and G2/M (nocodazole) arrested cells. c) Scc1 ChIP-on-chip experiment showing 
the association of the cohesin complex with the TER and ARS loop outs (Ocampo-
Hafalla et al, 2007). 
 
To test this, we decided to loop out replicated regions encompassing a 
termination site or a replication origin and compare the resulting topoisomers 




(Figure 3-12b). Against our expectations, catenanes were detectable at both 
TER501 and ARS508 after DNA replication, and at similar levels (around 12-15% 
of the loop out species; not shown). This shows that catenanes are not restricted to 
regions of replication termination. Our result could be explained by two alternatives: 
(1) catenanes form at termination regions but get distributed to other regions, or (2) 
precatenane formation gives rise to intertwinings throughout the chromosome. 
 
3.6.2 Catenanes are not restricted to regions of cohesin enrichment 
The cohesin complex has been proposed to protect intertwines from topo II–
mediated decatenation (Haering et al., 2008; Farcas et al., 2011; Charbin et al., 
2014). These observations suggest that catenanes might be indeed maintained at 
cohesin binding sites, where presumably sister chromatids are prevented from 
separating. In fact, in our experiment comparing the TER and ARS topologies, we 
noticed that both loop out regions present substantial Scc1 association (Figure 3-
12c); thus, the association of the cohesin complex could explain the presence of 
catenanes in these regions.  
We set out to compare the topologies between TER loci where cohesin 
association is enriched with loci where cohesin is absent or markedly reduced. We 
took advantage of previously generated Scc1 ChIP-on-chip maps (Ocampo-Hafalla 
et al., 2007), and designed a number of strains where a TER with or without 
cohesin enrichment would be looped out.  
As Figure 3-13 shows, catenanes were detectable at TER regions where the 
cohesin complex is enriched, but not to a greater extent than at TER regions where 
cohesin association was markedly reduced (12% of the loop out species are 
catenanes at TER301, compared with 11% at TER603). We note that there is a 
small Scc1 peak along TER603, and thus we cannot completely discard the 
possibility that, locally, cohesin is required to maintain catenanes. Nevertheless, 
the relative enrichment of cohesin on chromatin does not correlate with the levels 
of catenanes found on these two TER loop outs. Although this does not indicate 
whether the presence of catenanes depends on an active cohesin complex, it does 
suggest that intertwinings are not restricted to cohesin-enriched sites. 
 





Figure 3-13. Analysis of catenane accumulation and cohesin enrichment. 
Scc1 association is enriched around the TER301 region (top left).  Loop of this 
region in G2/M presents some catenated topoisomers (bottom left). Conversely, the 
TER603 region does show substantial Scc1 association (top right). Topological 
analysis of this looped out region shows catenated species, nevertheless. 
 
3.6.3 Catenanes are present at condensin-binding sites 
In contrast to the cohesin complex, the condensin complex has been 
proposed to stimulate topo II–mediated decatenation (Baxter et al., 2011; Charbin 
et al., 2014). We therefore decided to compare the topologies between condensin-
enriched and condensin-free TER regions. Using Brn1 ChIP-on-chip data 
(D’Ambrosio et al., 2008b), we designed a number of strains where a TER with or 
without condensin enrichment would be looped out.  





Figure 3-14. Correlation between DNA catenation and condensin enrichment. 
Brn1 ChIP-on-chip analysis (D’Ambrosio et al., 2008b) and southern blotting shows 
that in G2/M catenanes are present in chromosomal regions with reduced (left) as 
well as in substantial condensin enrichment (right). 
 
Figure 3-15 shows that in both cases, i.e regions of marked condensin 
enrichment and regions of reduced condensin association, catenanes are present 
in G2/M (nocodazole) arrested cells. Quantification of these samples indicated that 
the proportion of the loop out corresponding to catenated species was 10% for 
TER702 and 15% for TER404 (not shown). We note the presence of some 
condensin enrichment at the TER703 loop out and thus we cannot conclusively 
compare between condensin-binding and condensin-free regions. However, the 
similar accumulation of catenanes in both loop out regions suggests that DNA 
catenation (or at least its maintenance during a nocodazole arrest) is not restricted 
to regions where condensin is not markedly accumulated, nor it is excluded from 
condensin-enriched loci.  




3.7 Topology of the loop out during the cell cycle 
3.7.1 Loop out of the efficient replication origin: ARS508 
We next turned to topological analysis of a looped out chromosomal 
segment during cell cycle progression. Only loop outs encompassing a replication 
origin can be used for this purpose because they can sustain DNA replication after 
loop out. We first arrested cells in G1 and induced Cre for 90 min. We then 
released the cells to pass through a synchronous cell cycle and collected aliquots 
for DNA isolation for topological analysis every 20 min (Figure 3-15a). Figure 3-15b 
& c show that in G1, only the monomeric forms of the loop out accumulate; as cells 
go through S phase, the catenated species appear, which are then lost as cells 
rearrest in G1. 
 
Figure 3-15. Analysis of the ARS508 loop out during one cell cycle. 
a) Experimental scheme: exponentially growing cells were arrested in G1; 1.5 h 
into the arrest, Cre activity (and loop out) was induced. 1.5 h later, cells were 
released into the cell cycle, and time points for DNA preparation taken every 20 
min. b) Southern blot showing the topology of the loop out within one cell cycle. c) 
FACS showing cell cycle progression during the experiment. 
 
Quantification of the bands indicated that loop out levels reached 60-65%; 
catenanes reached their maximum levels, 17% of the loop out species, 60 min after 
G1 release (not shown). In contrast, a similar experiment using a 21 kb centromeric 
minichromosome presented a maximum of 31% of the topoisomers as catenanes, 




also 60 min after G1 release (not shown). The slight discrepancy in maximum 
catenane levels might be explained by the different sizes of the substrates (loop out 
is 17 kb; minichromosome is 21 kb), and/or in differential firing efficiencies of the 
replication origins contained within the two DNAs. Nevetherless, in both cases the 
catenated fraction of the DNAs slowly decreased after 60 min, and was completely 
absent by the 120 min time point, when cells were rearrested in G1.  
This experiment emulates studies using minichromosomes in that it follows 
the topology of a DNA molecule outside the chromosomal context. The fact that we 
detect catenated loop out molecules as DNA replication occurs, and that this 
species is no longer detectable upon mitotic exit suggests that our recombination-
based method indeed captures the physiological topology of eukaryotic 
chromosomes. 
 
3.7.2 Chromosome topology of a heterochromatic region 
The experiments presented above have examined the topology of 
chromosomal regions with similar ‘open’ chromatin structure. Open chromatin could 
allow the translocation or distribution of catenanes along different chromosomal 
regions. Thus, we decided to investigate the topology of a region with different 
chromatin structure, namely the HMR locus. This locus assembles hypoacetylated 
histones (which have been reported to have a distinct supercoiling configuration; Bi 
& Broach, 1997) and is transcriptionally repressed (Cheng et al., 2005). We used a 
strain that contains a LacO array adjacent to the HMR locus, with both these 
elements surrounded by R target sites, and a copy of the R recombinase under the 
control of a galactose inducible promoter (gifted by M. Gartenberg; Figure 3-16a). 
Zygosaccharomyces rouxii R recombinase, like Cre, belongs to the tyrosine 
recombinase family. There are two origins in this loop out region, ARS317 and 
ARS318, which fire later and are less efficient than the previously studied ARS508 
(according to the OriDB database, cerevisiae.oridb.org).  
We first monitored the topoisomer distribution of the HMR loop out during 
the course of one cell cycle. Topological analysis of this region shows that 
catenated topoisomers appear later than in the case of ARS508 (Figure 3-16c), 
consistently with the relative timing of firing of their respective origins. Moreover, 




the reduced accumulation of catenated species (10% of the total loop out at 60 min, 
not shown) could reflect the relative inefficiencies of ARS317 and ARS318. As 
aforementioned, when cells undergo chromosome segregation and return to G1, 
the catenated species disappear, most probably due to topo II action. 
 
 
Figure 3-16. Loop out of the HMR locus and southern blot analysis of the 
resulting topoisomers. 
a) Schematic of the HMR loop out: two silencers (shown in black) flank the 
heterochromatin-like region (shown in brown). The loop out also encompasses a 
LacO array (green bar).   b) Cohesin (top) and condensin localization (bottom) to 
the HMR locus; y-axis shows the Smoothed ChIP value (log2), x-axis shows a 30 
kb region of Chr. III centered around the HMR locus. c) Topology of the HMR loop 
out during the cell cycle. R activity was induced in G1-arrested cells, and upon 
release into the cell cycle, samples were taken every 20 min for DNA isolation and 
topological analyses. d) Time-course showing R–mediated loop out of the HMR 
during a G2/M arrest. 
 
 Interestingly, in a G2/M HMR loop outs do not appear as catenated species 
(Figure 3-16d). This could reflect the fact that recombination of heterochromatin-
like regions is less efficient (M. Gartenberg, personal comm.). However, it is 
probably not sufficient to explain why catenanes are not detectable in the 120 min 
time point, where the proportion of looped out species almost matches previous 
levels of recombination by Cre (58% recombination at 120 min, not shown). 
Similarly, time points 90 and 120 min in Figure 3-16c show comparable levels of 




recombination as time point 60 Figure 3-16b, where we detect 55% recombination 
and catenated species are visible. An alternative (and biological) explanation would 
be that topo II has removed most intertwines at this locus, and that catenanes from 
nearby regions might not redistribute into the HMR region due to local chromatin 
elements that act like topological barriers (Chang et al., 2005). 
 
3.8 Exploring the models for catenane formation 
Our second research aim regarding the local topologies of native budding 
yeast chromosomes was to investigate whether, in addition to catenane formation 
at replication termination, precatenane formation during elongation is prevalent. 
3.8.1 Analysis of the ARS508 loop out in the absence of replication 
termination 
In order to test whether precatenanes form during replication elongation, we 
decided to carry out our loop out experiment in a scenario where replication is 
ongoing but has not terminated yet. For this, we decided to release the cells from a 
G1 arrest into low concentrations of hydroxyurea (HU), which would markedly 
reduce the speed of the replisomes without causing severe stalling. Cre was 
induced 30 min into the arrest, to allow early origin firing and replication of the loop 
out region. We also added bromodeoxyuridine (BrdU) to the cells, to analyse 
replication progression by ChIP-on-chip analysis of incorporated BrdU.  
After 90 minutes in HU, the loop out (LO) region around ARS508 has 
replicated, but no major termination events between the forks arising from this 
replication origin and the forks from neighbouring origins could be detected, as 
judged by the BrdU peaks (IP/input), that had not merged (Figure 3-17, left panel). 
Under these conditions, topological analysis of the loop out revealed that the 
catenated species had already formed (Figure 3-17, right panel). This result 
supports idea that catenanes already form during ongoing DNA replication and 
before termination of DNA synthesis, consistent with the prediction of the 
precatenane model for DNA catenation. 
One potential caveat of this experiment is that termination events could be 
artificially triggered in the loop out. This would be the case if recombination 




occurred before the replisome had passed through the loxP sites, which would 
cause the convergence of the two incoming replication forks within the excised loop 
out. However, this is unlikely, because analysis of BrdU incorporation shows that 
replication of the loop out region has already occurred 60 min into the HU arrest 
(not shown), which corresponds to 30 min post-Cre induction, when loop out is just 
beginning to be detectable (See Section 3.5).  Nevertheless, further experiments 




Figure 3-17. Catenanes form during replication elongation 
At low levels of HU (0.1 M), replisomes progress slowly. BrdU ChIP-on-chip 
analysis (left) shows the incorporation of BrdU 90 min after release from G1 into 
HU and 60 minutes after Cre induction. Looping out of a region encompassing 
ARS508 that is already replicated but that does not present major replication 
termination events shows that the catenane band is present in HU (right panel, 
middle lane). For comparison, a G2/M (nocodazole) sample is shown (right panel, 
right lane).  
 
3.8.2 The introduction of a replication fork barrier does not affect the 
levels of catenanes  
Replication termination is stochastic in budding yeast. The sites of fork 
convergence are largely determined by origin position and firing timing (McGuffee 




et al., 2013). Thus the TER regions we have studied so far have low efficiencies of 
termination, i.e. they are sites of replisome convergence in a proportion of the cells 
within a population. There is one notable exception to stochastic termination, 
namely the replication fork barrier (RFB) of the rDNA locus. The RFB sequence 
constitutes a polar fork barrier, allowing the progression of the fork in the direction 
of 35S transcription, but not the opposite (Kobayashi et al., 2001). This sequence 
can act as a replication barrier when placed ectopically, i.e. at loci other than the 
rDNA locus (Cebrian et al., 2014). 
We reasoned that integrating the RFB into our loop outs would create or 
reinforce termination events in ARS and TER loop outs, respectively. To determine 
the contribution of precatenation and catenation at termination towards total levels 
of intertwinings, we would compare the proportion of catenane species of a loop 
out that has an ARS only, with that of ARS+RFB. As a control, we could place the 
RFB in a TER loop out. This would increase the termination events in the predicted 
TER vicinity. For example, an estimated 40% of the cell population experiences 
termination in that the predicted TER301 (McGuffee et al, 2013), which would 
expectedly be close to 100% after RFB introduction. However, it would not 
markedly increase the total number of termination events in the whole 17 kb loop 
out (since the replication origins around TER301 are very efficient and the majority 
of the forks are expected to meet in this region). Thus, catenanes forming at 
termination sites would not increase noticeably between TER301 and 
TER301+RFB. 
We integrated the RFB sequence next to ARS508 or to the predicted 
TER301 region in the loop out strains (at coordinates V: 96700 and III: 58771, 
respectively; Figure 2-2; 3-18a). As expected, we did not detect striking differences 
when we compared the pattern and relative abundances of topoisomers between 
TER301 and TER301+RFB, neither in G2/M nor in S (in our conditions, 90 min 
after release into 0.1 M HU, most cells had already replicated this region; 3-18b &c). 
Quantification indicated that in all cases, the catenated species corresponded to 
around 10% of the loop out species. This is probably because, as mentioned 
before, introducing the RFB sequence is not expected to markedly increase the 
number of termination events in the loop out region. Figure 3-18c shows that the 
ARS508+RFB did not noticeably show an increased proportion of catenanes with 
respect to ARS508 in G2/M (with 9% of the loop out species corresponding to 




catenanes in the case of ARS508, and 11% in the case of ARS+RFB, not shown). 
This could be either because (1) catenanes formed at termination events have 
distributed evenly throughout the chromosome, or (2) termination events do not 
generate more intertwines that would otherwise form during elongation. 
Considering the results we obtained in the previous experiment, we favour the 
second explanation: a number of intertwines form per kb replicated, and whether 
that is during elongation or termination does not make a substantial difference. 
 
Figure 3-18. Introduction of an RFB sequence does not noticeably affect the 
levels of catenanes. 
a) Schematic showing how the RFB was introduced in our loop out strains TER301 
and ARS508. b) BrdU enrichment at the TER301 region during the HU arrest. c) 
Southern comparing the topologies of the loop outs with and without TER. Note 
that the +RFB loop outs are slightly larger than their –RFB counterparts due to the 
additional insertion of the K.l URA3 marker.  
3.8.3 Replication of the ARS loop out in the absence of functional topo II 
What are the topological consequences of the lack of topo II activity during 
replication of chromosomes? To gain insight into this question, we crossed our 




ARS508 loop out strain with a temperature sensitive top2-4 allele. We induced the 
loop out in G1 arrested cells (1.5 h into the arrest, for 1.5 h) and split the culture 
into three: one third of the cells was released into the cell cycle at the restrictive 
temperature (sample 1), another third was released at the permissive temperature 
but switched to the 37°C 60 min after release (after S phase, sample 2), and the 
remaining cells were released and maintained at 25°C (sample 3; Figure 3-19a).  
 
Figure 3-19. Replication of an ARS loop out in the top2-4 cells at restrictive 
temperature gives rise to a high molecular weight replication intermediate. 
a) Experimental design. The region around ARS508 was looped out during a G1 
arrest and its topology analysed during interphase in the absence or presence of 
functional topo II. b) Southern blot showing the loop out topology in G1, S phase 
and G2 for the three experimental conditions. c) FACS showing cell cycle 
progression during the assay. 
 
Loop out occurred with similar efficiency in the three cases (Figure 3-19b, 
around 45-50% in G1), manifest from the monomeric forms of the excised region. 
However, the topology of the loop out during replication markedly differed in 
conditions where topo II was inactive (sample 1) or active (samples 2 & 3; Figure 3-
19b & c). Whereas in the latter case, we detected the supercoiled and open 
catenanes, as seen in previous experiments, the presence of catalytically dead 
topo II through S phase resulted in the accumulation of a slower migrating species 
appearing as a smear. This probably represents a heterogeneous population of 
replication intermediates, perhaps containing branched structures that hinder their 
migration through the agarose gel.  




Budding yeast cells can undergo DNA replication in the absence of topo II 
without major problems, but reporter plasmids become highly catenated, and cells 
fail to segregate their chromosomes (Baxter & Diffley, 2008). Topo II catalytic 
mutants are slightly different: DNA replication proceeds with overall normal kinetics, 
but cells fail to complete DNA replication termination, with reporter plasmids being 
highly catenated and containing gaps or exposed 3’ strands (Baxter & Diffley, 
2008). Thus, the final stages of replication are compromised in this mutant, which is 
probably what we observe when the loop out undergoes DNA replication in the 
top2-4 background at restrictive temperature. Ideally, we would make use of a top2 
allele that can result in the effective and conditional depletion of the protein to 
confirm that in the absence of topo II, the proportion of loop outs that undergo 
replication become catenated.  
 
3.9 Unidirectional recombination 
A potential problem associated with our loxP/Cre system is that 
recombination is bidirectional. This can theoretically allow several recombination 
events per cell that could allow the recombination of the loop out back into the 
chromosome and/or the fusion between two excised loop outs. In practice, this is 
unlikely for two reasons: (1) Cre prefers intramolecular over intermolecular 
recombination reactions (van Duyne, 2015), and (2) in vitro treatment with topo II 
would not remove fusions between two excised loop outs (but it does remove the 
putative loop out catenanes). Nevertheless, to discard the possibility of additional 
recombination events, we turned to a unidirectional recombination system. 
In contrast to tyrosine recombinases, the large serine recombinase family 
carries out a unidirectional integration reaction with no competing reverse reaction 
(Sclimenti et al., 2001). The most thoroughly-studied member of this family, the 
Streptomyces phage ϕC31 integrase, needs no cofactors to perform efficient 
recombination between its attB and attP sites, and produces hybrid sites, attL and 
attR (Thorpe et al., 2000). This recombinase exhibits strict site selectivity: in vitro 
and in heterologous hosts, it only catalyses attB/P recombination. It has been 
shown to work in fly (Groth et al., 2004), mouse (Belteki et al., 2003), zebrafish 
(Lister, 2010) and human genomes (Groth et al., 2000). While serine recombinases 




have the obvious advantage of unidirectionality, they have not been so well 
characterized in our model organism of choice (Xu & Brown, 2016).  
3.9.1 Construction of a ϕC31 integrase system 
We first constructed strains containing the attB and attP sites around TER 
regions of interest (Table 7; supplementary 7.4). The strategy was similar to the 
loxP strain construction, with the slight modification that we left the selective 
markers in the chromosome for simplicity (Figure 3-20). 
Table 7. Characteristics of the attB/ϕC31 strains used in this study 
Locus (Chr. 
no.) 
Element Efficiency AttB AttP LO (bp) 
(+K.l URA3) 
Telo R (I) TELO, ARS, 
CN 
 311 12888 
14277 
ARS508 (V) ARS, CH, CN 0.919 84680 96593 13613 
TER1417 (XIV) TER,  -0.427 420890 429872 8982 
TER603 (VI) TER, CN -0.642 176871 184501 9267 
TER1004b (X) TER, CEN, 
CH, CN 
-0.504 432667 438403 
7235 
TER: termination region; ARS: autonomous replication sequence; CEN: 
centromere; CH: cohesin binding site; CN: condensing binding site; efficiency is an 
estimate of the proportion of a cell population that fires a given replication origin 
(Efficiency: from 0 to 1; McGuffee et al., 2013), or experiences fork convergence at 
a given termination region (Efficiency: from -1 to 0; McGuffee et al., 2013). 
 





Figure 3-20. Strategy for the construction of attB/ attP Loop out strains. 
The attB-K.l URA3 cassette was integrated in the genome, upstream of the region 
of excision (ROE), and positive integrants were identified by genotyping PCR and 
sequencing. Subsequently, the attP-KanMX cassette was inserted downstream of 
the ROE, and positive colonies were confirmed by genotyping PCR and 
sequencing. Finally, cells were transformed with a centromeric plasmid containing 




 The attB/attP ϕC31 system enables unidirectional recombination, and thus 
ensures that recombination only occurs once per cell (Figure 3-21a). Expression of 
the ϕC31 integrase, under the control of the galactose inducible promoter, showed 
similar kinetics to that of PGAL1 Cre (Figure 3-21b). Excision rates were also 
comparable to those observed in the loxP/Cre system: loop out levels reached 68% 
after 180 min at TER603 and 70% at TER1417 after 120 min (not shown). Figure 3-
21c shows the topological analysis of loop outs excised with ϕC31 integrase. The 
pattern observed is similar to that previously seen in the Cre-mediated loop outs. In 
G2/M, two additional bands are apparent that are absent in G1, putatively 
corresponding to the supercoiled and open catenanes. We are currently identifying 




these bands with the aforementioned in vitro enzymatic treatments, namely nicking 
enzyme and topo II. 
 
Figure 3-21. Unidirectional site-specific recombination system to study 
chromosomal topology 
a) Schematic showing the basis of the ϕC31 system: recombination occurs only 
between attB and attP sites, and produces attR and attL. b) Western showing the 
induction of PGAL1-ϕC31 upon galactose addition. c) Southern blots of attB-TER603-
attP loop out in G2/M arrested cells (right) and of attB-TER1417-attP loop outs in 
G1 and G2/M. 
 
3.9.2 Telomeres 
The unidirectional recombinase system allowed us to study the topology of a 
telomeric region (construction of a similar strain with the loxP system was not 
possible because excision of the K.l. URA3-loxP cassette on 5-FOA plates never 
yielded the right sequence). Topological analysis of this chromosomal locus 
revealed a different pattern from other regions (Figure 3-22).  





Figure 3-22. Analysis of a telomeric loop out 
a) Schematic of the loop out region. b) Southern blot of the excised right telomeric 
region in Chr. I before, during or after DNA replication. c) Enzymatic treatments 
with topo II and nicking enzyme of a G2/M sample. 
 
First, we did not detect catenanes after DNA replication in telomeric loop outs, or 
at least they did not accumulate to the levels we have observed in other genomic 
loci. They only become apparent following treatment with nicking enzyme (Figure 
3-22c), which we cannot currently explain. Secondly, we detected a ladder of 
topoisomers, probably ranging from the supercoiled to the open monomer. This is 
present in samples obtained from cells arrested in G1, S and G2/M, suggesting that 
it is not specific to a given cell cycle stage. Where does this topoisomer ladder 
come from? A potential explanation could arise from the fact that there is some 




rotation around chromosomal ends (Joshi et al., 2010). If free rotation around 
telomeres indeed occurs, this could allow some torsional stress, i.e. supercoils and 
catenanes, to dissipate through chromosomal ends. Over a period of time, the 
torsional stress in the region would be a tug-of-war between DNA transactions 
generating it (e.g. transcription), and topoisomerases and free end rotation 
removing it. The ladder of topoisomers could be reflecting the fact that, in our 
population of cells, there are different degrees of torsional stress in the telomeric 
region (i.e. excision is capturing a mixture of progressively less supercoiled species, 
with those molecules that have lost most of their supercoils running close to open 
monomeric species). An additional degree of variation probably arises due to the 
fact that site-specific recombination is not strictly synchronous, and Cre might be 
looping out this chromosomal segment with different timings among the cell 
population during the 90 min from its induction. While this needs additional work to 
confirm the topoisomer assignments, we consider it interesting to note the different 
















Mapping Active topoisomerases 
  




Chapter 4. Mapping active topoisomerases  
How do topoisomerases resolve all the topological stress that accumulates 
during DNA transactions? An approach to tackle this question is investigating the 
association of topoisomerases along chromosomes using chromatin 
immunoprecipitation (ChIP)–based methods. Budding yeast topo I and topo II 
associate with chromatin during S phase, and bind around active early replication 
origins (Bermejo et al., 2007). Both proteins are expected to localize to the rDNA 
locus, on account of their reported roles in transcription and condensation (Shau & 
Hsieh, 1998; D’Ambrosio et al., 2008b), and probably to a multitude of other sites 
where they resolve topological problems. However, the interpretation of ChIP-on-
chip experiments could be complicated by the transient nature of the topology-
remodelling reactions of topoisomerases together with their abundance in the cell: 
cross-linking could create false positive peaks corresponding to more accessible 
DNA regions (Nolivos et al., 2016) or to binding sites where the proteins are not 
necessarily engaged in their reactions. On the other hand, this could be overcome 
by selectively immunoprecipitating topoisomerase molecules that were engaged in 
their topoisomerization reactions. In this chapter, we propose a method to trap 
active topoisomerases in budding yeast, through crosslinking these enzymes with 
poisons that enhance the concentration of cleavage complexes.  
4.1 Rationale 
To gain a better understanding into where topoisomerases act (and where 
topological problems arise), it is perhaps more instructive to perform ChIP-on-chip 
using drugs that trap the cleavage complexes (i.e. topo covalently bound to the 
newly generated termini it creates on its DNA substrate). This would enable the 
selection of “active” topoisomerases, namely those that are engaged in their 
topology-remodelling reactions. Trapping an active topo-DNA complex is possible 
with the use of topoisomerase poisons, namely camptothecin for topo I, and 
etoposide for topo II, which inhibit the religation of the topoisomerase-generated 
breaks on DNA. Moreover, these drugs would override the need for formaldehyde 
crosslinking used in ChIP experiments because topo-DNA cleavage complexes are 
covalently attached, thus reducing non-specific background. This type of approach 




involving topoisomerase poisons and ChIP-based assays has been recently 
reported for E. coli topo IV using norfloxacin (El Sayyed et al., 2016) and for human 
topo I in the presence of camptothecin (Baranello et al., 2016). 
The topo II poison etoposide, however, has very low efficacy in budding yeast 
because it does not accumulate at high enough intracellular levels. The pleiotropic 
drug resistance (PDR) genes modulate the expression of a number of transporters 
of the ABC family that limit the intracellular accumulation of drugs (Balzi & Goffeau, 
1995). Indeed, interfering with this gene network can render cells sensitive to a 
number of pharmacological compounds, including etoposide (Stepanov et al., 
2008). We made use of a construct that contains a fusion of the DNA-binding 
domain of PDR1, a transcriptional regulator that usually activates several efflux 
pumps, and the open reading frame of the CYC8 repressor (Stepanov et al., 2008). 
When integrated at the PDR1 locus, this fusion protein represses the genes that 
are under the control of PDR1.  
 
Figure 4-1. Etoposide sensitivities of the PDR mutant strains. 
a) Simplified scheme of the PDR gene network. PDR1, 3, 7 & 9 (top line) are the 
transcriptional regulators that control the expression of the ABC transporters and 
other genes (bottom line; adapter from Balzi & Goffeau, 1995). b) Spot dilution 
assay of the PDR mutant strains in YPD + solvent (left), low (100 μg/ml; middle) 
and high (300 μg/ml; right) etoposide concentrations. PDR mutations confer 
sensitivity to etoposide, which is greatly enhanced by combining PDR1, PDR3 and 
PDR5 deletions. c) Etoposide efficiency in liquid cultures, as inferred from Rad53 
phosphorylation. Cycling cells were added 500 μg/ml etoposide, TCA extracts 
collected 60 min later, and analysed using Western blot. 
 




Initial trials showed that this mutation slightly increased etoposide sensitivity with 
respect to wildtype, but not to sufficient levels for ChIP-on-chip analyses (not 
shown). Thus, we additionally deleted PDR5, encoding a transporter/efflux pump, 
and PDR3, encoding another transcriptional regulator (Balzi & Goffeau, 1995). 
Together, these mutations markedly increased the sensitivity of the cells to 
etoposide (Figure 4-1). 
 
4.2 Establishing the conditions for the ChIP 
We first optimized the experimental conditions for the ChIP-on-chip assay, by 
testing different concentrations of etoposide and various exposure times to the drug. 
We reasoned that if etoposide were effectively trapping topo II-DNA cleavage 
complexes, DNA damage would ensue (as DNA-tracking complexes, such as the 
replication or transcriptional machinery, collide with the cleavage complex and 
trigger the formation of a permanent DSB). To monitor DNA damage, we examined 
Rad53 phosphorylation (Tercero et al., 2003). Rad53 is a central checkpoint kinase 
that, upon DNA damage, gets activated and ultimately prevents late replication 
origin firing as well as aids in the maintenance of replication fork stability (Tercero 
et al., 2003).  
We first compared the levels of Rad53 phosphorylation between the different 
PDR mutants, and noticed that, in agreement with the spot dilution assay (Figure 4-
1), the combination of PDR1, PDR3 and PDR5 mutations led to a more 
pronounced Rad53 phosphorylation after treatment with 300 μg/ml etoposide for 90 
min (Figure 4-2a). To define when etoposide treatment started having an effect, we 
arrested the triple mutant in G2/M (nocodazole) and monitored the appearance of 
phosphorylated Rad53 (Figure 4-2b), which indicated that DNA damage was 
triggered 45-60 min after etoposide addition. Finally, we tested how the etoposide 
concentration correlated with the extent of Rad53 phosphorylation (Figure 4-2c), 
which suggested that higher doses of this topo II poison resulted in the most 
extensive phosphorylation of Rad53 (300 and 500 μg/ml).  
From these experiments, we decided to perform our ChIP-on-chip 
experiments 60 minutes after addition of 500 μg/ml etoposide. 
 






Figure 4-2. Preliminary tests to determine the timing and concentration of 
etoposide 
a) Western blot showing Rad53 phosphorylation in cycling cells of the different 
PDR mutant backgrounds 90 min after addition of 300 μg/ml etoposide. b) Time 
course showing when Rad53 phosphorylation appears following etoposide 
treatment during a G2/M arrest (PDR1-CYC8, PDR5Δ, PDR3Δ background). c) 
Effect of the etoposide concentration on the extent of Rad53 phosphorylation in 
G2/M arrested cells (PDR1-CYC8, PDR5Δ, PDR3Δ background) 
 
4.3 Mapping active topoisomerases 
4.3.1 Etoposide-trapped topo II maps to replicating regions during S 
phase 
We first decided to compare the association and the activity of topo II on 
budding yeast chromosomes during replication. Thus, we compared the pattern 
obtained by ChIP-on-chip between topo II crosslinked by formaldehyde (hereby 
referred to as ‘association’) and by etoposide (referred to as ‘activity’) during an HU 
arrest. We used the R package Ringo (Toedling et al., 2007) to define peaks: 
briefly, threshold values (above which enrichment was called a “peak”) were 
automatically calculated using the distribution of intensities of the smoothed data 




(IP/input). Minimum and maximum peak widths were set to 40 bp and 600 bp, 
respectively. 
 
Figure 4-3. Association and activity of topo II during S phase along Chr. III. 
Cells were released from a G1 arrest into 0.1 M HU. BrdU incorporation is shown to 
give an indication of replication progression at the time of sample collection. To 
map topo II’s association with chromatin, cells were collected 90 min after G1 
release and fixed with formaldehyde (second panel). The third panel shows a 
biological replicate of the topo II ChIP map. To analyse activity, etoposide was 
added to the cells 30 min into the HU arrest (final 500 μg/ml etoposide) and cells 
were collected 60 min later; no formaldehyde was added (third panel). Bottom 
panel shows the unspecific detection of topo II using an untagged version of this 
enzyme (negative control). The enrichment of DNA in the IP fraction compared to a 
whole genome DNA sample along Chr. III is shown; centromere is marked with the 
dashed line, ARS with pink dots and coding DNA sequence (CDS) with orange 
lines. 




We performed two independent repeats for each experiment. Duplicates had 
92% overlapping peaks (not shown), indicating that there was a high degree of 
correlation between biological replicates. Overall, we detected 1556 peaks in the 
topo II-ChIP sample and 500 in the topo II-Etoposide sample.  
While we found topo II broadly associated with replicating regions (Fig. 4-3 
and in agreement with Bermejo et al., 2007), there is a clearer correlation between 
replication and topo II activity, etoposide-trapped topo II enrichment noticeably 
matching that of BrdU (Figure 4-3). This could reflect the role of topo II in dealing 
with replication-induced topological stress, perhaps both in relaxing the supercoils 
ahead of the fork, as well as the precatenanes in its wake. Moreover, we can also 
detect accumulation of active topo II around the centromeric region, which is not a 
distinctive feature in the case of formaldehyde-crosslinked topo II. 
There was a high degree of correlation between genome-wide topo II-ChIP 
and topo II-Etoposide enrichments (Figure 4-4c & d). However, most of the overlap 
came from replicating regions, and there was little discernible overlap outside these 
regions. This is in agreement with analogous experiments that compared bacterial 
topo IV association and activity: topo IV cleavage sites, identified by norfloxacin 
treatment reportedly differed from topo IV-ChIP peaks (El Sayyed et al., 2016). 
These authors hypothesised that a number of topo IV-binding sites act as a 
reservoir, of which only a subset are activated. Nevertheless, further optimization of 
our topo II-Etoposide ChIP is probably required, as the relative enrichment over the 
input DNA was usually of lower intensity compared to topo II ChIP following 
formaldehyde crosslinking. 
In addition to replicating regions, we found that topo II associated with 
centromeres, but the relative enrichment around the 16 budding yeast centromeres 
was only observed following etoposide treatment (Figure 4-3). S. cerevisiae 
centromeres are early-replicating loci; however, this fact alone cannot account for 
the accumulation of etoposide-trapped topo II, as other early-replicating regions do 
not see such pronounced accumulation. Other factors, including endogenous 
regulatory pathways that affect topo II activity (Bachant et al., 2002), unique 
topological characteristics of centromeres (Diaz-Ingelmo et al., 2015; Furuyama & 
Henikoff, 2009) and/or microtubule-generated forces (Farcas et al, 2011) might 
contribute to the specific localization of active topo II. 





Figure 4-4. Analysis of genome-wide topo II peaks 
a) Overlap between topo II-ChIP (association) and BrdU enrichment b) Overlap 
between topo II-Etoposide (activity) and BrdU peaks. c) Overlap between topo II-
ChIP and topo II-Etoposide. d) Graph representation the correlations in a, b and c. 
 
4.3.2 Ectopic topo II associates with replicating regions during S phase 
To examine whether the pattern of topo II activity was dictated by 
endogenous regulatory pathways or simply by topological stress accumulation, we 
decided to do a similar analysis of Paramecium bursaria chlorella virus topo II (CV 
topo II; see section 5.1, Fig. 4-5) expressed in budding yeast, and presumably not 
subject to putative endogenous yeast topo II regulation.  
Analogously to endogenous topo II, the association of CV topo II with 
chromatin correlates with DNA replication. Remarkably, the location of both 
topoisomerases is very similar, both at replicating and non-replicating regions. We 
do not know the precise reason that brings these topoisomerases to the latter 
regions; further analyses and experiments will investigate a potential correlation 
with transcription. 






Figure 4-5. Comparison between endogenous and ectopic topo II association and 
activity along budding yeast Chr. I during replication. 
Topo II association correlates with replicating regions, and also shows some 
additional peaks that do not overlap with topo II activity. The bottom two panels 
show the association and activity of the ectopic CV topo II, respectively, expressed 
in budding yeast after release from G1 into HU. Centromere CEN1 is marked with 
the dashed line, ARS with pink dots and CDS with orange lines.  
 
The fact that the patterns of association and activity are extremely similar 
between the two enzymes (Figure 4-6) suggests that in most instances, it is 
probably topological stress (e.g. DNA crossovers) that brings topoisomerases to a 
given chromatin site, rather than putative regulatory factors, which would probably 
only affect endogenous topo II localization. The CV topo II map is slightly noisier; 
perhaps reflecting the fact the enzyme is overexpressed. The striking and 
consistent difference between the activities of the two topoisomerases lies around 
the centromeric regions; though both are associated with this locus, only 
endogenous topo II is enriched with respect to the rest of the genome (Figure 4-6c). 




This opens the possibility that there is an endogenous regulatory mechanism that 
targets endogenous topo II to centromeres and to which CV topo II is insensitive. A 
potential candidate is sumoylation, which has been reported to target topo II to 
centromeres in mammalian (Mao et al., 2000; Yoshida et al., 2016) and yeast 
systems (Takahashi et al., 2006; Edgerton et al., 2016). 
 
Figure 4-6. Correlation between ectopic and endogenous topo II 
a) Peak overlap between the association of SC and CV topo II. b,c) Close-up 
of etoposide-trapped topo II ChIP enrichment on b) chromosome I arm and c) 
centromeric regions. Centromere (CEN1) is marked with the dashed line, ARS with 
pink dots and CDS with orange lines. 
4.3.3 Topo I activity maps to narrow regions around early-firing origins 
during S phase 
We also compared the association and activity of topo I during replication, to 
distinguish between torsional stress coming from supercoiling and catenation, since 
topo I can only resolve the former. Topo I activity can be mapped by trapping the 
fraction of topo I molecules engaged in their topology-remodelling reaction using 
the drug camptothecin, which acts in an analogous manner to etoposide for topo II. 
We see topo I mainly associated with replicating regions, in agreement with 
previous results (Bermejo et al., 2007), and with a high degree of correlation with 




topo II association (41%, 754/1848 peaks overlapped with topo II peaks). Active 
topo I was also mostly found in chromatin regions undergoing replication. However, 
camptothecin trapped topo I in narrow regions surrounding early firing origins, 
whereas formaldehyde crosslinked topo I along broad areas of replication (Figure 
4-7). 
 
Figure 4-7. Comparison between association and activities of topo I and topo II 
during DNA replication. 
Cells were released from a G1 arrest into 0.1 M HU. BrdU incorporation is shown to 
give an indication of replication progression at the time of sample collection. Topo I 
association (formaldehyde-crosslinked) and activity (crosslinked with 100 μg/ml 
camptothecin) along Chr. VI are shown. For comparison, the two bottom panels 
show topo II-ChIP and topo II-Etoposide enrichment along the same chromosome. 
Centromere is marked with dashed line; ARS with pink dots and CDS with orange 
lines. 
 
Etoposide trapping of topo II occurred along broad areas too. We do not know 
the reason behind the difference in the activity patterns of topo I and topo II. It 
could point to a contribution of topo I during replication initiation, for example, as 
the replication bubble unwinds, but less so during elongation. However, we cannot 




discard potential dissimilarities in topoisomerase poison efficiencies and/or timings. 
Overall, these results are in line with the idea that topo I, like topo II, is required for 
the removal of DNA replication-induced topological stress. 
4.3.4 Topoisomerase association and activity are reduced during G2/M 
Finally we assessed the distribution of topoisomerase activity in G2/M by 
means of a nocodazole arrest. At this stage of the cell cycle, most of the 
replication-induced torsional stress has been removed, except for a small 
population of catenanes (See Chapter 3; Charbin et al., 2014; Farcas et al., 2011). 
Thus, comparing the activities of topoisomerases between S-phase and G2/M 
could indicate how the remaining catenanes are distributed along chromosomes, 
and what other topological challenges arise after DNA replication. 
We assessed the pattern of topo II activity during G2/M (Figure 4-8) and 
noticed two major differences from that during S phase. Firstly, the number of 
peaks detected was vastly reduced, as was the height of these peaks 
(Nocodazole/HU: 589/1556 for topo II-ChIP and 308/500 for topo II-Etoposide 
ChIP). The reduction in topoisomerase enrichment could be explained by the fact 
that in this stage of the cell cycle there is less single-stranded DNA, that would 
facilitate protein bining and/or crosslinking and subsequent immunoprecipitation. 
This possibility needs to be further assessed.  
Topo II activity appeared less well defined and more spread out along 
chromosomes. Its accumulation at centromeric regions was still detectable, albeit 
less pronounced, possibly due to the absence of spindle microtubules during the 
nocodazole arrest. Nevertheless, further analysis is required to compare the 
genome-wide patterns more in detail. A similar effect was seen for topo I activity. 
The number and height of topo I-camptothecin peaks was reduced 
(Nocodazole/HU: 995/1848 for topo I-ChIP and 329/ 695 for topo I-Camptothecin), 
and no longer matched the early replicating regions detected in HU. The presence 
of peaks at this stage of the cell cycle might correlate with actively transcribed 
regions, a hypothesis that we will test in our future experiments. A comparable 
reduction in enrichment was also observed between active CV topo II in S and 
G2/M phases (Nocodazole/HU: 474/1338 for CV topo II-ChIP and 439/637 for CV 
topo II-Etoposide).  




Put together, these results make two suggestions. Firstly, it seems that in 
G2/M there may be a less substantial topological stress burden on chromosomes 
than during replication. Secondly, the lack of defined peaks after from DNA 
replication suggests that replication-dependent torsional stress (that forms 
supercoils and catenanes) may not be necessarily maintained in the chromosomal 
region where it originated, but perhaps is able to distribute along chromatin. 
 
 
Figure 4-8. Topoisomerase activities along Chr. III during nocodazole arrest. 
Cells were arrested in G2/M upon addition of nocodazole. Etoposide or 
camptothecin was added 1.5 h into the arrest, and samples were collected 60 min 
after drug addition. Top panel shows topo II activity during an S-phase arrest, for 
comparison. Centromere CEN1 is marked with dashed line, ARS with pink dots and 
CDS with orange lines. NOC: nocodazole. 
 




In summary, we report in this chapter the application of a method to trap and 
detect active topoisomerases along budding yeast chromosomes. Similar 
strategies employing topoisomerase poisons have been used to compare the 
association and activity of topo I in human cells (Baranello et al., 2016) and topo IV 
in E. coli (El Sayyed et al., 2016), but had been inaccessible for analysis of budding 
yeast topo II, because the PDR gene network limited the intramolecular 
accumulation of etoposide. Our mutant strain (PDR1-CYC8, ΔPDR5, ΔPDR3) 
allows the analysis of etoposide-trapped type II topoisomerases for the first time.  
While these results are preliminary and require further validation and analysis, 
they are in line with a number of observations. First, topo II and topo I are both 
implicated in dealing with DNA replication-induced topological stress (Bermejo et 
al., 2007; Figures 4-3 and 4.7). Topo II-Etoposide mapped to broad replicating 
regions, whereas topo I-Camptothecin was enriched in narrow regions around 
active replication origins, perhaps reflecting differential requirements for these 
topoisomerases during the different stages of replication. Secondly, the correlation 
between the enrichment of topo II and CV topo II (which is refractory to putative 
regulatory pathways that control endogenous topo II), suggests that it is probably 
topological stress that brings topo II to its sites of action. The observed centromeric 
accumulation of topo II, which was only noticeable after etoposide treatment, opens 
the possibility that modulation of this enzyme (e.g. sumoylation) rather than a 
topological property of this locus, targets topo II to the centromeres, as this early-
replicating locus did not present such pronounced topo I or CV topo II enrichments. 
Finally, there seems to be a smaller topological burden during G2/M than in S 











Catenation and Sister Chromatid Cohesion 
  





Chapter 5. Catenation and sister chromatid 
cohesion 
The results from the previous two chapters suggest that chromosomal 
catenation persists into G2/M. This is consistent with previous observations in 
minichromosomes indicating that, while most catenanes are removed soon after 
their formation, a small population of catenanes is retained until chromosome 
segregation (Charbin et al., 2014; Farcas et al., 2011). Why are these catenanes 
resolved so late in the cell cycle, given their potential disruptive effect on 
chromosome segregation? One possibility is that they contribute towards sister 
chromatid cohesion, and that topo II is regulated to act on these specifically at the 
time of segregation. 
5.1 Paramecium Bursaria Chlorella Virus topo II: an 
unregulated topo II 
To test this hypothesis, we turned to a topo II enzyme that is not subject to 
putative budding yeast regulatory pathways, namely PBCV topo II (CV topo II; 
D’Ambrosio et al., 2008a). CV topo II is one of the smallest topo II enzymes 
characterized up to date, and it lacks the regulatory C-terminal domain (CTD) of 
eukaryotic topoisomerases (Lavrukhin et al., 2000). We postulated that CV topo II, 
when introduced in budding yeast cells, would be efficient in removing those 
catenanes that endogenous topo II might be inhibited to resolve. 
5.2 Sister chromatid cohesion 
A relatively simple assay to assess sister chromatid cohesion is provided by 
the tetO array/tetR-GFP system. An array of tet operators (tetO) is introduced at a 
chromosomal locus (e.g. the URA3 locus, on the right arm of Chr. V, 35 kb away 
from the centromere), and can be visualized by expressing a fluorescent fusion of 
the tet repressor, tetR-GFP. When sister chromatid cohesion is intact, only a single 
GFP dot is visible; conversely, if it is compromised, two dots are detectable (Figure 
5-1a). 




We measured the percentage of URA3/GFP separation in cells 
overexpressing CV topo II during a G2/M arrest (nocodazole; Figure 5-1b), and 
noticed that 3 h after the induction of this topoisomerase, around 25% of the cells 
exhibited discernible sister chromatid separation. Moreover, the increase of 
URA3/GFP separation correlated with the levels of CV topo II (i.e. the higher the 
expression level, the higher the proportion of cells with separated GFP dots; not 
shown). In contrast, only 5% of the cells overexpressing endogenous topo II 
presented two separated URA3/GFP dots, similar to wildtype levels. This suggests 
that catenanes might contribute to sister chromatid cohesion, or at least to sister 
chromatid proximity. 
 
Figure 5-1. Sister chromatid cohesion assay in the presence of an ectopic topo II 
a) Scheme of the assay (top): the tagged URA3 locus is visible as a single GFP dot 
when sister chromatid cohesion is intact, but as two dots when the two sister 
chromatids are separated. Micrographs of the assay showing the two possible SCC 
scenarios (bottom; from Xu et al., 2007). b) Quantification of cells with separated 
GFP dots. Overexpression of CV topo II causes premature sister chromatid 
separation in >25% cells, similarly to the scc1-73 allele, reported to experience 
cohesion defects even at permissive temperature. Conversely, only 5% of cells 
overexpressing endogenous topo II experience sister chromatid separation, close 
to levels observed in wildtype cells. SCC: sister chromatid cohesion; CV: 
Paramecium Bursaria Chlorella virus 1; SC: Saccharomyces cerevisiae; gal: 
galactose.  




5.3 DNA damage in the presence of CV-topo II 
Overexpression of CV topo II leads to low levels of Rad53 phosphorylation, 
indicative of DNA damage (Figure 5-2a). This could reflect the fact that CV topo II 
has a higher cleavage activity than budding yeast topo II (Fortune et al., 2001), and 
that the higher levels of cleavage complexes are more likely to be collided into by 
DNA tracking enzymes, ultimately resulting in permanent DSB, which are detected 
by DNA damage signalling pathways. Alternatively, it could indicate that CV topo II 
is triggering DSB formation, which could in turn disturb cohesin’s topological 
embrace of DNA and thereby affect sister chromatid cohesion.  
 
 
Figure 5-2. Effect of CV topo II overexpression on genome integrity. 
a) Overexpression of CV topo II results in mild Rad53 phosphorylation. b) 
Chromosome integrity, observed by PFGE and GelRedTM staining, is unaffected in 
cells expressing CV topo II. c) Chr. V, which contains the tetO array is not 
detectably broken upon overexpression of CV topo II.  
 
To distinguish between these two possibilities, we checked chromosome 
integrity using PFGE (Figure 5-2b). This assay showed that chromosomes were not 




detectably broken by CV topo II: further analysis by Southern blotting showed that 
Chr. V (where the tetO array is integrated) was indistinguishable between wildtype 
and CV topo II–expressing cells (Figure 5-2c). This indicates that the decreased 
sister chromatid proximity observed in the URA3/GFP assay is not a result of DNA 
damage caused by CV topo II overexpression. 
 
5.4 Overexpression of CV topo II reduces the levels of 
catenated reporter plasmid in G2/M 
We further investigated whether the effect of CV topo II expression on sister 
chromatid cohesion is a consequence of extensive decatenation. For this purpose, 
we used the reporter plasmid ‘prs-rDNA’ (see Section 2.1.1), a centromeric 
minichromosome containing one 9.1 kb rDNA repeat. We arrested cells in G2/M by 
addition of nocodazole and overexpressed CV topo II, collecting samples at 0, 1.5 
h and 3 h after the induction of the ectopic topoisomerase. As a control, we 
sampled wildtype cells 3 h after addition of galactose. Topological analysis of the 
minichromosome samples revealed that induction of CV topo II had removed 
substantially more catenanes than endogenous SC topo II during the arrest (Figure 
5-3). This suggests that an ectopic topo II can remove catenanes that are not 
removed by its endogenous counterpart, which opens the possibility that 
endogenous topo II is in some way prevented from removing this population of 
catenanes in G2/M. Why endogenous topo II is unable to decatenate these 
intertwinings is unclear, but is in agreement with previous studies (Charbin et al., 
2014; Farcas et al., 2011). Our results are in line with the hypothesis that the 
remaining catenanes in G2/M contribute to SCC, and thereby their removal by CV 
topo II leads to higher levels of sister chromatid separation. Moreover, the linear 
topoisomer does not markedly increase in the presence of CV topo II, again 
indicating that the viral topoisomerase does not cause more DSBs than its 
endogenous counterpart in vivo. 
Put together, the results of this chapter indicate that post-replicative 
catenanes might contribute to SCC. Three lines of evidence point to this hypothesis. 
First, the penetrance of the phenotype of cohesin mutants is locus- specific (Figure 
1-8; Antoniacci & Skibbens, 2006; Ciosk et al., 2000; Diaz-Martinez et al., 2008; 




Guacci et al., 1997; Michaelis et al., 1997; Sullivan et al., 2004; Toth et al., 1999), 
so cohesin alone probably cannot explain genome-wide SCC. Secondly, catenanes 
persist into G2/M in minichromosomes (Farcas et al., 2011; Charbin et al., 2014) 
and authentic chromosomes (Espeli et al., 2003; Chapter 3). Finally, we have 
shown that expression of ectopic CV topo II removes most of the remaining G2/M 
catenanes in minichromosome DNA (Figure 5-3) and leads to increased 
URA3/GFP separation in nocodazole-arrested cells (Figure 5-1). 
We note that CV topo II has higher cleavage levels than other type II 
topoisomerases. Thus, it would be important to repeat this assay in the presence of 
another enzyme, for example E. coli topo IV, to rule out the possibility that the 
sister chromatid separation phenotype results from DNA cleavage rather than 
decatenation. 
 
Figure 5-3. CV topo II expression reduces minichromosome catenation in G2/M  
a) Southern blot comparing the topologies of prs-rDNA in cells the presence of 
ectopic CV topo II (0, 1.5 and 3 h after CV topo II induction) and wildtype cells 





















Chapter 6. Discussion 
This project was aimed at understanding a number of aspects of chromosomal 
DNA topology, in particular DNA catenation. We first devised a system to study the 
local topologies of linear chromosomes, and used it to investigate the formation 
and distribution of catenanes. We then took a more protein-centric approach, and 
attempted to examine where active topoisomerases accumulate on chromosomes. 
Finally, we addressed the question of whether DNA catenation contributes towards 
the establishment and/or maintenance of sister chromatid cohesion. The following 
section will discuss the findings of this work and their significance, as well as future 
directions. 
 
6.1 Local topologies of budding yeast chromosomes 
Topological analyses have largely been performed using minichromosomes 
or plasmids to study the origins of chromosomal catenation and the factors that 
contribute to its dissolution. Using a similar initial approach, we explored how a 
number of chromosomal elements, including additional replication origins and the 
RFB sequence, might affect formation, maintenance and dissolution of intertwines 
on such circular minichromosomes (not shown). We found that additional 
replication origins and the RFB sequence had no noticeable effects on DNA 
catenation. Our experiments were challenged by the technical limitations of 
minichromosomes, and we therefore do not discuss them in this thesis. Moreover, 
it still remains unclear how accurately these ectopic circular DNAs represent the 
behaviour and topology of endogenous chromosomes.  
At the same time, investigating the topology of endogenous chromosomes is 
technically very challenging, which probably accounts for the very low number of 
published studies on the topic. Catenation along native chromosomes had been 
previously looked at using genome-wide analysis of budding yeast chromosome 
breakage by PFGE (Spell and Holm, 1994), which attributed breakage sites to 
intertwines that failed to be decatenated at mitosis in a top2-4 temperature 
sensitive background at restrictive temperature. This study identified very few 
breaks, mostly in large chromosomes. However, the relationship between 




catenation and breakage is not certain. It is hardly imaginable that small 
chromosomes would not experience catenation events during the cell cycle when 
much smaller plasmid substrates exhibit a proportion of molecules catenated until 
G2/M even in the presence of topo II activity (Charbin et al., 2014). Moreover, the 
proportion of catenation events inferred from this study seems very low considering 
that the main cellular decatenase has been inactivated, and assuming that at least 
each replication termination site gives rise to intertwinings. It is therefore more 
likely that the sites identified in this study relate to fragile sites in the genome, 
rather than intertwinings between sister chromatids.  DNA catenation has also been 
inferred from the phenotypes of topo II mutant cells, largely from anaphase bridges 
and lagging chromosomes (Uemura et al., 1987). The inability to directly visualize 
catenanes has been attributed to their transient nature (Spell & Holm, 1994; 
Koshland & Hartwell, 1987) and, as a consequence, little is known about their 
nature and distribution along chromosomes.  
We used site-specific recombination to reveal unprecedented and direct 
information about catenation along native budding yeast chromosomes. Our loop 
outs reveal a pattern of topoisomers similar to that seen in minichromosome 
studies (Charbin et al., 2014; Farcas et al., 2011). One small difference is that the 
minichromosomes can be detected as three catenated species, namely 
open/nicked, supercoiled and mixed, whereas we only detected two species of 
catenated loop outs (open and supercoiled). We do not know the reason for this 
difference, but we suspect that the non-looped out (chromosomal) band could 
mask the detection of the mixed catenanes population (and possibly other 
topoisomers). Isolation of the loop out from the rest of the genome or removal of 
the unrecombined fraction (for example, by using an exonuclease) would shed 
some light into the source of this discrepancy. 
We confirmed the identity of the different bands by determining their 
dependence on DNA replication and by in vitro enzymatic treatments. This 
demonstrated that post-replicative loop outs can be found as monomers as well as 
catenated species. Furthermore, we verified that the observed catenanes reflect 
the topology of chromosomes in vivo (as opposed to artefactually catenated 
monomers) by showing that catenanes are present only after DNA replication, but 
not in diploid cells arrested in G1 (Section 3.5.2). Nevertheless, the conformation of 
homologous chromosomes might differ from sister chromatids, i.e., the former may 




be farther away from each other than the latter, and thus, we cannot completely 
rule out that the catenanes we detect may form as a result of Cre–mediated 
recombination. Due the little knowledge on chromosomal intertwinings, we could 
not design alternative negative controls. However, the fact that the presence of the 
mitotic spindle could dramatically reduce the accumulation of catenanes in a 
centromeric loop out (Section 3.5.3) suggests that the topoisomer pattern we detect 
is biologically relevant. Moreover, our analyses of catenanes throughout the cell 
cycle (Section 3.7) show that the timing and levels of catenane accumulation 
correlate with measured firing timing and efficiency of replication origins. 
Furthermore, the fact that the catenated species in the loop outs disappear when 
cells return to G1 from mitosis strongly argues for their physiological relevance. A 
potentially insightful experiment would be to observe the configuration of our 
catenated loop outs in high resolution through electron microscopy. This approach 
will also enable the quantification of catenanes in our loop out, which has not been 
technically possible with 1D gel electrophoresis. We typically observe sharp bands 
for the two catenated species we detect (i.e. open/nicked and supercoiled 
catenanes), perhaps suggesting the presence of homogeneous populations of 
these topoisomers with similar interlinking numbers. However, we cannot rule out 
the possibility that these bands contain a multitude of differently catenated 
molecules that cannot be further resolved through 1D gel electrophoresis. We tried 
to address this by using 2-dimensional gel electrophoresis, but the large size of 
molecules did not allow the completion of this analysis. Finally, our assay probes 
the topologies of chromosomal regions in a large number of cells (i.e. it is a 
population assay). As such, we could think of two possible scenarios to explain the 
accumulation of catenanes G2/M: (1) the majority of the cells present low levels of 
catenation or (2) a small proportion of the cell population has highly catenated loop 
outs. Because we employ synchronized cultures of wildtype cells (and thus we 
would not expect large variations in topoisomerase activity between cells), and 
because there can only be two looped out molecules per cell, the former option is 
probably more likely; however, we cannot completely discard the latter possibility.  
Site-specific recombination could alter the topology of chromosomes. First, 
Cre shares some similarities with type IB topoisomerases, and could potentially 
alter the supercoiling status of a given DNA substrate. However, in vitro studies 
have shown that Cre-mediated intramolecular excision does not noticeable change 




Lk (Abremski et al., 1986). Furthermore, because of the reaction mechanism of Cre, 
we would not expect it to remove or introduce catenation events. Importantly, the 
relative fraction of the catenated loop out species remains fairly constant as 
recombination occurs (Figure 3.8), suggesting that catenation is not an indirect 
result of Cre-mediated excision of a given chromosomal region. Moreover, Cre, R 
recombinase and ϕ31C (from a different family of site-specific recombinases) 
produce a similar topoisomer pattern, which may indicate that, in vivo, topology is 
not discernibly affected, apart from the obvious production of a loop out. The fact 
that uni- and bidirectional recombination events produce a similar topoisomer 
pattern suggests that bidirectional systems (i.e. Cre and R) do not produce multiple 
recombination events (that could lead to re-integration of excised regions or fusion 
of monomeric loop outs) with detectable frequency. Finally, there is a third possible 
recombination event, namely the unequal exchange between sister chromatids (i.e. 
upstream loxP/attB and downstream loxP/attP on the sister chromatid). This 
recombination event would yield a different pattern after restriction digest than that 
expected from loop outs. Because we have not observed unexpected bands after 
treatment with restriction enzymes (Figure 3.7), we suggest that this recombination 
event does not occur with detectable frequencies.  
One point of concern is that the recombination kinetics, which are similar 
between the recombination systems used in this study, may widely differ from 
topoisomerase reaction kinetics. This could result in loss of topological information: 
if a given topological domain was extensively torsionally strained, topoisomerases 
could alter its topology until reaching a certain equilibrium level of supercoiling 
and/or intertwinings. In principle, this effect could be more deleterious on 
catenanes, since transcription-induced torsional stress would be similar between 
chromosomal DNA and loop outs, as the genes in the latter are probably being 
transcribed after its excision from the chromosome. Thus, the catenane levels we 
detect could be an underestimate of those in chromosomal DNA. Further 
experiments addressing loop outs combined with conditional topo II depletion will 
help explore these possibilities. 
Our experiments indicate that catenanes are distributed throughout 
chromosomal loci in cells arrested in G2/M (Figure 6-1). We have studied early-
replicating regions, and detected catenanes in regions containing centromeres, 
replication origins and replication termination sites. This finding contrasts with early 




minichromosome studies that found no detectable levels of catenated species 
(Koshland & Hartwell, 1987), but is in agreement with more recent studies that 
detected catenated minichromosomes before chromosome segregation (Farcas et 
al., 2011; Charbin et al., 2014).  
 
Figure 6-1. Model for catenane formation and distribution along native budding 
yeast chromosomes 
Our experiments have suggested that during DNA replication, precatenanes form 
before termination events. Precatenanes, together with catenanes inevitably 
formed at replisome convergence regions are probably distributed across 
chromosomal regions. In G2/M a small population of catenanes is detected in 
replication origin, TER and centromeric regions, and is not confined to cohesin-
binding sites or excluded from condensin-binding sites (not shown). 
 
A possible explanation of this discrepancy is that the early studies used 
smaller minichromosomes; indeed, it seems like size positively correlates with the 
level of catenation of a given DNA molecule (Charbin et al., 2014). However, we 




detected catenated species of our smaller loop outs (8 kb), but a similarly sized 
minichromosome would probably not detectably retain intertwinings. The presence 
of a centromere in these smaller minichromosomes (and its absence in our small 
loop outs) could account for this discrepancy: centromeric attachments to 
kinetochores and the tension exerted on them by mitotic spindles stimulate 
decatenation by topo II (Farcas et al., 2011; Charbin et al., 2014). Indeed, we 
recapitulate this effect in our centromeric loop outs, which experience a reduction in 
their catenated topoisomers when the mitotic spindle is present (Section 3.5.3). 
6.1.1 SMCs and catenation 
The roles of the different SMC complexes in chromosome organization have 
been the focus of intensive study over the past two decades. With respect to 
topology, the cohesin complex has been suggested to protect catenanes from topo 
II–mediated disentanglement (Farcas et al., 2011).  Although the molecular nature 
of this protection remains unclear, it has been shown that in the absence of a 
functional cohesin complex or when cohesion establishment factors like Eco1 or 
Scc2/4 are not present, the levels of centromeric minichromosomes in a G2/M 
arrest are reduced with respect to those found in wildtype cells (Farcas et al., 2011). 
We have detected catenanes in wildtype cells in chromosomal regions where 
cohesin is enriched during G2/M; however, regions with substantially less cohesin 
enrichment present no markedly different levels of catenanes. This suggests that 
catenanes are not restricted to regions of cohesin enrichment. It does not rule out, 
however, a dependence of catenanes on the presence of active cohesin 
complexes; future experiments will test this by looking at the topoisomer distribution 
of loop outs under conditions where cohesin is depleted.  
In contrast, the condensin complex has been suggested to stimulate topo II–
mediated decatenation. How condensin helps topo II in removing intertwinings is 
uncertain, with direct protein interaction and indirect modification of topo II 
substrate DNAs proposed as alternatives. We could not detect obvious differences 
in the levels of catenanes between loci with substantial condensin enrichment and 
loci with reduced condensin association, suggesting that intertwinings are not 
excluded from condensin-enriched regions. To examine the effect of condensin on 
chromosomal catenanes, loop outs should be carried out in the absence of 




functional condensin complexes (and possibly in the presence of mitotic spindles; 
Baxter et al., 2011). Future experiments will also look at the relationship between 
DNA catenation and the Smc5/6 complex. Although, its proposed role in marking 
catenanes (Jeppssonn et al., 2014) is not in agreement with our findings that 
catenanes are widely distributed along chromosomes. 
Interestingly, two of our loop out regions did not present detectable levels of 
catenanes in a G2/M arrest, namely a telomere and the HMR locus. The vast 
reduction in catenanes at telomeres could be explained by free rotation of 
chromosome ends, which may allow the dissipation of torsional stress (since it 
does not behave like a topological domain where Lk is constant). The pattern of 
topoisomers we see in the loop out of this region, where we detect a ladder of 
topoisomers running from the most supercoiled to the open monomeric species, 
probably reflects the telomeric free end rotation. The second region that seems not 
to be catenated in G2/M is the mating locus, HMR. The HMR locus resembles 
closed heterochromatin regions, typical of higher eukaryotes: it assembles 
hypoacetylated histones, is refractory to a number of DNA modification enzymes, 
and is transcriptionally silent (Cheng et al., 2005). One explanation for the lack of 
intertwines at the HMR locus is that topological stresses are strictly confined in this 
region, so that distribution of catenanes and supercoiling from and/or to the HMR 
locus is more restricted than elsewhere in the genome. Catenanes do form during 
replication at the HMR locus (visible in a G1 to G1 time-course experiment, Section 
3.7.2); however, after their removal by topo II, catenanes from other regions might 
not be able to translocate to this region. We do not know whether this has a 
functional relevance for topology regulation, or whether it is just a consequence of 
the specific chromatin structure. Future experiments will look at the topology of this 
loop out in the absence of silent-chromatin establishment proteins, like Sir1p and 
Sir2p (Cheng et al., 2005), and compare the topoisomer pattern in the absence of 
chromatin silencing. However, we do need to confirm that the absence of 
detectable catenanes is not due to insufficient levels of recombination by R 
recombinase.  
An important area that has not been addressed in this work is chromosome 
topology in the absence of topoisomerases. We made an initial attempt using the 
top2-4 allele to look at the cell cycle topology of the ARS508 region. However, as it 
has been previously reported (Baxter & Diffley, 2008), this allele causes replication 




problems during replication at restrictive temperature, as it specifically prevents the 
completion of termination events (observed in reporter plasmids, but also in native 
chromosomes). In our study, we detect a high molecular weight smear above the 
catenane band that probably corresponds to intertwined replication intermediates. 
The smear possibly reflects the heterogeneity in the size or replication completion 
of these molecules; their slow migration probably indicates that their structures are 
branched, which impedes migration through the agarose gel. Ideally, we would use 
an effective conditional allele that not just inactivates but also degrades topo II. We 
have tried a number of variations of the auxin-inducible degron tags to conditionally 
knock out this topoisomerase. However, in our hands, degradation did not occur to 
completion, and the low levels of topo II left are sufficient to maintain topological 
homeostasis (in agreement with previous observations, where leaky transcription 
leaky transcription of topo II driven by the repressed GAL1 promoter complemented 
the lethality of the temperature sensitive allele top2-4; Caron et al., 1994). We 
cannot use degron systems that rely on galactose induction (as we have our 
recombinases under the control of PGAL1), or on high temperatures, which might 
affect the kinetics of recombination and topoisomerase action.  
On the other hand, current experiments are focusing on the use of viral 
topoisomerases, like the CV topo II, in our loop out strains. Because (putative) 
yeast endogenous pathways are not expected to regulate viral topoisomerases, 
their expression in the cell could remove more topological stress than the 
endogenous enzymes. Our current focus lies on analysing the topology of our loop 
outs in the presence of CV topo II, to see if the catenane population is reduced. 
Importantly, the fact that catenanes are present in G2/M raises some 
questions about the Rybenkov effect—the reported ability of topo II to simplify 
topology beyond the equilibrium distribution (Rybenkov et al., 1997). In vivo, 
topology simplification of chromosomal loop outs does not seem to occur to the 
levels seen of plasmid DNA in vitro, as reflected in the fact that catenanes are 
detected in our loop outs during prolongued metaphase arrests. Topo II treatment 
in vitro of G2/M loop outs (and minichromosomes; Charbin et al., 2014) does result 
in topology simplification. Thus, our observations point at additional mechanisms 
that control how much topoisomerases deal with torsional stress in the cell. Topo II 
is not sufficient to account for complete decatenation by chromosome segregation; 




probably other molecules and/or chromosome movement (during mitosis) affect the 
activity of topo II in space and time.  
6.1.2 Catenane formation during DNA replication 
Empirically, whether replication termination alone gives rise to catenation, or 
whether precatenanes form during elongation has not been decided. 
Understanding topological changes during replication has proven challenging, due 
to the fact that the topology of replication intermediates might be affected upon 
their isolation. Moreover, minichromosomes, due to their small size, are quickly 
replicated, and in unchallenged cells it is technically impossible to isolate 
replication intermediates without the introduction of artificial replication fork barriers. 
Thus, whether catenation arises from precatenanes generated during replication 
elongation or from replication termination is not easily distinguishable.  
We have used our loop out system to probe budding yeast chromosomes 
for precatenane formation. We first analysed the topology of regions around a 
replication origin during elongation but before termination events. This indicated 
that intertwinings are present before termination events. In addition, we saw that 
introduction of the RFB sequence— which triggers a polar fork barrier and specifies 
a termination site— in our ARS loop out did not substantially increase the levels of 
intertwines. Our results suggest that precatenanes do form during replication 
elongation, and that termination events probably do not create more intertwines 
than elongating forks (Figures 3-17 & 3-18), which is in line with previous evidence 
in other model systems (Cebrian et al., 2015; Lucas et al., 2001; Peter et al., 1998). 
Precatenanes are formed when (+) supercoiling ahead of the replisome is 
transmitted to the region in its wake; a prediction of this model is that inhibiting topo 
I would result in an increase in precatenanes (as long as topo II cannot completely 
compensate for the lack of topo IB activity). Upcoming lines of research could look 
into this, by inhibiting topo I (e.g. using topo I inhibitors and/or poisons in the PDR 
mutant strain). 
Although the fact that catenanes are detectable before termination (Section 
3.8.1) clearly argues for the precatenane model, there are a couple of caveats. 
First, the use of hydroxyurea and its effects on replication fork progression could 
alter the topology of the replicon: topoisomerases oppose topological constraints 




generated by the replisome, and both machineries have their own reaction/activity 
rates. Under our conditions (i.e. 0.1 M hydroxyurea), where replisomes have 
slowed down, topoisomerases could still be working at their original rates; thus, this 
would create an artificial situation where topoisomerases have removed more 
torsional stress than is normally generated. Moreover, in our conditions there may 
be some termination events (between forks coming from ARS507 and ARS508). 
These are probably too few to give rise to detectable catenanes; besides, analysis 
of replication progression between 60 and 90 min post release from G1-arrest— 
where most of the excision reaction occurs— suggests that the few termination 
events occur towards the 90 min time point. Nevertheless, future experiments will 
focus on looping out the region around ARS508 in a strain where ARS507 has 
been deleted (ΔARS507; Figure 6-2a). 
 
Figure 6-2. Future experiments to study catenane formation along native 
chromosomes 
a) Deletion of ARS507 will provide a region completely free of termination events 
between the looped out ARS508 and ARS507. b) In addition, we could avoid the 
use of HU by constructing a system containing two constitutive RFBs (to block the 
outgoing forks from the ARS of interest), and inducible RFBs pausing the incoming 
forks from nearby replication origins. 
 
Additionally, although it has been shown that ectopically placed RFB 
sequences are effective (Cebrian et al., 2014), we still need to measure the 
proportion of forks that stall in RFB-containing loop outs under our experimental 
conditions. Finally, a more conclusive experiment would be to loop out a replication 
origin that is farther away from neighbouring origins, if possible in the absence of 
HU. This would possibly require the constitutively expressed Cre-ER construct, so 
that recombination occurs before replication of additional origins and subsequent 




termination events. Alternatively, we could make use of replication fork barriers to 
allow replication to progress at normal speeds, while preventing termination. For 
example, ARS508 could be surrounded by constitutive RFBs stopping the outgoing 
forks from this origin. Two inducible RFB sequences (e.g. the Tus/Ter system; 
Larsen et al., 2014) could be placed adjacent to the constitutive barriers, but in the 
opposite direction, i.e. to inducibly pause the incoming forks from ARS507 and 
ARS510 (Figure 6-2b). 
 
6.2 Topo II activity across the genome 
In eukaryotes, the division of labour between the different topoisomerase 
enzymes dealing with torsional stress generated during DNA transactions remains 
unclear. Whether topos act uniformly across the entire genome is also not 
completely understood, with evidence suggesting differential topo II requirements 
at telomeric regions (Germe et al., 2009) and mitotic centromeres, (Bachant et al., 
2002; Dawlaty et al., 2008; Christensen et al., 2002). Mapping the association of 
these enzymes to chromatin has not particularly helped to clear these issues, as 
they are abundant and their association with their substrate is highly dynamic. 
ChIP–based studies in higher eukaryotes have been able to specifically map 
the activity, rather than the association, of topoisomerases with chromatin, by 
trapping the cleavage complexes using topoisomerase poisons (Baranello et al., 
2016; Dykhuizen et al., 2013). In yeast, similar assays have not been possible, 
because of the network of efflux pump/ABC transporters that interfere with the 
accumulation of topoisomerase poisons in the cells. In this work, we map 
topoisomerase activity across the budding yeast genome for the first time. We were 
able to do this by interfering with the PDR gene network, namely, by repressing the 
expression of the efflux pumps, which in turn allows the intracellular accumulation 
of etoposide and camptothecin. We based our strategy on a previously published 
construct (Stepanov et al., 2008) that targets the main PDR transcriptional 
regulator, in combination with two additional mutations in the PDR gene network 
(Section 4.1).  
Chapter 4, thus, shows a new strategy to selectively target active 
topoisomerases in budding yeast. We generated a useful tool and optimized the 




conditions of an assay that allows the previously inaccessible analysis of 
topoisomerases actively engaged in their topology-remodelling reactions along 
budding yeast chromosomes. Importantly, we show that this assay is reproducible, 
and although we note that further experimental work and analyses are required, our 
preliminary experiments provide some interesting observations. 
First, we noticed potential differences between topoisomerase association 
and activity on chromatin. During S phase, topo II activity markedly correlates with 
replisome progression, underscoring the role of this topoisomerase in removing 
replication-induced topological stress (Section 4.3.1). Furthermore, the association 
and activity patterns of endogenous and ectopic topo II enzymes (i.e. 
Saccharomyces cerevisiae topo II and Chlorella virus topo II, respectively) highly 
correlate (Section 4.3.2). Although preliminary, this suggests that topological stress 
(supercoils and catenanes) is probably sufficient to recruit type II topoisomerases 
to chromatin. In contrast, at the centromeric region we mainly detect the active 
population of topo II. Similar observations had been made in higher eukaryotes 
(Porter & Farr, 2004; Rattner et al., 1996), but, again, because of the inefficacy of 
etoposide in yeast cells, this had not been shown in S. cerevisiae. Why would 
active topo II accumulate at this region in S phase? Perhaps it could be triggered 
by spindle microtubule–kinetochore attachments, which already are formed in this 
phase of the cell cycle. In the absence of spindles (i.e. nocodazole arrest) the 
accumulation is still present, but it seems less substantial (we note that this 
requires confirmation, e.g. through qPCR).  A second possibility is that, due to the 
fact that the ectopic CV topo II is not as markedly enriched at this locus, there may 
be a regulatory basis (rather than a topological one) to account for the enhanced 
accumulation of endogenous topo II at centromeres. One likely scenario is that this 
centromeric topo II represents the sumoylated population of the enzyme 
(Takahashi et al., 2006). Further tests, including a G2/M arrest in the presence of 
mitotic spindles (i.e. depletion of Cdc20), as well as using non-sumoylatable 
mutants of topo II will help clarify these questions. At the last stages of mitosis, 
topological interlinks must be resolved to allow chromosome segregation; thus, an 
important future experiment will compare topo II activity in cells arrested in 
metaphase with cells released into anaphase. 
 Importantly, further experiments will focus on validating these initial results. 
A better time resolution during S phase could potentially helps us determine 




whether topo II works ahead and/or behind the fork, which would, in the latter case, 
provide evidence for precatenane resolution. Moreover, we will focus on 
replication-specific torsional stress by using transcription inhibitors (e.g. thiolutin), 
to remove torsional stress generated by the transcription machinery.  
6.2.1 Organization of chromosomes 
Bacterial chromosomes are covalently closed circular molecules seemingly 
organized into distinct topological domains (Sinden & Pettijohn, 1981; Postow et al., 
2004). Modulation of helical tension is mostly dependent on the type II 
topoisomerases topo IV and gyrase (Joshi et al., 2010). Eukaryotic chromosomes, 
however, are linear and organized into more complex chromatin fibres (Joshi et al., 
2010). Whether helical tension is confined to topological domains that are 
demarcated by tight boundary barriers is a controversial issue (Esposito & Sinden, 
1988; Freeman & Garrard, 1992; Joshi et al., 2010). Topoisomerases and DNA 
transactions are the main factors known to dissipate and generate, respectively, 
torsional stress in eukaryotic chromosomes (Salceda et al., 2006; Liu & Wang, 
1987), although more extensive research to analyse the topology of these large 
DNA molecules will be required to determine the relative contribution of each factor 
towards chromosome topological homeostasis. 
The notion of tight constraints holding chromosomes in budding yeast has 
been recently questioned. Cells lacking topo I and topo II activities and expressing 
the bacterial topA– which targets (-) sc for relaxation– present the expected 
reduction in transcription due to overaccumulation of (+) sc in most genes; however, 
transcription of genes within 100 kb from the telomere is not affected, suggesting 
that torsional stress is diffused through the chromosome ends, and therefore they 
must not be tightly held or bound (Joshi et al., 2010). Moreover, the gradual 
transcriptional stall (from telomeres towards internal regions of the chromosomes) 
indicates that helical stress dissipates slowly— as the rotation of the chromatin 
fibre overcomes the viscous rotational drag— and homogenously, arguing against 
strict barriers determining distinct topological domains (Joshi et al., 2010). 
Our experiments also suggest that tight, permanent barriers separating 
topological domains are unlikely to be present in budding yeast. The finding that 
catenanes are present in most loci tested using the loop out system suggests that 




intertwinings are possibly mobile and argues against strong barriers preventing 
their movement. Moreover, we find similar catenane densities across different 
chromosomal regions, indicating that their diffusion along chromosomes over time 
probably proceeds until reaching equilibrium. Additionally, our preliminary analysis 
of the topoisomer pattern of telomeric loop outs suggests that there may be some 
degree of rotation around chromosomal ends that allows the dissipation of torsional 
stress, which manifests as a ladder of differentially supercoiled monomers and the 
absence of catenated species. Although previous results (Joshi et al., 2010) and 
our data together argue against the presence of fixed, static topological domains, 
our detection methods cannot distinguish between the absence of barriers or the 
presence of dynamic barriers that allow some degree of movement and rotation. 
Ideally, this idea could be tested by artificially (and tightly) tethering telomeres to, 
for example, the nuclear membrane, and assessing the topology of the telomeric 
region or measuring the transcriptional effect (in top1Δ, top2-4, topA cells); 
however, such a strategy might not be technically feasible. 
6.3 Catenation and SCC 
A striking observation of this study is the fact that low levels of catenanes are 
present throughout most chromosomal loci tested. This is surprising because it 
implies that a notable amount of decatenation by topo II occurs in a short span of 
time (from G2/M until anaphase). The prevalence of catenanes after S-phase leads 
to the question of whether they have a role in chromosome organization and are 
actively maintained until chromosome segregation, or whether they are merely by-
products of DNA replication. A parallel idea has been recently demonstrated for 
topo I: it is recruited to the transcriptional machinery at the time of pause release, 
and its activity is stimulated to remove supercoils alongside the elongating RNA 
polymerase (Baranello et al., 2016). In the case of topo II, it could be prevented 
from removing all catenanes immediately after their formation if DNA catenation 
contributes to maintaining SCC (Diaz-Martinez et al., 2008; Murray & Szostak, 
1985). We tested this hypothesis by expressing the ectopic CV topo II that would 
not be modulated by putative budding yeast regulatory pathways, which indeed led 
to increased premature separation of sister chromatids (Section 5.2). We ascribe 
this effect to the ability of CV topo II to remove residual catenanes that endogenous 




topo II leaves behind, rather than some impairment of chromosome integrity. 
However, further experiments are needed to corroborate this observation, and 
ensure that it is not an indirect effect, e.g. CV topo II affecting the levels and/or 
localization of cohesin on chromosomes, rather than catenanes. 
Importantly, the fact that chromosomes are catenated in G2/M and that their 
intertwining might contribute towards SCC circumstantially argues against the 
existence of the so-called ‘catenation checkpoint’, at least as a sensor of 
intertwinings. The idea of such checkpoint came about observations that topo II 
inhibitors (which were originally thought not to cause DNA damage) caused cells to 
arrest in mitosis. The catenation checkpoint has been associated with ATM/ATR 
signalling (Deming et al., 2001), presents DNA damage signature features like 
phosphorylation of histone H2AX (Mikhailov et al., 2002) and results in a reduction 
in the activities of Polo-like kinase I, and Cdk1-cyclin B1 (Deming et al., 2002). 
Importantly, it was originally proposed that checkpoint activation was triggered 
upon high levels of DNA catenation. There is, however, no direct evidence 
suggesting that catenanes are used as signals for a pathway that results in a cell 
cycle arrest or delay. Indeed, it is hard to consolidate the idea of such a checkpoint 
with the fact that depletion of budding yeast topo II prior to DNA replication does 
not lead to a delay in mitotic entry, and only results in DNA damage and lagging 
chromosomes at mitotic exit, in manner that is dependent on the formation of the 
septin ring (Baxter & Diffley, 2008). Considering the observations made in this work, 
namely, that G2/M chromosomes are catenated, and that catenation may 
contribute towards complete SCC, it is unlikely that cells would sense these 
intertwinings to trigger a cell cycle delay. 
 
6.4 Concluding remarks 
We used site-specific recombination to analyse the local topology of several 
chromosomal regions. This enabled us to address, for the first time, questions 
regarding the nature of DNA intertwinings. Thus, we report here that catenanes 
persist along chromosomes through G2/M, both at replication origins and regions of 
replication termination. Moreover, their presence is not restricted to cohesin-binding 
sites, nor it is excluded from condensin-associated regions. Our results indicate 




precatenanes form during the elongation step of DNA replication. Termination does 
not substantially contribute towards catenane formation, probably because 
catenanes form evenly during the replication process. Finally, we propose that 
catenanes contribute to sister chromatid cohesion, which in turn may explain why 
some catenanes are allowed to persist until chromosome segregation. 
It has been over 60 years since the proposal of the double helix as the 
structure of the genetic blueprint. Since then, we have formed a “big picture” of the 
implications of this structure, the multitude of topological relationships that are 
generated during DNA transactions. We have also encountered the cellular 
effectors that control DNA topology, the topoisomerase family of enzymes, and 
have characterized their biochemical and structural properties. However, we are 
still far from elucidating the whole story. Indeed, their evolutionarily origin remains 
mysterious: why so many different topoisomerase flavours to deal with probably 
similar topological challenges? We need to fully understand the topologies that 
arise during DNA metabolism, the kind of substrates that topos have to work on in 
the cell (which can probably not be deciphered using in vitro experiments with 
plasmids). Studies similar to the work presented here are required to comprehend 
how topoisomerization is carried out in authentic eukaryotic chromosomes. Finally, 
future lines of research need to follow up on putative regulatory mechanisms that 
direct topoisomerase activity to ensure that chromosome topology is adequate for a 


















Chapter 7. Appendix 
7.1 Distribution and biochemistry of topoisomerases 
Table 8. Classification of the major types of topoisomerases  
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B: bacteria; A: Archaea; P: Plants; E; eukaryotes; SP: strand passage; R: rotation. 
(Adapted from Sissi & Palumbo, 2009) 
7.2 SMC complexes 
 
Figure 7-1. Eukaryal SMC complexes 
Schematic representation of the three SMC complexes found in eukaryotes: 





7.3 Construction of loxP /Cre loop out strains 
7.3.1 Introduction of loxP sites across the genome 
Table 9. Primers for the construction of the loxP/Cre strains 































Gagttcctacatttatacgaaggtaaaattgtaaaaaacatgaatgcggcccgttgagtcactgtcga/                          





TER ggcttttgcctttgccgtaccgatcgggaaattgtgcccctgaaagattccgtt ccgttgagtcactgtcga/                   








catttcttcggacattgataacttcg                  
TER 
701 
ttgggtcgtgtataatgatacatattaacaactggggagttcaaaagttgcctt ccgttgagtcactgtcga/                              
accaacctaattacaaatacttcgaagtgactatcataagtttccttatctagcg ccatacttcttcggacat    
ccatttaatcttatgtagttacattatactgtcattttagttgcagtaagtatacttttttatctagtctttttttctg 
cactgtcgaataacttcgtataa/      
gttcacatagcatagaattgtataatacagaaataacaatatattagagtttagtagaattctgagtcttttctca
aaaaaaaggttcttcggacattgataacttcg                      
TER 
1004 
agacctcttgctgcagttcacaaccaaaaatagcatatctttactattgtcccgttgagtcactgtcga /                            







agacctcttgctgcagttcacaaccaaaaatagcatatctttactattgtcccgttgagtcactgtcga /                           





Primers for the construction of loop out strains (loxP/Cre system); primers were 
ordered from Sigma Aldrich, 0.05 μM HPLC purified. For each strain, the primer 
pair for introducing the loxP upstream is shown in grey, and for the downstream 
loxP in black. 
 
7.3.2 Checking the loxP strains 
Table 10. Primers for genotyping and sequencing of the loxP /Cre strains 



















tccggtcattccacggtaat                               
cttccttgttggactgctt                                
ggcagtgataaacttttgg 
ttggtgttaacttgagcg 
TER404 cacatattactgataaggatggac                                                    
acattgcgatcttatcaacttatt                                                    
ctttcttaccggcgaagt                                                          
aacaccacctcctgaaaga                                                         
TER603 ggttccaggaacccatagg                                                       
cacatgtgatttatagttctcctcc   
gtctcgcctcgaaggcaa                                                        
gttcggtctggataaggtagc                                                     
TER 701 ccaaggattgagcagctt                                                                    
tttgcgcgtcgattgac                                                                     
ggcaatgaccacatggaattaaa                                                               
gaagtggcctaggtcac                                                               
TER1004 cagtaaagacagctgggaa                                                             
ctatctgttgttcttgttcttcc                                                         
caaacgattgatgtccacttg                                                          
caagctcttcaacaccgatc                                                            
TER1004b cagtaaagacagctgggaa                                                             
ctatctgttgttcttgttcttcc                                                         
tgggattgagatatagtgaacctc                                                        
gcgaaaatagcgatagatcgag                                                          
Primer pairs for genotyping and sequencing for each loxP strain are shown. 
Introduction of the loxP-K.l.URA3-loxP was checked by a genotyping PCR. 
Excision of the cassette (leaving a single loxP in the chromosome) was further 
confirmed by sequencing. 
7.4 Construction of attB/ϕ31C 
7.4.1 Introduction of attB and attP sites across the genome 
Table 11. List of primers for the construction of the attB/ϕ31C strains 




































Primers for the construction of loop out strains (attB/ϕ31C system); primers were 
ordered from Sigma Aldrich, 0.05 μM HPLC purified. For each strain, the primer 
pair for introducing the attB site is shown in grey, and for the attP site in black. 
 
7.4.2 Checking the attB/ϕ31C strains 
Table 12. List of primers used for genotyping and sequencing the attB/ϕ31C 
strains 









TER603 ggttccaggaacccatagg                                                       
cacatgtgatttatagttctcctcc   
gtctcgcctcgaaggcaa                                                        









Primer pairs for genotyping and sequencing for each loxP strain are shown. 
Introduction of the attB-K.l URA3 and the attP-KanMX cassettes was confirmed by 
genotyping and sequencing PCRs. 
 
7.5 Detection of loop outs 
Table 13. List of probes used in this study 












































































ABDURASHIDOVA, G., RADULESCU, S., SANDOVAL, O., ZAHARIEV, S., DANAILOV, M.B., 
DEMIDOVICH, A., SANTAMARIA, L., BIAMONTI, G., RIVA, S., FALASCHI, A. (2007). 
Functional interactions of DNA topoisomerases with a human replication origin. EMBO J. 26, 
998-1009. 
ABREMSKI, K., FROMMER, B., HOESS, R.H. (1986). Linking-number changes in the DNA 
substrate during cre-mediated loxP site-specific recombination. J. Mol. Biol. 192, 17-26. 
ACKERMAN, P., GLOVER, C.V., OSHEROFF, N. (1988). Phosphorylation of DNA 
topoisomerase II in vivo and in total homogenates of Drosophila Kc cells. The role of casein 
kinase II. J. Biol. Chem. 263, 12653-12660. 
ADACHI, N., MIYAIKE, M., IKEDA, H., KIKUCHI, A. (1992). Characterization of cDNA encoding 
the mouse DNA topoisomerase II that can complement the budding yeast top2 mutation. 
Nucleic Acids Res, 20, 5297-5303. 
ADRIAN, M., TEN HEGGELER-BORDIER, B., WAHLI, W., STASIAK, A.Z., STASIAK, A. 
DUBOCHET, J. (1990). Direct visualization of supercoiled DNA molecules in solution. The 
EMBO J. 9, 4551. 
AGOSTINHO, M., RINO, J., BRAGA, J., FERREIRA, F., STEFFENSEN, S., FERREIRA, J. 
(2004). Human topoisomerase II alpha: targeting to subchromosomal sites of activity during 
interphase and mitosis. Mol. Biol. Cell 15, 2388-2400. 
ALMAGRO, S., RIVELINE, D., HIRANO, T., HOUCHMANDZADEH, B., DIMITROV, S. (2004). 
The mitotic chromosome is an assembly of rigid elastic axes organized by structural 
maintenance of chromosomes (SMC) proteins and surrounded by a soft chromatin envelope. J. 
Biol. Chem. 279, 5118-5126. 
ALONSO-SARDUY, L., RODUIT, C., DIETLER, G., KASAS, S. (2011). Human topoisomerase 
II-DNA interaction study using atomic force microscopy. FEBS Letter 385, 3139-3145. 
ALSNER, J., SVEJSTRUP, J.Q., KJELDSEN, E., SORENSEN, B.S., WESTERGAARD, O. 
(1992). Identification of an N-terminal domain of eukaryotic DNA topoisomerase I dispensable 
for catalytic activity but essential for in vivo function. J. Biol. Chem. 267, 12408–12411. 
ALTSCHUL, S.F., GISH, W., MILLER, W., MYERS, E.W. & LIPMAN, D.J. (1990). Basic local 
alignment search tool. J. Mol. Biol. 215, 403-410. 
ANDERSEN, C.L., WANDALL, A., KJELDSEN, E., MIELKE, C., KOCH, J. (2002). Active, but 
not inactive, human centromeres display topoisomerase II activity in vivo. Chromosome Res. 
10, 305-312. 
ANDREWS, C.A., VAS, A.C., MEIER, B., GIMENEZ-ABIAN, J.F., DIAZ-MARTINEZ, L.A., 
GREEN, J., ERICKSON, S.L., VARDERWALL, K.E., HSU, W.S., CLARKE, D.J. (2006). A 
mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts 





ANTONIACCI, L.M. & SKIBBENS, R.Y. (2006). Sister-chromatid telomere cohesion is 
nonredundant and resists both spindle forces and telomere motility. Curr. Biol. 16, 902-906 
AZARO, M.A. & LANDY, A. (2002).  integrase and the  Int family. In Mobile DNA genetic 
elements II. ASM Press, Washington, DC, pp 118-148. 
AZUMA, Y., ARNAOUTOV, A., DASSO, M. (2003). SUMO-2/3 regulates topoisomerase II in 
mitosis. J. Cell Biol. 163, 477-487. 
BAASE, W.A. & WANG, J.C. (1974) Ι protein from Drosophila melanogaster. Biochemistry 13, 
4299-4303. 
BACHANT, J., ALCASABAS, A., BLAT, Y., KLECKNER, N., ELLEDGE, S. J. (2002). The 
SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of 
DNA topoisomerase II. Mol. Cell. 9, 1169-1182. 
BACHRATI, C.Z. & HICKSON, I.D. (2003). RecQ helicases: suppressors of tumorigenesis and 
premature aging. Biochem. J. 374, 577-606. 
BALDWIN, E.L. & OSHEROFF, N. (2005). Etoposide, topoisomerase II and cancer. Curr. Med. 
Chem. Anticancer Agents 5, 363–372. 
BALZI, E. & GOFFEAU, A. (1995). Yeast multidrug resistance: the PDR network. J. Bioenerg. 
Biomembr. 27, 71-76. 
BARANELLO, L., WOJTOWICZ, D., CUI, K., DEVAIAH, B.N., CHUNG, H.J., CHAN-SALIS, K.Y., 
GUHA, R., WILSON, K., ZHANG, X., ZHANG, H., PIOTROWSKI, J., THOMAS, C.J., SINGER, 
D.S., PUGH, B.F., POMMIER, Y., PRZYTYCKA, T.M., KOUZINE, F., LEWIS, B.A., ZHAO, K., 
LEVENS, D. (2016). RNA polymerase II regulates topoisomerase 1 activity to favor efficient 
transcription. Cell 165, 357-371. 
BATES, A.D., O’DEA, M.H., GELLERT, M. (1996). Energy coupling in Escherichia coli DNA 
gyrase: the relationship between nucleotide binding, strand passage and DNA supercoiling. 
Biochemistry 35, 1409-1416. 
BATES, A.D. & MAXWELL, A. (2005). DNA topology. New York: Oxford University Press. 
BATES, A.D. & MAXWELL, A. (2007). Energy coupling in type II topoisomerases: why do they 
hydrolize ATP? Biochem. 46, 7929-7941. 
BAUER, W.R., RESSNER, E.C., KATES, J., PATZKE, J.V. (1977). A DNA nicking-closing 
enzyme encapsidated in vaccinia virus: partial purification and properties. Proc. Natl. Acad. Sci. 
USA 74, 1841-1845. 
BAUER PI, BUKI KG, COMSTOCK JA, KUN E (2000) Activation of topoisomerase I by poly 
[ADP-ribose] polymerase. Int. J. Mol. Med. 5, 533–540. 
BAXTER, J. & ARAGON, L. (2012). A model for chromosome condensation based on the 
interplay between condensin and topoisomerase II. Trends Genet 28, 110-117. 
BAXTER, J., SEN, N., MARTINEZ, V.L., DE CARANDINI, M.E., SCHVARTZMAN, J.B., 
DIFFLEY, J.F., ARAGON, L. (2011). Positive supercoiling of mitotic DNA drives decatenation by 





BAXTER, J. & DIFFLEY, J.F. (2008). Topoisomerase II inactivation prevents the completion of 
DNA replication in budding yeast. Mol. Cell 30, 790-802. 
BELTEKI, G., GERTSENSTEIN, M., OW, D.W., NAGY, A. (2003). Site-specific cassette 
exchange and germline transmission with mouse ES cells expressing φC31 integrase. Nature 
Biotech. 21, 321-324. 
BENSIMON, D., SIMON, A., CROQUETTE, V., BENSIMON, A. (1995). Stretching DNA with a 
receding meniscus: experiments and models. Phys. Res. Lett. 74, 4754-4757. 
BERGERAT, A., DE MASSY, B., GADELLE, D., VAROUTAS, P.C., NICOLAS, A., FORTERRE, 
P. (1997). An atypical topoisomerase II from Archaea with implications for meiotic 
recombination. Nature 386, 414-417. 
BERMEJO, R., BRANZEI, D., FOIANI, M. (2008). Cohesion by topology: sister chromatids 
interlocked by DNA. Genes Dev. 22, 2297-2301. 
BERMEJO, R., DOKSANI, Y., CAPRA, T., KATOU, Y.M., TANAKA, H., SHIRAHIGE, K., 
FOIANI, M. (2007). Top1- and Top2-mediated topological transitions at replication forks ensure 
fork progression and stability and prevent DNA damage checkpoint activation. Genes Dev. 21, 
1921-1936. 
BERMUDEZ, I., GARCIA-MARTINEZ, J., PEREZ-ORTIN, J.E., ROCA, J. (2010). A method for 
genome-wide analysis of DNA helical tension by means of psoralen-DNA photobinding. Nucleic 
Acid Res. 38, e182 
BERMUDEZ-LOPEZ, M., CESCHIA, A., DEPICCOLI, G., COLOMINA, N., PASERO, P., 
ARAGON, L., TORRES-ROSELL, J. (2010). The Smc5/6 complex is required for dissolution of 
DNA-mediated sister chromatid linkages. Nucleic Acids Res.38, 6502-6512. 
BHALLA, N., BIGGINS, S., MURRAY, A.W. (2002). Mutation of YCS4, a budding yeast 
condensin subunit, affects mitotic and nonmitotic chromosome behaviour. Mol. Biol. Cell 13, 
632-645. 
BHAT, M.A., PHILIP, A.V., GLOVER, D.M., BELLEN, H.J. (1996) Chromatid segregation at 
anaphase requires the barren product, a novel chromosome-associated protein that interacts 
with topoisomerase II. Cell 87, 1103-1114. 
BHRIAIN , N.N. & DORMAN, C.J. (1993). Isolation and characterization of a topA mutant of 
Shigella flexneri. Mol. Microbiol. 7, 351-358. 
BI, X. & BROACH, J.R. (1997). DNA in transcriptionally silent chromatin assumes a distinct 
topology that is sensitive to cell cycle progression. Mol. Cell. Biol. 17, 7077-7087 
BLOOM, K.S. & CARBON, J. (1982). Yeast centromere DNA is in a unique and highly ordered 
structure in chromosomes and small circular minichromosomes. Cell 29, 305-317. 
BLOOM, K. (2008). Beyond the code: the mechanical properties of DNA as they relate to 
mitosis. Chromosoma 117, 103-110. 
BOCQUET, N., BIZARD, A.H., ABDULRAHMAN, W., LARSEN, N.B., FATY, M., CAVADINI, S., 





Structural and mechanistic insight into Holliday-junction dissolution by Topoisomerase IIIα and 
RMI1. Nature Struct. Mol. Biol. 21,  261-268. 
BOTCHAN, P., WANG, J.C., ECHOLS, H. (1973). Effect of circularity and superhelicity on 
transcription from bacteriophage λ DNA. Proc. Natl. Acad. Sci. USA 70, 3077-3081. 
BRANZEI, D. & FOIANI, M. (2008). Regulation of DNA repair throughout the cell cycle. Nature 
Rev. Mol. Cell Biol. 9, 297-308. 
BREIER, A.M., WEIER, H.U., COZZARELLI, N.R. (2005). Independence of replisomes in 
Escherichia coli chromosomal replication. Proc. Natl. Acad. Sci. 102, 3942-3947. 
BRILL, S.J., DINARDO, S., VOELKEL-MEIMAN, K., STERNGLANZ, R. (1987). Need for DNA 
topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA. 
Nature 326, 414-416. 
BROWN, P.O. & COZZARELLI, N.R. (1981). Catenation and knotting of duplex DNA by type 1 
topoisomerases: a mechanistic parallel with type 2 topoisomerases. Proc. Natl. Acad. Sci. 
USA 31, 843-847. 
BUCK, D. (2009). DNA topology. Applications of knot theory (Proc. Sympos. Appl. Math., 66, 
Amer. Math. Soc., 2009), pp.47-79. 
BUCK, G.R. & ZECHIEDRICH, E.L. (2004). DNA disentangling by type-2 topoisomerases. J. 
Mol. Biol. 340, 933-939 
BURGESS, S.M. & KLECKNER, N. (1999). Collisions between yeast chromosomal loci in vivo 
are governed by three layers of organization. Genes Dev. 13, 1871-1883. 
BURNIER, Y., DORIER, J., STASIAK, A. (2008). DNA supercoiling inhibits DNA knotting. 
Nucleic Acids Res. 36, 4956-4963. 
CARDENAS, M.E., DANG, Q., GLOVER, C.V. & GASSER, S.M. (1992). Casein kinase II 
phosphorylates the eukaryote-specific C-terminal domain of topoisomerase II in vivo. EMBO J. 
11, 1785. 
CARON, P.R., WATT, P. & WANG, J.C. (1994). The C-terminal domain of Saccharomyces 
cerevisiae DNA topoisomerase II. Mol. Cell Biol. 14, 3197-3207. 
CAPRANICO, G. & BINASCHI, M. (1998). DNA sequence selectivity of topoisomerases and 
topoisomerase poisons. Biochim. Biophys. Acta 1400, 185-194. 
CEBRIAN, J., CASTAN, A., MARTINEZ, V., KADOMATSU-HERMOSA, M.J., PARRA, C., 
FERNANDEZ-NESTOSA, M.J., SCHAERER, C., HERNANDEZ, P., KRIMER, D.B., 
SCHVARTZMAN, J.B. (2015). Direct evidence for the formation of precatenanes during DNA 
replication. J. Biol. Chem. 290, 13725-13735. 
CEBRIAN, J., MONTURUS, E., MARTINEZ-ROBLES, M.L., HERNANDEZ, P., KRIMER, D.B., 
SCHVARTZMAN, J.B. (2014). Topoisomerase 2 is dispensable for the replication and 
segregation of small yeast artificial chromosomes (YACs). PloS one 9, e104995. 
CEJKA, P., PLANK, J. L., DOMBROWSKI, C. C., KOWALCZYKOWSKI, S. C. (2012). 
Decatenation of DNA by the S. cerevisiae Sgs1–Top3–Rmi1 and RPA complex: A mechanism 





CERRITELLI, S.M., CHON, H., CROUCH, R.J. (2011). A new twist for topoisomerase. Science 
332, 1510-1511. 
CHAMPOUX, J.J. (2001). DNA topoisomerases: structure, function, and mechanism. Annu. 
Rev. Biochem. 70, 369-413. 
CHAMPOUX, J.J. & BEEN, M. (1980). Mechanistic studies of DNA replication and genetic 
recombination. In ICN-UCLA symposia on molecular and cellular biology (ed. B. Alberts), 
pp. 909-815. Academic, New York.  
CHAMPOUX, J.J. & DULBECCO, R. (1972). An activity from mammalian cells that untwists 
superhelical DNA- a possible swivel for DNA replication. Proc. Natl. Acad. Sci. USA 74, 1841-
1845. 
CHAN, K.L., NORTH, P.S., HICKSON, I.D. (2007). BLM is required for faithful chromosome 
segregation and its localization defines a class of ultrafine anaphase bridges. EMBO J. 26, 
3397-3409. 
CHANG, C.R., WU, C.S., HOM, Y., GARTENBERG, M.R. (2005). Targeting of cohesin by 
transcriptionally silent chromatin. Genes Dev. 19, 3031-3042. 
CHARBIN, A., BOUCHOUX, C., UHLMANN, F. (2014). Condensin aids sister chromatid 
decatenation by topoisomerase II. Nucleic Acids Res. 42,340-348. 
CHARVIN, G., BENSIMON, D., CROQUETTE, V. (2003). Single-molecule study of DNA 
unlinking by eukaryotic and prokaryotic type-II topoisomerases. Proc. Natl. Acad. Sci. USA 
100, 9820-9825. 
CHARVIN, G., STRICK, T.R., BENSIMON, D, CROQUETTE, V. (2005). Tracking 
topoisomerase activity at the single-molecule level. Annu. Rev. Biophys. Biomol. Struct. 34, 
201-219. 
CHEN, Y.T., WU, J., MODRICH, P., HSIEH, T.S. (2016). The C-terminal 20 amino acids of 
drosophila topoisomerase 2 are required for binding to a BRCA1 C Terminus (BRCT) domain-
containing protein, Mus101, and fidelity of DNA segregation. JBC 291, 13216-13228. 
CHENG, C., KUSSIE, P., PAVLETICH, N., SHUMAN, S. (1998). Conservation of structure and 
mechanism between eukaryotic topoisomerase I and site-specific recombinases. Cell 92, 841-
850. 
CHUNG, H.M., SHEA, C., FIELDS, S., TAUB, R.N., VAN DER PLOEG, L.H.T., TSE, D.B. 
(1990). Architectural organization in the interphase nucleus of the protozoan Trypanosoma 
brucei: location of telomeres and mini-chromosomes. EMBO J. 9, 2611-2619. 
CHRISTENSEN, M. O., LARSEN, M.K., BARTHELMES, H.U., HOCK, R., ANDERSEN, C.L., 
KJELDSEN, F., KNUDSEN, B.R., WESTERNGAARD, O., BOEGE, F., MIELKE, C. (2002). 
Dynamics of human DNA topoisomerases IIα and IIβ in living cells. J. Cell Biol. 157, 31-44. 
CHRISTENSEN, M.O., KROKOWSKI, R.M., BARTHELMES, H.U., HOCK, R., BOEGE, F., 
MIELKE, C. (2004) Distinct effects of topoisomerase I and RNA polymerase I inhibitors suggest 






CIOSK, R., SHIRAYAMA, M., SHEVCHENKO, A., TANAKA, T., TOTH, A., SHEVCHENKO, A. 
& NASMYTH, K. (2000). Cohesin’s binding to chromosomes depends on a separate complex 
consisting of Scc2 and Scc4 proteins. Mol. Cell 5, 243-254. 
CLARKE, D.J. (ed.) (2009). DNA topoisomerases. Methods in Mol. Biol. 582, DOI 
10.1007/978-1-60761-340-4_1 ©Humana Press. 
CLARKE, L. & CARBON, J. (1980). Isolation of a yeast centromere and construction of 
functional small circular chromosomes. Nature 287, 504-509. 
COEHLO, P.A., QUEIROZ-MACHADO, J., SUNKEL, C.E. (2003). Condensin-dependent 
localisation of topoisomerase II to an axial chromosomal structure is required for sister 
chromatid resolution during mitosis. J. Cell Sci. 116, 4763-4776. 
COOK, P.R. (1991). The nucleoskeleton and the topology of replication. Cell 66, 627-635 
CORBETT, K.D., SCHOEFFLER, A.J., THOMSEN, N.D., BERGER, J.M. (2005). The structural 
basis for substrate specificity in DNA topoisomerase IV. J. Mol. Biol. 351, 545-561. 
CRISONA, N.J., STRICK, T.R., BENSIMON, D., CROQUETTE, V. & COZZARELLI, N.R. (2000) 
Preferential relaxation of positively supercoiled DNA by E. coli topoisomerase IV in single-
molecule and ensemble measurements. Genes Dev., 14, 2881–2892. 
CRISONA, N.J. & COZZARELLI, N.R. (2006). Alteration of Escherichia coli topoisomerase IV 
conformation upon enzyme binding to positively supercoiled DNA. J. Biol. Chem. 281, 18927-
18932. 
CUVIER, O. AND HIRANO, T. (2003). A role of topoisomerase II in linking DNA replication to 
chromosome condensation. J. Cell Biol. 160, 645-655. 
D’AMBROSIO, C., KELLY, G., SHIRAHIGE, K., UHLMANN, F. (2008a). Condensin-dependent 
rDNA decatenation introduces a temporal pattern to chromosome segregation. Current Biol. 18, 
1084-1088. 
D’AMBROSIO, C., SCHMIDT, C.K., KATOU, Y., KELLY, G., ITOH, T., SHIRAHIGE, K., 
UHLMANN, F. (2008b). Identification of cis-acting sites for condensing loading onto budding 
yeast chromosomes. Genes & Dev. 22, 2215-2227. 
D’AMOURS, D., STEGMEIER, F., AMON, A. (2004). Cdc14 and condensing control the 
dissolution of cohesion-independent linkages at repeated DNA. Cell 117, 455-469. 
D’ARPA, P., BEARDMORE, C., LIU, L.F. (1990). Involvement of nucleic acid synthesis in cell 
killing mechanisms of topoisomerase poisons. Cancer Res.50, 6916-6924. 
DASSO, M. (2008). Emerging roles of the SUMO pathway in mitosis. Cell Div. 2, 5. 
DAVEY, C.A., SARGENT, D.F., LUGER, K., MAEDER, A.W., RICHMOND, T.J. (2002). Solvent 
mediated interactions in the structure of the nucleosome core particle at 1.9 a resolution. J. Mol. 
Biol. 319, 1097-1113. 
DAWLATY, M.M., MALUREANU, I., JEGANATHAN, K.B., KAO, F., SUSTMANN, C., TAHK, S., 
SHUAI, K., GORSSCHEDL, R., VAN DEURSEN, J.M. (2008). Resolution of sister centromeres 





DEEHAN KENNEY, R. & HEALD, R. (2006). Essential roles for cohesion in kinetochore and 
spindle function in Xenopus egg extracts. J. Cell Sci. 119, 5057-5066 
DEIBLER, R.W., MANN, J.K., DE SUMMERS, W.L., ZECHIEDRICH, L. (2007). Hin-mediated 
DNA knotting and recombining promote replicon dysfunction and mutation. BMC Mol. Biol. 8, 
44. 
DELBRÜCK M. (1954). On the replication of deoxyribonucleic acid (DNA). Proc. Natl. Acad. 
Sci. USA 40, 783–788 
DELIUS, H. & WORCEL, A. (1974). Electron microscopic visualization of the folded 
chromosome of Escherichia coli. J. Mol. Biol. 82, 107IN1109-108IN2. 
DEMING, P.B., CISTULLI, C.A., ZHAO, H., GRAVES, P.R., PIWNICA-WORMS, H., PAULES, 
R.S., DOWNES, C.S., KAUFMANN, W.K. (2001). The human decatenation checkpoint. Proc. 
Natl. Acad. Sci. USA 98, 12044-12049. 
DEMING, P.B., FLORES, K.G., DOWNES, C.S., PAULES, R.S., KAUFMANN, W.K. (2002). 
ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase. 
J. Biol. Chem. 277, 36832-36838. 
DE PICCOLI, G., CORTES-LEDESMA, F., IRA, G., TORRES-ROSELL, J., UHLE, S., FARMER, 
S., HWANG, J.Y., MACHIN, F., CESCHIA, A., MCALEENAN, A., CORDON-PRECIADO, V., 
CLEMENTE-BLANCO, A., VILELLA-MITJANA, F., ULLAL, P., JARMUZ, A., LEITAO, B., 
BRESSAN, D., DOTIWALA, F., PAPUSHA, A., ZHAO, X., MYUNG, K., HABER, J.E., 
AGUILERA, A. & ARAGON, L. (2006). Smc5–Smc6 mediate DNA double-strand-break repair 
by promoting sister-chromatid recombination. Nature Cell Biol. 8,1032-1034. 
DEVORE, R.F., CORBETT, A.H. AND OSHEROFF, N. (1992). Phosphorylation of 
Topoisomerase II by Casein Kinase II and Protein Kinase C: Effects on Enzyme-mediated DNA 
Cleavage/Religation and Sensitivity to the Antineoplastic Drugs Etoposide and 4′-(I-
Acridinylamino) methane-sulfon-m-anisidide. Cancer Res. 52, 2156-2161. 
DEWAR, J.M., BUDZOWSKA, M., WALTER, J.C. (2015). The mechanism of DNA replication 
termination in vertebrates. Nature 525, 345-350. 
DEWAR, H., TANAKA, K., NASMYTH, K., TANAKA, T.U. (2004). Tension between two 
kinetochores suffices for their bi-orientation on the mitotic spindle. Nature 428, 93-98. 
DEWEESE, J.E., OSHEROFF, M.A., OSHEROFF, N. (2009). DNA topology and 
topoisomerases: teaching a “knotty” subject. Biochem. Mol. Biol. Educ. 37, 2-10. 
DEWEESE, J.E. & OSHEROFF, N.  (2009). The DNA cleavage reaction of topoisomerase II: 
wolf in sheep’s clothing. Nucleic Acids Res. 37, 738-748.  
DIAZ-INGELMO, O., MARTINEZ-GARCIA, B., SEGURA, J., VALDES, A., ROCA, J. (2015). 
DNA topology and global architecture of point centromeres. Cell Reps. 13, 667-677. 
DIAZ-MARTINEZ, L.A., GIMENEZ-ALBIAN, J.F., AZUMA, Y., GUACCI, V., GIMENEZ-
MARTINEZ, G., LANIER, L.M., CLARKE, D.J. (2006). PIASγ is required for faithful chromosome 





DIAZ-MARTINEZ, L.A., GIMENEZ-ALBIAN, J.F., CLARKE, D.J. (2008). Chromosome 
cohesion- rings knots and fellowship. J. Cell. Sci. 121, 2107-2114. 
DINARDO, S., VOELKEL, K., STERNGLANZ, R. (1984). DNA topoisomerase II mutant of 
Saccharomyces cerevisiae: Topoisomerase II is required for segregation of daughter molecules 
at the termination of DNA replication. Proc. Natl. Acad. Sci. USA 81, 2616-2620. 
DINGMAN, C.W. (1974). Bidirectional chromosome replication: some topological considerations. 
J. Theor. Biol. 43, 187-195. 
DONG, K.C. & BERGER, J.M. (2007). Structural basis for gate-DNA recognition and bending by 
type IIA topoisomerases. Nature 450, 1201-1205. 
DOWNES, C.S., CLARKE, D.J., MULLINGER, A.M., GIMENEZ-ABIAN, J.F., CREIGHTON, 
A.M., JOHNSON, R.T. (1994). A topoisomerase II-dependent G2 cycle checkpoint in 
mammalian cells. Nature 372, 467-470. 
DROLET, M. (2006). Growth inhibition mediated by excess negative supercoiling: the interplay 
between transcription elongation, R‐loop formation and DNA topology. Mol. Microbiol. 59, 723-
730. 
DROLET, M., PHOENIX, P., MENZEL, R., MASSÉ, E., LIU, L.F. & CROUCH, R.J. (1995). 
Overexpression of RNase H partially complements the growth defect of an Escherichia coli 
delta topA mutant: R-loop formation is a major problem in the absence of DNA topoisomerase I. 
Proc. Natl. Acad. Sci. USA, 92, 3526-3530. 
DUGUET, M. (1997). When helicase and topoisomerase meet! J. Cell Sci. 110, 1345-1350. 
DYKHUIZEN, E.C., HARGREAVES, D.C., MILLER, E.L., CUI, K., KORSHUNOV, A., KOOL, M., 
PFISTER, S., CHO, Y.J., ZHAO, K., CRABTREE, G.R. (2013). BAF complexes facilitate 
decatenation of DNA by topoisomerase IIα. Nature 497, 624-627. 
EDGERTON, H., JOHANSSON, M., KEIFENHEIM, D., MUKHERJEE, S., CHACON, J.M., 
BACHANT, J., GARDNER, M., CLARKE, D.J. (2016).  A noncatalytic function of the 
topoisomerase II CTD in Aurora B recruitment to inner centromeres during mitosis. J. Cell Biol. 
213, 651-664. 
EL SAYYED, H., LE CHAT, L., LEBAILLY, E., VICKRIDGE, E., PAGES, C., CORNET, F., 
LAGOMARSINO, M.C., ESPELI, O. (2016). Mapping Topoisomerase IV binding and activity 
sites on the E. coli genome. PLoS Genet. 12, e1006025.  
EMBLETON, M.L., VOLOGODSKII, A.V., HALFORD. S.E. (2004). Dynamics of DNA loop 
capture by the SfiI restriction endonuclease on supercoiled and relaxed DNA. J. Mol. Biol. 339, 
53-66. 
ESPELI, O., LEVINE, C., HASSING, H., MARIANS, K.J. (2003). Temporal regulation of 
topoisomerase IV activity in E-coli. Mol. Cell 11, 189-201 
ESPOSITO, F. & SINDEN, R.R. (1988). DNA supercoiling and eukaryotic gene expression. Oxf. 
Surv. Eukaryot. Genes 5, 1-50. 
FACHINETTI, D., BERMEJO, R., COCITO, A., MINARDI, S., KATOU, Y., KANOH, Y., 





at eukaryotic chromosomes is mediated by topo II and occurs at genomic loci containing 
pausing elements. Mol. Cell. 39,595-605. 
FALASCHI, A. (2000). Eukaryotic DNA replication: a model for a fixed double replisome. 
Trends Genet. 16, 88-92. 
FARCAS, A.M., ULUOCAK, P. HELMHART, W., NASMYTH, K. (2011). Cohesin’s 
concatenation of sister DNAs maintains their intertwining. Mol. Cell 44, 97-107 
FARNSHAW, W.C., HALLIGAN, B., COOKE, C.A., HECK, M.M., LIU, L.F. (1985). 
Topoisomerase II is a structural component of mitotic chromosome scaffolds. J. Cell Biol. 100, 
1706-1715. 
FERGUSON, M. & WARD, D.C. (1992). Cell cycle dependent chromosomal movement in pre-
mitotic human T-lymphocyte nuclei. Chromosoma 101, 557-565. 
FIELD-BERRY, S.C. & DEPAMPHILIS, M.L (1989). Sequences that promote formation of 
catenated intertwines during termination of DNA replication. Nucleic Acids Res, 17, 3261-3273. 
FLORIDIA, G., ZATTERALE, A., ZUFFARDI, O., TYLER-SMITH, C. (2000). Mapping of a 
human centromere onto the DNA by topoisomerase II cleavage. EMBO Rep. 1, 489-493. 
FORTERRE, P. & GADELLE, D. (2009). Phylogenomics of DNA topoisomerases: their origin 
and putative roles in the emergence of modern organisms. Nucleic Acids Res. 37, 679-692. 
FORTERRE, P. GRIBALDO, S., GADELLE, D. SERRE, M.C. (2007). Origin and evolution of 
DNA topoisomerases. Biochimie 89, 427-446. 
FORTUNE, J.M., LAVRUKHIN, O.V., GURNON, J.R., VAN ETTEN, J.L., LLOYD, S., 
OSHEROFF, N. (2001). Topoisomerase II from Chlorella virus PBCV-1 has an exceptionally 
high DNA cleavage activity. J. Biol. Chem. 276, 24401-24408. 
FORTUNE, J.M., & OSHEROFF, N. (2000). Topoisomerase II as a target for anticancer drugs: 
when enzymes stop being nice. Prog. Nucl. Acid. Res. Mol. Biol. 64, 221-253. 
FRANKLIN, R. & GOSLING, R.G. (1953). Molecular configuration in sodium thymonucleate. 
Nature 171, 740-741. 
FREEMAN, L.A. & GARRARD, W.T. (1992). DNA supercoiling in chromatin structure and gene 
expression. Crit. Rev. Eukaryot. Gene Expr. 2, 165-209. 
FRIEDMAN, K. & BREWER, B. (1995) Analysis of replication intermediates by two-dimensional 
agarose gel electrophoresis. Meth. Enzymol. 262, 613-627. 
FURUYAMA, T. & HENIKOFF, S. (2009). Centromeric nucleosomes induce positive DNA 
supercoils. Cell 138, 104-113. 
GALANDE, S. & MUNIYAPPA, K. (1997). Effects of nucleosomes and antitumor drugs on the 
catalytic activity of type II topoisomerase from rat testis. Biochem. Pharmacol. 53, 1229-1238 
GALLEGO-PAEZ, L.M., TANAKA, H., BANDO, M., TAKAHASHI, M., NOZAKI, N., NAKATO, R., 
SHIRAHIGE, K., HIROTA, T. (2014). Smc5/6-mediated regulation of replication progression 






GARTERNBERG, M.R., & WANG, J.C. (1992) Positive supercoiling of DNA greatly diminishes 
mRNA synthesis in yeast. Proc. Natl. Acad. Sci. USA 89, 11461-11465.  
GARTENBERG, M.R. & WANG, J.C. (1993). Identification of barriers to rotation of DNA 
segments in yeast from the topology of DNA rings excised by an inducible site-specific 
recombinase. Proc. Natl. Acad. Sci. USA 90, 10514-10518. 
GELLERT, M., MIZUUCHI, K., O’DEA, M.H., NASH, H.A. (1976a). DNA gyrase: an enzyme that 
introduces superhelical turns into DNA. Proc. Natl. Acad. Sci. USA 73, 3872-3876. 
GELLERT, M., O’DEA, M.H., ITOH, T., TOMIZAWA, J.I. (1976b). Novobiocin and coumermycin 
inhibit DNA supercoiling catalysed by DNA gyrase. Proc. Natl. Acad. Sci. USA 74, 4474-4478. 
GERLICH, D., BEAUDOUIN, J., KALBFUSS, B., DAIGLE, N., EILS, R., ELLENBERG, J. (2003). 
Global chromosome positions are transmitted through mitosis in mammalian cells. Cell 112, 
751-764. 
GERME, T., MILLER, K. & COOPER, J.P. (2009). A non-canonical function of topoisomerase II 
in disentangling dysfunctional telomeres. EMBO J. 28, 2803-2811. 
GERMOND, J.E., ROUVIERE-YANIV, J., YANIV, M., BRUTLAG, D. (1979). Nicking-closing 
enzyme assembles nucleosome-like structures in vitro. Proc. Natl. Acad. Sci. USA 76, 3770-
3783. 
GOBERT, C., BRACCO, L., ROSSI, F., OLIVIER, M., TAZI, J., LAVELLE, F., LARSEN, A.K., 
RIOU, J.F. (1996). Modulation of DNA topoisomerase I activity by p53. Biochemistry 35,5778–
5786. 
GOODWIN, A., WANG, S.W., TODA, T., NORBURY, C., HICKSON, I.D. (1999).Topoisomerase 
III is essential for accurate nuclear division in Schizosaccharomyces pombe. Nucleic Acids 
Res. 27, 4050-4058. 
GORBSKY, G.J. (1994). Cell cycle progression and chromosome segregation in mammalian 
cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 [(+)-1,2-bis(3,5-
dioxopiperazinyl-1-yl)propane; ADR-529] and ICRF-159 (Razoxane). Cancer Res. 54, 1042-
1048. 
GOTO, T. & WANG, J.C. (1982). Yeast topoisomerase II. J. Biol. Chem. 257, i5866-5872. 
GOTO, T., & WANG, J.C. (1984). Yeast DNA topoisomerase II is encoded by a single-copy, 
essential gene. Cell 36, 1073-1080. 
GRAINGE, I. & JAYARAM, M. (1999). The integrase family of recombinases: organization and 
function of the active site. Mol. Microbiol. 33, 449-456. 
GROTH, A.C., OLIVARES, E.C., THYGARAJAN, B., CALOS, M.P. (2000). A phage integrase 
directs efficient site-specific integration in human cells. Proc. Natl. Acad. Sci. USA 97, 5995-
6000. 
GROTH, A.C., FISH, M., NUSSE, R., CALOS, M.P. (2004). Construction of transgenic 
Drosophila by using the site-specific integrase from phage φC31. Genetics 166, 1775-1782. 
GUACCI, V., HOGAN, E., KOSHLAND, D. (1994). Chromosome condensation and sister 





HABER, J.E., THORBURN, P.C., ROGERS, D. (1984). Meiotic and mitotic behavior of dicentric 
chromosomes in Saccharomyces cerevisiae. Genetics 106, 185-205. 
HAERING, C., FARCAS, A.M., ARUMUGAM, O., METSON, J. NASMYTH, K. (2008). The 
cohesin ring concatenates sister DNA molecules. Nature 454, 297-301. 
HALMER, L., VESTNER, B., GRUSS, C. (1998). Involvement of topoisomerases in the initiation 
of simian virus 40 minichromosome replication. J. Biol. Chem. 273, 34792-34798. 
HANDE, K.R. (1998) Etoposide: four decades of development of a topoisomerase II inhibitor. 
Eur. J. Cancer 34, 1514–1521. 
HARMON, F.G., DIGATE, R.J., KOWALCZYKOWSKI, S.C. (1999). ReqQ helicase and 
topoisomerase III comprise a novel DNA strand passage function: a conserved mechanism for 
control of DNA recombination. Mol. Cell. 3, 611-620. 
HAYAMA, R. & MARIANS, K.Y. (2010). Physical and functional interaction between the 
condensin MukB and the decatenase topoisomerase IV in Escherichia coli. Proc. Natl. Acad. 
Sci. USA 107, 18826-18831. 
HEDIGER, F., NEUMANN, F.R., VAN HOUWE, G., DUBRANA, K., GASSER, S.M. (2002). Live 
imaging of telomeres, ku and sir proteins define redundant telomere-anchoring pathways in 
yeast. Curr. Biol. 12, 2076-2089. 
HERSHEY, A.D., BURGI, E., INGRAHAM, L. (1963). Cohesion of DNA molecules isolated from 
phage lambda. Proc. Natl. Acad. Sci. USA 49, 748-755. 
HIASA H. & MARIANS, K.J. (1994) Topoisomerase III, but not topoisomerase I, can support 
nascent chain elongation during theta-type DNA replication. J. Biol. Chem. 269, 32655-32659. 
HIRANO, T. (2000). Chromosome cohesion, condensation, and separation. Annu. Rev. 
Biochem. 69, 115-144. 
HIRANO, T. (2010). How to separate entangled sisters: interplay between condensin and 
decatenase. Proc. Natl. Acad. Sci. USA 107, 18749-18750. 
HIRANO, T., FUNAHASHI, S.I., UEMUERA, T., YANAGIDA, M. (1986). Isolation and 
characterization of Schizosaccharomyces pombe cut mutants that block nuclear division but not 
cytokinesis. EMBO J. 5, 2973-2979. 
HOLM, C., GOTO, T., WANG, J.C., BOTSTEIN, D. (1985). DNA topoisomerase II is required at 
the time of mitosis in yeast. Cell 41, 553-563. 
HOLM, C.O., STEARNS, T., BOTSTEIN, D. (1989). DNA topoisomerase II must act at mitosis 
to prevent nondisjunction and chromosome breakage. Mol. Cell Biol. 9, 159-168. 
HOLM, C.  (1994).Coming undone:  how to untangle a chromosome. Cell 77, 955-957. 
HOLMES, V.F. & COZZARELLI, N.R. (2000). Closing the ring: links between SMC proteins and 
the partitioning, condensation and supercoiling of chromosomes. Proc. Natl. Acad. Sci. USA 
97, 1322-1324. 
HOUCHMANDZADEH, B., MARKO, J.F., CHATENAY, D., LIBCHABER, A. (1997). Elasticity 
and structure of eukaryote chromosome studied by micromanipulation and micropipette 





HSIANG, Y.H. & LIU, L.F. (1985). Identification of mammalian DNA topoisomerase I as an 
intracellular target of the anticancer drug camptothecin. Cancer Res. 48, 1722-1726. 
HU, Y., CLOWER, R.V., MELENDY, T. (2006). Cellular topoisomerase I modulates origin 
binding by bovine papilloma virus type 1 E1. J. Virol. 80, 4363-4371. 
HUERTAS, P. & AGUILERA, A. (2003). Cotranscriptionally formed DNA: RNA hybrids mediate 
transcription elongation impairment and transcription-associated recombination. Mol. Cell 12, 
711-721. 
IROBALIEVA, R.N., FOGG, J.M., CATANESE, D.J., SUTTHIBUTPONG, T., CHEN, M., 
BARKER, A.K., LUDTKE, S.J., HARRIS, S.A., SCHMID, M.F., CHIU, W. AND ZECHIEDRICH, 
L. (2015). Structural diversity of supercoiled DNA. Nature Comms. 6. 
ISHIDA, R., TAKASHIMA, R., KOUJIN, T., SHIBATA, M., NOZAKI, N., SETO, M., MORI, H., 
HARAGUCHI, T. AND HIRAOKA, Y. (2001). Mitotic specific phosphorylation of serine-1212 in 
human DNA topoisomerase II alpha. Cell Struct. Funct. 26, 215-226. 
IVANOV, D., & NASMYTH, K. (2008). A physical assay for sister chromatid cohesion in vitro. 
Mol. Cell 27, 300-310. 
JACOB, F., BRENNER, S., CUZIN, F. (1963). On the regulation of DNA replication in bacteria. 
Cold Spring Harbor Symp. Quant. Biol. 28, 329-347. 
JACKSON, D.A. & COOK, P.R. (1986). Replication occurs at the nucleoskeleton. EMBO J. 5, 
1403-1410. 
JENSEN, S., ANDERSEN, A.H., KJELDSEN, E., BIERSACK, H., OLSEN, E.H., ANDERSEN, 
T.B., WESTERGAARD, O., JAKOBSEN, B.K (1996). Analysis of functional domain organization 
in DNA topoisomerase II from humans and Saccharomyces cerevisiae. Mol. Cell. Biol. 16, 
3866-3877. 
JENSEN, L.H., DEJLIGBJERG, M., HANSEN, L.T., GRAUSLIND, M., JENSEN, P.B., 
SEHESTED, M. (2004). Characterisation of cytotoxicity and DNA damage induced by the 
topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in 
yeast and mammalian cells. BMC Pharmacol. 4, 31. 
JEPPSSON, K., CARLBORG, K.K., NAKATO, R., BERTA, D.G., LILIENTHAL, I., KANNO, T., 
LINDQVIST, A., BRINK, M.C., DANTUMA, N.P., KATOU, Y., SHIRAHIGE, K., SJÖGREN, C. 
(2014). The chromosomal association of the Smc5/6 complex depends on cohesion and 
predicts the level of sister chromatid entanglement. PLoS Genet. 10, e1004680. 
JOSHI, R.S., PIÑA, B., ROCA, J. (2010). Positional dependence of transcriptional inhibition by 
DNA torsional stress in yeast chromosomes. EMBO J. 29, 740-748. 
JOSHI, R.S., PIÑA, B., ROCA, J. (2012). Topoisomerase II is required for the production of long 
Pol II gene transcripts in yeast. Nucleic Acids Res. 40, 7907-7915. 
KAMPRANIS, S.C. & MAXWELL, A. (1996). Conversion of DNA gyrase into a conventional type 
II topoisomerase. Proc. Natl. Acad. Sci. USA 93, 14416-14421. 
KAMPRANIS, S.C., BATES, A.D., MAXWELL, A. (1999). A model for the mechanism of strand 





KARAYAN, L., RIOU, J.F., SEITE, P., MIGEON, J., CANTEREAU, A., LARSEN, C.J. (2001). 
Human ARF protein interacts with topoisomerase I and stimulates its activity. Oncogene 20, 
836–848. 
KAS , E. & LAEMMLI, U.K. (2001). In vivo topoisomerase II cleavage of the Drosophila histone 
and satellite III repeats: DNA sequence and structural characteristics. EMBO J. 11, 705-716. 
KAUFMANN, S.H. (1998). Cell death induced by topoisomerase-targeted drugs: more questions 
than answers. Biochim. Biophys. Acta Gene Struct. Expr. 1400, 195-211. 
KAWAMURA, R., POPE, L.H., CHRISTENSEN, M.O., SUN, M., TEREKHOVA, K., BOEGE, F., 
MIELKE, C., ANDERSEN, A.H., MARKO, J.F. (2010). Mitotic chromosomes are constrained by 
topoisomerase II-sensitive DNA entanglements. J. Cell Biol. 188, 653-663.  
KAWANISHI, M. (1993). Topoisomerase I and II activities are required for Epstein-Barr virus 
replication. J. Gen. Virol. 74, 2263-2268. 
KEENEY, S., GIROUX, C.N. & KLECKNER, N. (1997) Meiosis-specific DNA double-strand 
breaks are catalyzed by Spo11, a member of a widely conserved protein family. Cell, 88, 375–
384. 
KEGEL, A., BETTS-LINDROOS, H., KANNO, T., JEPPSSON, K., STROM, L., KATOU, Y., 
ITOH, T., SHIRAHIGE, K., SJOGREN, C. (2011). Chromosome length influences replication-
induced topological stress. Nature 471, 392-396. 
KIKUCHI, Y. & NASH, H.A. (1979). Nicking-closing activity associated with bacteriophage 
lambda int gene product. Proc. Natl. Acad. Sci. USA 76, 3760-3764. 
KIM, N., HUANG, S.N., WILLIAMS, J., LI, Y.C., CLARK, A.B., CHO, J.E., KUNKEL, T.A., 
POMMIER, Y., JINKS-ROBERTSON, S. (2011). Mutagenic processing of ribonucleotides in 
DNA by yeast topoisomerase I. Science 332, 1561-1564. 
KIM, R.A. & WANG, J.C. (1989a). Function of DNA topoisomerases as replication swivels in 
Saccharomyces cerevisiae. J. Mol. Biol. 208, 257-267. 
KIM, R.A. & WANG, J.C. (1989b). A subthreshold level of DNA topoisomerases leads to the 
excision of yeast rDNA as extrachromosomal rings. Cell 57, 975-985. 
KIM, R.A. & WANG, J.C. (1992). Identification of the yeast TOP3 gene product as a single 
strand-specific DNA topoisomerase. J.  Biol. Chem. 267, 17178-17185. 
KIMURA, K. & HIRANO, T. (1997). ATP-dependent positive supercoiling of DNA by 13S 
condensing: a biochemical implication for chromosome condensation. Cell 90, 625-634. 
KIRKEGAARD, K. & WANG, J.C. (1981). Mapping the topography of DNA wrapped around 
gyrase by nucleolytic and chemical probing of complexes of unique DNA sequences. Cell 23, 
721-729. 
KOBAYASHI, T., NOMURA, M., HORIUCHI, T. (2001). Identification of DNA cis elements 
essential for expansion of ribosomal DNA repeats in Saccharomyces cerevisiae. Mol. Cell. Biol. 
21, 136-147. 
KORNBERG, A. (1984). Enzyme studies on the replication of the Escherichia coli chromosome. 





KOSHLAND, D., & HARTWELL, L.H. (1987). The structure of sister minichromosome DNA 
before anaphase in Saccharomyces cerevisiae. Science 238, 1713-1716 
KOSTER, D.A., CROQUETTE, V., DEKKER, C., SHUMAN, S., DEKKER, N.H. (2005) Friction 
and torque govern the relaxation of DNA supercoils by eukaryotic topoisomerase Iβ. Nature 343, 
671-674. 
KRAMLINGER, V.M. & HIASA, H. (2006). The ‘‘GyrA-box’’ is required for the ability of DNA 
gyrase to wrap DNA and catalyze the supercoiling reaction. J. Biol. Chem., 281, 3738–3742. 
KRETZSCHMAR, M., MEISTERERNST, M., ROEDER, R.G. (1993). Identification of human 
DNA topoisomerase I as a cofactor for activator-dependent transcription by RNA polymerase II. 
Proc. Natl. Acad. Sci. USA 90, 11508–11512 
KREUZER, K.N. & COZZARELLI, N.R. (1980). Formation and resolution of DNA catenanes by 
DNA gyrase. Cell 20, 245-254. 
KROGH, B.O. & SHUMAN, S. (2000). Catalytic mechanism of DNA topoisomerase IB. Mol. Cell 
5, 1035-1041. 
KROGH, B.O. & SHUMAN, S. (2002). A poxvirus-like type IB topoisomerase family in bacteria. 
Proc. Natl. Acad. Sci. USA, 99, 1853–1858. 
KWAN, K.Y. & WANG, J.C. (2001). Mice lacking DNA topoisomerase IIIβ develop to maturity 
but show a reduced mean lifespan. Proc. Natl. Acad. Sci. USA 98, 5717-5727. 
LAINE, J.P., OPRESKO, P.L., INDIG, F.E., HARRIGAN, J.A., VON KOBBE, C., BOHR, V.A. 
(2003) Werner protein stimulates topoisomerase I DNA relaxation activity. Cancer Res 63, 
7136–7146. 
LANE, A.B., GIMENEZ-ABIAN, J.F., CLARKE, D.J. (2013). A novel chromatin tether domain 
controls topoisomerase Iiα dynamics and mitotic chromosome formation. J. Cell Biol. 200, 471-
486. 
LAPONOGOV, I., VESELKOV, D.A., CREVEL, I.M.T., PAN, X.S., FISHER, L.M. & 
SANDERSON, M.R. (2013). Structure of an ‘open’ clamp type II topoisomerase-DNA complex 
provides a mechanism for DNA capture and transport. Nucleic acids research 41, 9911-9923. 
LARSEN, N.B., SASS, E., SUSKI, C., MANKOURI, H.W, HICKSON, I.D. (2014). The 
Escherichia coli Tus–Ter replication fork barrier causes site-specific DNA replication 
perturbation in yeast. Nature Comms. 5. 
LAVOIE, B.D, HOGAN, E., KOSHLAND, D. (2002). In vivo dissection of the chromosome 
condensation machinery: reversibility of condensation distinguishes contributions of condensin 
and cohesin. J. Cell Biol. 156, 805-815. 
LAVRUKHIN, O.V., FORTUNE, J.M., WOOD, T.G., BURBANK, D.E., VAN ETTEN, J.L. & 
LLOYD, R.S. (2000). Topoisomerase II from Chlorella virus PBCV-1: Characterization of the 
smallest known type II topoisomerase. J. Biol. Chem. 275. 6915-6921. 
LEBEL, M., SPILLARE, E.A., HARRIS, C.C., LEDER, P. (1999). The Werner syndrome gene 
product co-purifies with the DNA replication complex and interacts with PCNA and 





LEPPARD, J.B., CHAMPOUX, J.J. (2005). Human DNA topoisomerase I: relaxation, roles, and 
damage control. Chromosoma 114, 75-85. 
LEVINE, C. & MARIANS, K.J. (1998). Identification of dnaX as a high-copy suppressor of the 
conditional lethal and partition phenotypes of the parE10 allele. J. Bacteriol. 180, 1232-1240. 
LEVINE, C., HIASA, H. AND MARIANS, K. (1998). DNA gyrase and topoisomerase IV: 
biochemical activities, physiological roles during chromosome replication, and drug sensitivities. 
BBA Gene Struct. Express. 1400, 29-43. 
LI, X. & MANLEY J.L. (2006). Cotranscriptional processes and their influence on genome 
stability. Genes Dev. 20,.1838-1847. 
LI, Y., STEWART, N.K., BERGER, A.J., VOS, S., SCHOEFFLER, A.J., BERGER, J.M., CHAIT, 
B.T. & OAKLEY, M.G. (2010). Escherichia coli condensin MukB stimulates topoisomerase IV 
activity by a direct physical interaction. Proc. Natl. Acad. Sci. USA 107,18832-18837. 
LI, W. & WANG, J.C. (1998). Mammalian DNA topoisomerase IIIα is essential in early 
embryogenesis. Proc. Natl. Acad. Sci. USA 95, 1010-1013. 
LINKA, R.M., PORTER, A.C., VOLKOV, A., MIELKE, C., BOEGE, F. & CHRISTENSEN, M.O. 
(2007). C-terminal regions of topoisomerase IIα and IIβ determine isoform-specific functioning of 
the enzymes in vivo. Nucleic Acids Res. 35, 3810-3822. 
LIPPERT, M.J., KIM, N., CHO, J.E., LARSON, R.P., SCHOENLY, N.E., O'SHEA, S.H. AND 
JINKS-ROBERTSON, S. (2011). Role for topoisomerase 1 in transcription-associated 
mutagenesis in yeast. Proc. Natl. Acad. Sci. USA 108, 698-703. 
LISTER, J.A. (2010). Transgene excision in zebrafish using the phiC31 integrase. Genesis 48, 
137-143. 
LIU, Z., DEIBLER, R.W., CHAN, H.S., ZECHIEDRICH, L. (2009). The why and how of DNA 
unlinking. Nucleic Acids Res. 37, 661-671. 
LIU, L.F., LIU, C.C., ALBERTS, B.M. (1980). Type II DNA topoisomerases: enzymes that can 
unknot a topologically knotted DNA molecule via a reversible double strand break. Cell 19, 697-
707. 
LIU, L.F., PERKOCHA, L., CALENDAR, R., WANG, J.C. (1981). Knotted DNA from 
bacteriophage capsids. Proc. Natl. Acad. Sci. USA 78, 5498-5502. 
LIU, L.F., ROWE, T.C., YANG, L., TEWEY, K.M., CHEN, G.L. (1983) Cleavage of DNA by 
mammalian DNA topoisomerase II. J. Biol. Chem., 258, 15365–15370. 67. 
LIU, L.F. & WANG, J.C. (1978). Micrococcus luteus DNA gyrase: active components and a 
model for its supercoiling of DNA. Proc. Acad. Sci. USA 75, 2098-2102. 
LIU, L.F. & WANG, J.C. (1981). DNA-DNA gyrase complex: the wrapping of the DNA duplex 
outside the enzyme. Cell 15, 979-984. 
LIU, L.F. & WANG, J.C. (1987). Supercoiling of the DNA template during transcription. Proc. 





LOPEZ, C.R., YANG, S., DEIBLER, R.W., RAY, S.A., PENNINGTON, J.M., DIGATE, R.J., 
HASTINGS, P.J., ROSENBERG, S.M., ZECHIEDRICH, E.L. (2005). A role for topoisomerase III 
in a recombination pathway alternative to RuvABC. Mol. Microbiol. 58, 80-101. 
LOU, Z., MINTER-DYKHOUSE, K., CHEN, J. (2005). BRCA1 participates in DNA decatenation. 
Nature Struct. Mol. Biol. 12, 589-593. 
LUCAS, I., GERME, T., CHEVRIER-MILLER, M., HYRIEN, O. (2001). Topoisomerase II can 
unlink replicating DNA by precatenane removal. EMBO J. 20, 6509-6519. 
LYNN, R., GIAEVER, G., SWANBERG, S.L., WANG, J.C. (1986). Tandem regions of yeast 
DNA topoisomerase II share homology with different subunits of bacterial gyrase. Science 233, 
647-649. 
MACHÍN, F., TORRES-ROSELL, J., JARMUZ, A. & ARAGÓN, L. (2005). Spindle-independent 
condensation-mediated segregation of yeast ribosomal DNA in late anaphase. J. Cell Biol. 168, 
209-219. 
MANICHANH, C., ROCA, J. (2013). Topoisomerase II minimizes DNA entanglements by 
proofreading DNA topology after DNA strand passage Nucleic Acid Res. gkt1037. 
MAO, Y., DESAI, S.D., LIU, L.F. (2000). SUMO-1 conjugation to human DNA topoisomerase II 
isozymes. J. Biol. Chem. 275, 26066-26073. 
MARCHETTI, F., BISHOP, J.B., LOWE, X., GENEROSO, W.M., HOZIER, J., WYROBEK, A.J. 
(2001). Etoposide induces heritable chromosomal aberrations and aneuploidy during male 
meiosis in the mouse. Proc. Natl. Acad. Sci. USA 98, 3952-3957. 
MARKO, J.F. (2008). Micromechanical studies of mitotic chromosomes. Chromosome Res. 16, 
469-497. 
MARKO, J.F. & SIGGIA, E.D. (1997). Polymer models of meiotic and mitotic chromosomes. Mol. 
Biol. Cell, 8, 2217-2231. 
MARTINCIC, D. & HANDE, K.R. (2005) Topoisomerase II inhibitors. Cancer Chemother. Biol. 
Response Modif. 22, 101–121. 
MARTINEZ-GARCIA, B., FERNANDEZ, X., DIAZ-INGELMO, O., RODRIGUEZ-CAMPOS, A.,  
MATERA, A.G. (1999). Nuclear bodies: multifaceted subdomains of the interchromatin space. 
Trends Cell Biol. 9, 302-309. 
MCCLENDON, A.K. & OSHEROFF, N. (2007). DNA topoisomerase II, genotoxicity, and cancer. 
Mutat. Res.-Fund. Mol. M. 623, 83-97. 
MCCLENDON, A.K., RODRIGUEZ, A.C. & OSHEROFF, N. (2005) Human topoisomerase IIα 
rapidly relaxes positively supercoiled DNA: implications for enzyme action ahead of replication 
forks. J. Biol. Chem. 280, 39337–39345. 
MCDONALD, W.H., PAVLOVA, Y., YATES, J.R. 3RD, BODDY, M.N. (2003). Novel essential 
DNA repair proteins Nse1 and Nse2 are subunits of the fission yeast Smc5-Smc6 complex. J. 
Biol. Chem. 278, 45460-45467. 
MCGUFFEE, S.R., SMITH, D.J., WHITEHOUSE, I. (2013). Quantitative, genome-wide analysis 





MEGEE, P.C. AND KOSHLAND, D. (1999). A functional assay for centromere-associated sister 
chromatid cohesion. Science 285, 254-257. 
MICHAELIS, C., CISOK, R., NASMYTH, K. (1997). Cohesins: chromosomal proteins that 
prevent premature separation of sister chromatids. Cell 91, 35-45. 
MIKHAILOV, A., COLE, R.W., RIEDER, C.L. (2002). DNA damage during mitosis in human 
cells delays the metaphase/anaphase transition via the spindle-assembly checkpoint. Curr. Biol. 
12, 1797-1806. 
MIRKIN, S.M. (2001). DNA topology: fundamentals. Encyclopedia of Life Sciences, DOI: 
10.1038/npg.els.0001038. 
MIRKIN, E.V. & MIRKIN, S.M. (2005). Mechanisms of transcription-replication collisions in 
bacteria. Mol. Cell. Biol. 25, 888-895. 
MISTELI, T. (2001). Protein dynamics: implications for nuclear architecture and gene 
expression. Science 291, 843-847. 
MITCHELL, J.S. & HARRIS, S.A. (2013). Thermodynamics of writhe in DNA minicircles from 
molecular dynamics simulations. Phys. Rev. Lett. 110, 148105. 
MITCHELL, J.S., LAUGHTON, C.A., HARRIS, S.A. (2011). Atomistic simulations reveal bubbles, 
kinks and wrinkles in supercoiled DNA. Nucleic Acids Res. 39, 2928-3938. 
MITKOVA, A.V., BISWAS-FISS, E.E., BISWAS, S.B. (2005). Modulation of synthesis in 
Saccharomyces cerevisiae nuclear extract by DNA polymerases and the origin recognition 
complex. J. Biol. Chem. 280, 6285-6292. 
MO, Y.Y., WANG, C., BECK, W.T. (2000). A novel nuclear localization signal in human DNA 
topoisomerase I. J. Biol. Chem. 275, 41107–41113. 
MONDAL, N. & PARVIN, J.D. (2001). DNA topoisomerase IIα is required for RNA polymerase II 
transcription on chromatin templates. Nature 413,435-438. 
MORHAM, S.G., KLUCKMAN, K.D., VOULOMANOS, N., SMITHIES, O. (1996). Targeted 
disruption of the mouse topoisomerase I gene by camptothecin selection. Mol. Cell Biol. 16, 
6804-6809. 
MORRISON, C., HENZING, A.J., JENSEN, O.N., OSHEROFF, N., DODSON, H., KANDELS‐
LEWIS, S.E., ADAMS, R.R. AND EARNSHAW, W.C. (2002). Proteomic analysis of human 
metaphase chromosomes reveals topoisomerase II alpha as an Aurora B substrate. Nucleic 
Acids Res. 26, 5318-5327. 
MURAKAMI, S., YANAGIDA, M., NIWA, O. (1995). A large circular minichromosome of 
Schizosaccharomyces pombe requires a high dose of type II DNA topoisomerase for its 
stabilization. Mol. Gen. Genet. 246, 671-679. 
MURRAY, A.W. & SZOSTAK, J.W. (1983). Construction of artificial chromosomes in yeast. 
Nature 305, 189-193. 
MURRAY, A.W. & SZOSTAK, J.W. (1985) Chromosome segregation in mitosis and meiosis. 





NAKAMURA, H., MORITA, T., SATO, C. (1986). Structural organisation of replicon domains 
during DNA synthetic phase in the mammalian nucleus. Exp. Cell Res. 165, 291-297. 
NASMYTH, K. (2005). How might cohesin hold sister chromatids together? Philos. Trans. R. 
Soc. Lond. B. Biol. Sci.360, 483-496. 
NEUMAN, K.C., CHARVIN, G., BENSIMON, D., CROQUETTE, V. (2009). Mechanisms of chiral 
discrimination by topoisomerase IV. Proc. Natl. Acad. Sci. USA 106, 6986-6991. 
NICOLAS, E., UPTON, A.L., UPHOFF, S., HENRY, O. BADRINARAYANAN, A., SHERRATT, D. 
(2014). The SMC complex MukBEF recruits topoisomerase IV to the origin of replication region 
in live Escherichia coli. mBio 5, e01001-e01003. 
NITISS, J.L. (1998). Investigating the biological functions of DNA topoisomerases in eukaryotic 
cells. Biochim. Biophys. Acta 1400, 63-81. 
NOLIVOS, S., UPTON, A.L., BADRINARAYANAN, A., MULLER, J., ZAWADZKA, K., WIKTOR, 
J., GILL, A., ARCISZEWSKA, L., NICOLAS, E., SHERRATT, D. (2016). MatP regulates the 
coordinated action of topoisomerase IV and MukBEF in chromosome segregation. Nat. 
Comms.7, 10466. DOI: 10.1038/ncomms10466. 
NORDEN, C., MENDOZA, M., DOBBELAERE, J., KOTWALIWALE, C.V., BIGGINS, S., 
BARRAL, Y. (2006). The NoCut pathway links completion of cytokinesis to spindle midzone 
function to prevent chromosome breakage. Cell 125, 85-98. 
OCAMPO-HAFALLA, M.T., KATOU, Y., SHIRAHIGE, K. AND UHLMANN, F., (2007). 
Displacement and re-accumulation of centromeric cohesin during transient pre-anaphase 
centromere splitting. Chromosoma 116, 531-544. 
OLAVARRIETA, L., HERNANDEZ, P., KRIMER, D.B., SCHVARTZMAN, J.B. (2002). DNA 
Knotting caused by head-on collision of transcription and replication. J. Mol. Biol. 322, 1-6. 
O’REILLY, N., CHARBIN, A., LOPEZ-SERRA, L., UHLMANN, F. (2012). Facile synthesis of 
budding yeast a-factor and its use to synchronize cells of a mating type. Yeast 29, 233-240. 
PAULSON, J.R.& LAEMMLI, U.K. (1977). The structure of histone-depleted metaphase 
chromosomes. Cell, 12, 817-828. 
PENG, H. & MARIANS, K.J. (1993). Decatenation activity of topoisomerase IV during oriC and 
pBR322 DNA replication in vitro. Proc. Natl. Acad. Sci. USA 90, 8571-8675. 
PETER, B.J., ULLSPERGER, C., HIASA, H., MARIANS, K.J., COZZARELLI, N.R. (1998). The 
structure of supercoiled intermediates in DNA replication. Cell 276, 819-827. 
POIRIER, M.G. & MARKO, J.F. (2002). Mitotic chromosomes are chromatin networks without a 
mechanically contiguous protein scaffold. Proc. Natl. Acad. Sci. USA 99, 15393-15397. 
POMMIER, Y., POURQUIER, P., FAN, Y., STRUMBERG, D. (1998). Mechanism of action of 
eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim. Biophys. Acta 
1400, 83-105. 
POPE, L.H., XIONG, C., MARKO, J.F. (2006). Proteolysis of mitotic chromosomes induces 
gradual and anisotropic decondensation correlated with a reduction of elastic modulus and 





PORTER, A.C.G., & FARR, C.J. (2004). Topoisomerase II untangling its contribution at the 
centromere. Chromosome Res. 12, 569-583. 
POSTOW, L., PETER, B.J., COZZARELLI, N.R. (1999). Knot what we thought before: the 
twisted story of replication. BioEssays 21, 805-808. 
POSTOW, L., ULLSPERGER, C., KELLER, R.W., BUSTAMANTE, C., VOLOGODSKII, A.V., 
COZZARELLI, N.R. (2001). Positive torsional strain causes the formation of a four-way junction 
at replication forks. J. Biol. Chem. 276, 2790-2796. 
POSTOW, L., HARDY, C.D., ARSUAGA, J., COZZARELLI, N.R. (2004). Topological domain 
structure of the Escherichia coli chromosome. Genes Dev. 18 1766-1779. 
RACKO, D., BENEDETTI, F., DORIER, J., BURNIER, Y., STASIAK, A. (2015). Generation of 
supercoils in nicked and gapped DNA drives DNA unknotting and postreplicative decatenation. 
Nucleic Acids Res. 43, 7229-7236. 
RAGHURAMAN, M.K., BREWER, B.J., FANGMAN, W.L. (1997). Cell cycle-dependent 
establishment of a late replication program. Science 276, 806-809.  
RAMSPERGER, U. & STAHL, H. (1995). Unwinding of chromatin by the SV40 large T antigen 
DNA helicase. EMBO J. 14, 3215-3225. 
RATTNER, J.B., HENDZEL, M.J., FURBEE, C.S., MULLER, M.T., BAZETT-JONES, D.P. 
(1996). Topoisomerase II alpha is associated with the mammalian centromere in a cell cycle- 
and species-specific manner and is required for proper centromere/kinetochore structure. J. 
Cell Viol. 134, 1097-1007. 
REDINBO, M.R., CHAMPOUX, J.J., HOL, W.G. (2000) Novel insights into catalytic mechanism 
from a crystal structure of human topoisomerase I in complex with DNA. Biochemistry 39, 
6832–6840. 
REMUS, D., BEALL, F.L., BOTCHAN, M.R. (2004). DNA topology, not DNA sequence, is a 
critical determinant for Drosophila ORC-DNA binding. EMBO J. 23, 897-907. 
RENSHAW, M.J., WARD, J.J., KANEMAKI, M., NATSUME, K., NEDELEC, F.J., TANAKA, T. 
(2010). Condensins promote chromosome recoiling during early anaphase to complete sister 
chromatid separation. Dev. Cell 19, 232-244. 
REYES-LAMOTHE, R., POSSOZ, C., DANILOVA, O., SHERRATT, D.L. (2008). Independent 
positioning and action of Escherichia coli replisomes in live cells. Cell 133, 90-102 
ROCA, J. & WANG, J.C. (1994). DNA transport by a type II DNA topoisomerase: evidence in 
favour of a two-gate mechanism. Cell 77, 609-616. 
ROCA, J., BERGER, J.M., HARRISON, S.C., WANG, J.C. (1996). DNA transport by a type II 
topoisomerase: direct evidence for a two-gate mechanism. Proc. Natl. Acad. Sci. USA 93, 
4057-4062. 
ROCA, J., BERGER, J.M., WANG, J.C. (1993). On the simultaneous binding of eukaryotic DNA 





ROGAKOU, E.P., PILCH, D.R., ORR, A.H., IVANOVA, V.S., BONNER, W.R. (1998). DNA 
double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 
273, 5858-5868. 
ROGAKOU, E.P., BOON, C., REDON, C., BONNER, W.M. (1999). Megabase chromatin 
domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146, 905-916. 
ROSE, D., THOMAS, W., HOLM, C. (1990). Segregation of recombined chromosomes in 
meiosis I requires DNA topoisomerase II. Cell 60, 1009-1017. 
ROTTMANN, M., SCHRÖDER, H.C., GRAMZOW, M., RENNEISEN, K., KURELEC, B., DORN, 
A., FRIESE, U., MUELLER, W.E. (1987). Specific phosphorylation of proteins in pore complex-
laminae from the sponge Geodia cydonium by the homologous aggregation factor and phorbol 
ester. Role of protein kinase C in the phosphorylation of DNA topoisomerase II. EMBO J. 6, 
3939. 
RYBENKOV, V.V., ULLSPERGER, C., VOLOGODSKII, A .V., COZZARELLI, N.R. (1997). 
Simplification of DNA topology below equilibrium values by type II topoisomerases. Science 
277, 690-693.  
SAKA, Y., SUTANI, T., YAMASHITA, Y., SAITOH, S., TAKEUCHI, M., NAKASEKO, Y., 
YANAGIDA, M. (1994). Fission yeast cut3 and cut14, members of a ubiquitous protein family, 
are required for chromosome condensation and segregation in mitosis. EMBO J. 13, 4938-4952. 
SALCEDA, J., FERNANDEZ, X., ROCA, J. (2006). Topoisomerase II, not topoisomerase I, is 
the proficient relaxase of nucleosomal DNA. EMBO J. 25, 2575-2583. 
SANDER, M. & HSIEH, T. (1983) Double strand DNA cleavage by type II DNA topoisomerase 
from Drosophila melanogaster. J. Biol. Chem., 258, 8421–8428. 
SAUCIER, J.M. & WANG, J.C. (1972). Angular alteration of the DNA helix by E. coli RNA 
polymerase. Nat. New Biol. 239, 167-170. 
SAHYOUN, N., WOLF, M., BESTERMAN, J., HSIEH, T.S., SANDER, M., LEVINE, H., CHANG, 
K.J., CUATRECASAS, P. (1986). Protein kinase C phosphorylates topoisomerase II: 
topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 
cells. Proc. Natl. Acad. Sci. 83, 1603-1607. 
SCHALBETTER, S.A., MANSOUBI, S., CHAMBERS, A.L., DOWNS, J.A., BAXTER, J. (2015). 
Fork rotation and DNA precatenation are restricted during DNA replication to prevent 
chromosomal instability. Proc. Natl. Acad. Sci. USA 112, e4565. 
Doi:10.1073/pnas.1505356112. 
SCHOEFFLER, A.J. & BERGER, J.M. (2008). DNA topoisomerases:  harnessing and 
constraining energy to govern chromosome topology. Q. Rev. Biophys. 41, 41-101. 
SCHULTZ, M.C., BRILL, S.J., JU, Q., STERNGLANZ, R., REEDER, R.H. (1992). 
Topoisomerases and yeast rRNA transcription: negative supercoiling stimulates initiation and 
topoisomerase activity is required for elongation. Genes Dev. 6, 1332-1341. 






SCLIMENTI, C.R., THYAGARAJAN, B., CALOS, M.P. (2001). Directed evolution of a 
recombinase for improved genomic integration at a native human sequence. Nucleic Acids 
Res. 29, 5044-5051. 
SHAIU, W.L. & HSIEH, T.S. (1998). Targeting to transcriptionally active loci by the hydrophilic 
N-terminal domain of Drosophila topoisomerase I. Mol. Cell. Biol. 18, 4358-4367. 
SHAPIRO, P.S., WHALEN, A.M., TOLWINSKI, N.S., WILSBACHER, J., FROELICH-AMMON, 
S.J., GARCIA, M., OSHEROFF, N., AHN, N.G. (1999). Extracellular signal-regulated kinase 
activates topoisomerase IIα through a mechanism independent of phosphorylation. Mol. Cell. 
Biol. 19, 3551-3560. 
SHARMA, S., DOHERTY, K.M., BROSH, R. M. Jr. (2006). Mechanisms of RecQ helicases: 
guardian angels of the DNA replication fork. Chromosoma 117, 219-33 
SHERRATT, D.J. & WIGLEY, D.B. (1998). Conserved themes but novel activities in 
recombinases and topoisomerases. Cell 93, 149-152. 
SIMMONS, D.T., MELENDY, T., USHER, D., STILLMAN, B. (1996). Simian virus 40 large T 
antigen binds to topoisomerase I. Virology 222, 365-374. 
SINDEN, R.R. & PETTIJOHN, D.E. (1981). Chromosomes in living Escherichia coli cells are 
segregated into domains of supercoiling. Proc. Natl. Acad. Sci. USA 78, 228-228. 
SISSI, C. & PALUMBO, M. (2009). Effects of magnesium and related divalent metal ions in 
topoisomerase structure and function. Nucleic Acids Res. 37, 702-711. 
SISSI, C. & PALUMBO, M. (2010). In front of and behind the replication fork: bacterial type IIA 
topoisomerases. Cell. Mol. Life Sci. 67, 2001-2004. 
SKOUFIAS, D.A., LACROIX, F.B., ANDREASSEN, P.R., WILSON, L., MARGOLIS, R.L. (2004). 
Inhibition of DNA decatenation, but not DNA damage, arrests cells at metaphase. Mol. Cell 15, 
977-990. 
SMILEY, R.D., COLLINS, T.R.L., HAMMES, G.G., HSIEH, T.S. (2007). Single-molecule 
measurements of the opening and closing of the DNA gate by eukaryotic topoisomerase II. 
Proc. Natl. Acad. Sci. USA 104, 4840-4845. 
SPELL, R.M. & HOLM, C. (1994). Nature and distribution of chromosomal intertwinings in 
Saccharomyces cerevisiae. Mol. Cell Biol. 14, 1465-1476. 
SPENCE, J.M., CRITCHER, R., EBERSOLE, T.A., VALDIVIA, M.M., EARNSHAW, W.C., 
FUKAGAWA, T. & FARR, C.J. (2002). Co-localization of centromere activity proteins and 
topoisomerase II within a subdomain of the major human X alpha-satellite array. EMBO J 21, 
5269-5280. 
SOGO, J.M., STASIAK, A., MARTINEZ-ROBLES, M.L., KRIMER, D.B., HERNANDEZ, P., 
SCHVARTZMAN, J.B. (1999). Formation of knots in partially replicated DNA molecules. J. Mol. 
Biol. 286, 637-643. 
STEWART, L., IRETON, G.C., CHAMPOUX, J.J. (1997). Reconstitution of human 





STEWART, L., IRETON, G.C., CHAMPOUX, J.J. (1999). A functional linker in human 
topoisomerase I is required for maximum sensitivity to camptothecin in a DNA relaxation assay. 
J. Biol. Chem. 274, 32950–32960. 
STINCHCOMB, D.T., MANN, C., DAVIS, R.W. (1982). Centromeric DNA from Saccharomyces 
cerevisiae. J. Mol. Biol. 158, 157-179. 
STRAY, J.E. & LINDSLEY, J.E. (2003). Biochemical analysis of the yeast condensin Smc2/4 
complex: an ATPase that promotes knotting of circular DNA. J. Biol. Chem. 278, 26238-26248. 
STRAY, J.E., CRISONA, N.J., BELOTSERKOVSKII, B.P., LINDSLEY, J.E., COZZARELLI, N.R. 
(2005). The Saccharomyces cerevisiae Smc2/4 condensin compacts DNA into (+) chiral 
structures without net supercoiling. J. Biol. Chem. 280, 34723-34734. 
STRICK, T.R., CROQUETTE, V. BENSIMON, D. (2000). Single-molecule analysis of DNA 
uncoiling by a type II topoisomerase. Nature 404, 901-904. 
STROS, M., BACIKOVA, A., POLANSKA, E., STOKROVA, J., STRAUSS, F. (2007). HMGB1 
interacts with human topoisomerase Iiα and stimulates its catalytic activity Nucleic Ac. Res. 35, 
5001-5013. 
STRUHL, K., STINCHCOMB, D.T., SCHERER, S., DAVIS, R. (1979). High frequency 
transformation of yeast: autonomous replication of hybrid DNA molecules. Proc. Natl. Acad. 
Sci. USA 76, 1035-1039. 
STRUNNIKOV, A.V., HOGAN, E., KOSHLAND, D. (1995). SMC2, a Saccharomyces cerevisiae 
gene essential for chromosome segregation and condensation, defines a subgroup within the 
SMC family. Genes Dev. 9, 587-599. 
STUCHINSKAYA, T., MITCHENALL, L.A., SCHOEFFLER, A.J., CORBETT, K.D., BERGER, 
J.M., BATES, A.D., MAXWELL, A. (2009). How do type II topoisomerases use ATP hydrolysis 
to simplify DNA topology beyond equilibrium? Investigating the relaxation reaction of 
nonsupercoiling type II topoisomerases. J. Mol. Biol. 385, 1397-1408. 
SUGIMOTO-SHIRASU, K., STACEY, N.J., CORSAR, J., ROBERTS, K. & MCCANN, M.C. 
(2002) DNA topoisomerase VI is essential for endoreduplication in Arabidopsis. Curr. Biol., 12, 
1782–1786.  
SULLIVAN, M., HIGUCHI, T., KATIS, V.L., UHLMANN, F. (2004). Cdc14 phosphatase induces 
rDNA condensation and resolves cohesin-independent cohesion during budding yeast 
anaphase. Cell 117, 471-482. 
SUNDIN, O. & VARSHAVSKY, A. (1980). Terminal stages of SV40 DNA replication proceed via 
multiply intertwined catenated dimers. Cell 21, 115-125. 
SUNDIN, O. & VARSHAVSKY, A. (1981). Arrest of segregation leads to accumulation of highly 
intertwined catenated dimers: dissection of the final stages of SV40 DNA replication. Cell 25, 
659-669. 
SUSKI, C. & MARIANS, K.J. (2008) Resolution of converging replication forks by RecQ and 





SZOSTAK, J.W. & BLACKBURN, E.H. (1982). Cloning yeast telomeres on linear plasmid 
vectors. Cell 29, 245-255. 
SZOSTAK, J.W. (1982). Structural requirements for telomere resolution. Cold Spring Harbor 
Symp. Quant. Biol. 47, 1187-1194. 
TACK, L.C., & DEPAMPHILIS, M.L. (1983). Analysis of simian virus 40 chromosome-T-antigen 
complexes: T-antigen is preferentially associated with early replication DNA intermediates. J. 
Virol. 48, 281-295. 
TAKAHASHI, Y., YONG-GONZALEZ, V., KIKUCHI, Y., STRUNNIKOV, A. (2006). SIZ1/SIZ2 
control of chromosome transmission fidelity is mediated by the sumoylation of topoisomerase II. 
Genetics 172, 783-794. 
TAKAHASHI, Y., & STRUNNIKOV, A. (2008). In vivo modelling of polysumoylation uncovers 
targeting of topoisomerase II to the nucleolus via optimal level of SUMO modification. 
Chromosoma 117, 189-198. 
TAMAICHI, H., SATO, M., PORTER, A.C.G., SHIMIZU, T., MIZUTANI, S., TAKAGI, M. (2013). 
Ataxia telangiectasia mutated-dependent regulation of topoisomerase alpha expression and 
sensitivity to topoisomerase II inhibitor. Cancer Sci. 104, 178-184. 
TANAKA, T., COSMA, M.P., WIRTH, K. & NASMYTH, K. (1999). Cohesin ensures bipolar 
attachment of microtubules to sister centromeres and resists their precocious separation. Nat. 
Cell. Biol. 2, 492-499. 
TAVORMINA, P.A., COME, M.G., HUDSON, J.R. (2002). Rapid exchange of mammalian 
topoisomerase II alpha at kinetochores and chromosome arms in mitosis. J. Cell Biol. 158, 23-
29. 
TERCERO, J.A., LONGHESE, M.P., DIFFLEY, J.F.X. A central role for DNA replication forks in 
checkpoint activation and response. Mol. Cell 11, 1323-1336. 
TEWEY, K.M., CHEN, G.L., NELSON, E.M., LIU, L.F. (1984) Intercalative antitumor drugs 
interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. Biol. 
Chem. 259, 13560-13566. 
THADANI, R., UHLMANN, F., HEEGER, S. (2012). Condensin, chromatin crossbarring and 
chromosome condensation. Curr. Biol. 22, pR1012-R1021. 
THORPE, H.M., WILSON, S.E., SMITH, M.C.M. (2000). Control of directionality in the site-
specific recombination system of the Streptomyces phage φC31. Mol. Microbiol. 38, 232-241. 
THYAGARAJAN, B., OLIVARES, E.C., HOLLIS, R.P., GINSBURG, D.S., CALOS, M.P. (2001). 
Site-specific genomic integration in mammalian cells mediated by phage φC31 integrase. Mol. 
Cell. Biol. 21, 3926-3934. 
TIMSIT, Y. (2011). Local sensing of global DNA topology: from crossover geometry to type II 
topoisomerase processivity. Nucleic Acids Res. 39, 8665-8676. 
TRIGUEROS, S., SALCEDA, J., BERMUDEZ, I., FERNANDEZ, X., ROCA, J. (2004). 
Asymmetric removal of supercoils suggests how topoisomerase II simplifies DNA topology. J. 





TOEDLING, J., SKLYAR, O. & HUBER, W. (2007). Ringo–an R/Bioconductor package for 
analyzing ChIP-chip readouts. BMC bioinformatics 8, p.1. 
TOMSON, B.N., D’AMOURS, D., ADAMSON, B.S., ARAGON, L., AMON, A. (2006). Ribosomal 
DNA transcription-dependent processes interfere with chromosome segregation. Mol. Cell. Biol. 
26, 6239-6247. 
TORRES-ROSELL, J., SUNJEVARIC, I., DEPICCOLI, G., SACHER, M., ECKERT-BOULET, N., 
REID, R., JENTSCH, S., ROTHSTEIN, R., ARAGON, L., LISBY, M. (2007). The Smc5-Smc6 
complex and SUMO modification of Rad52 regulates recombinatorial repair at the ribosomal 
gene locus. Nat. Cell Biol. 9, 923-931. 
TOYODA, Y. & YANAGIDA, M. (2006). Coordinated requirements of human topo II and 
cohesion for metaphase centromere alignment under Mad2-dependent spindle checkpoint 
surveillance. Mol. Biol. Cell. 17, 2287-2302. 
TSCHUMPER, G. & CARBON, J. (1983). Copy number control by a yeast centromere. Gene 23, 
221-232. 
TSE, Y. & WANG, J.C. (1980). E. coli and M. luteus DNA topoisomerase I can catalyse 
catenation or decatenation of double-stranded DNA rings. Cell 22, 269-276. 
TUDURI, S., CRABBÉ, L., CONTI, C., TOURRIERE, H., HOLTGREVE-GREZ, H., JAUCH, A., 
PANTESCO, V., DE VOS, J., THOMAS, A., THEILLET, C., POMMIER, Y. (2009). 
Topoisomerase I suppresses genomic instability by preventing interference between replication 
and transcription. Nature Cell Biol.11, 1315-1324. 
UEMURA, T. & YANAGIDA, M. (1986). Mitotic spindle pulls but fails to separate chromosomes 
in type II DNA topoisomerase mutants:  uncoordinated mitosis. EMBO J 5, 1003. 
UEMURA, T., OHKURA, H., ADACHI, Y., MORINO, K., SHIOZAKI, K. AND YANAGIDA, M. 
(1987). DNA topoisomerase II is required for condensation and separation of mitotic 
chromosomes in S. pombe. Cell 50, 917-925. 
UHLMANN, F., LOTTSPEICH, F., NASMYTH, K. (1999). Sister-chromatid separation at 
anaphase onset is promoted by cleavage of the cohesin subunit Scc1. Nature 400, 37-42. 
UHLMANN, F., WERNIC, D., POUPART, M.A., KOONIN, E.V., NASMYTH, K. (2000). Cleavage 
of cohesin by the CD clan protease separin triggers anaphase in yeast. Cell 103, 375-386. 
VAGNARELLI, P., MORRISON, C., DODSON, H., SONODA, E., TAKEDA, S., EARNSHAW, 
W.C. (2004). Analysis of Scc1-deficient cells defines a key metaphase role of vertebrate 
cohesin in linking sister kinetochores. EMBO Rep. 5, 167-171. 
VAN DUYNE, G.D. (2015). Cre Recombinase. Microbiol. Spectrum 3. 
VELEZ-CRUZ, R., RIGGINS, J.N., DANIELS, J.S., CAI, H., GUENGERICH, F.P., MARNETT, 
L.J., OSHEROFF, N. (2005). Exocyclic DNA lesions stimulate DNA cleavage mediated by 
human topoisomerase IIα in vitro and in cultured cells. Biochemistry 44, 3972-2981.  
VERZIJLBERGEN, K.F., MENENDEZ-BENITO, V., VAN WELSEM, T., VAN DEVENTER, S.J., 





(2010). Recombination-induced tag exchange to track old and new proteins. Proc. Natl. Acad. 
Sci. 107, 64-68.  
VINOGRAD, J. LEBOWITZ, J., RADLOFF, R., WATSON, R., LAIPIS, P. (1965). The twisted 
circular form of polyoma viral DNA. Proc. Natl. Acad. Sci. USA 53, 1104-1111. 
VISINTIN, R., H, WANG, E.S., AMON, A. (1999). Cfi1 prevents premature exit from mitosis by 
anchoring Cdc14 phosphatase in the nucleolus. Nature 398,  818-823. 
VOLOGODSKII, A. (2009). Theoretical models of DNA topology simplification by type IIA DNA 
topoisomerases. Nucleic Acids Res. 37, 5126-5137. 
VOLOGODSKII, A. & COZZARELLI, N.R. (1996). Effect of supercoiling on the juxtaposition and 
relative orientation of DNA sites. Biophys. J. 70, 2548-2556. 
VOLOGODSKII, A.V., ZHANG, W., RYBENKOV, V.V., PODTELEZHNIKOV, A.A., 
SUBRAMANIAN, D., GRIFFITH, J.D., COZZARELLI, N.R. (2001). Mechanism of topology 
simplification by type II DNA topoisomerases. Proc. Natl. Acad. Sci. 98, 3045-3049. 
VOS, S.M., TRETTER, E.M., SCHMIDT, B.H., BERGER, J.M. (2011). All tangled up: how cells 
direct, manage and exploit topoisomerase function. Nature Rev. Mol. Cell Biol., 12, 827-841. 
WALLIS, J.W., CHREBET, G., BRODSKY, G., ROLFE, M., ROTHSTEIN, R. (1989). A hyper-
recombination mutation in S. cerevisiae identifies a novel eukaryotic topoisomerase. Cell 58, 
409-419. 
WAN, L.H., MAYER, B., STEMMANN, O., NIGG, E.A. (2009). Centromere DNA decatenation 
depends on cohesin removal and is required for mammalian cell division. J. Cell Sci. 123, 806-
813. 
WANG, J.C. (1969). Variation of the average rotational angle of the DNA helix and the 
superhelical turns of covalently closed cyclic λ DNA. J. Mol. Biol. 43, 25-39. 
WANG, J.C. (1971). Interaction between DNA and an Escherichia coli protein ω. J. Mol. Biol. 
55, 523-533. 
WANG, J.C. (1973). In DNA Synthesis in Vitro, R.D. Wells and R.B. Inman, eds (Baltimore: 
University Park Press) pp 163-174. 
WANG, J.C. (1974a). The degree of unwinding of the DNA helix by ethidium: I. Titration of 
twisted PM2 DNA molecules in alkaline cesium chloride density gradients. J. Mol. Biol. 89, 783-
801. 
WANG, J.C. (1974b). Interactions between twisted DNAs and enzymes: the effects of 
superhelical turns. J. Mol. Biol. 87, 797-816. 
WANG, J.C. (1979). Helical repeat of DNA in solution. Proc. Natl. Acad. Sci. USA 76, 200-203. 
WANG, J.C. (1996). DNA topoisomerases. Annu. Rev. Biochem. 65, 635-692. 
WANG, J.C. (1998). Moving one DNA double helix through another by a type II DNA 
topoisomerase: the story of a simple molecular machine. Q. Rev. Biophys. 31, 107-144. 
WANG, J.C. (2002). Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. 





WANG, J.C. (2009). A journey in the world of DNA rings and beyond. Annu. Rev. Biochem. 78, 
31-54. 
WANG, J.C., CARON, P.R., KIM, R.A. (1990). The role of DNA topoisomerases in 
recombination and genome stability: a double-edged sword? Cell 62, 403-406. 
WANG, X., REYES-LAMOTHE, R., SHERRATT, D.J. (2008). Modulation of Escherichia coli 
sister chromosome cohesion by topoisomerase IV. Genes & Dev 22, 2426-2433. 
WASSERMAN, R.A., AUSTIN, C.A., FISHER, L.M., WANG, J.C. (1993). Use of yeast in the 
study of anticancer drugs targeting DNA topoisomerases: expression of a functional 
recombinant human DNA topoisomerase IIα in yeast. Cancer Res., 53, 3591-3596. 
WASSERMAN, S.A., DUNGAN, J.M., COZZARELLI, N.R. (1985). Discovery of a predicted DNA 
knot substantiates a model for site-specific recombinationl Science 229, 171-174. 
WATSON, J.D. & CRICK, F.H.C. (1953a). A structure for deoxyribose nucleic acid. Nature 171, 
737-738. 
WATSON, J.D. & CRICK, F.H.C. (1953b). Genetical implications of the structure of 
deoxyribonucleic acid. Nature 171, 964-967. 
WATT, P.M., & HICKSON, I.D. (1994). Structure and function of type II topoisomerases. 
Biochem. J. 303, 681-695. 
WILKINS, M.H.F., STOKES, A.R., WILSON, H.R. (1953). Molecular structure of deoxypentose 
nucleic acids. Nature 171, 738-740. 
WORLAND, S.T. & WANG, J.C. (1989). Inducible overexpression, purification, and active site 
mapping of DNA topoisomerase II from the yeast Saccharomyces cerevisiae. J. Biol. Chem. 
264, 4412-4416. 
WU, J. & LIU, L.F. (1997). Processing of topoisomerase I cleavable complexes into DNA by 
transcription. Nucleic Acids Res.25, 4181-4186. 
WYCKOFF, E. &HSIEH, T.S. (1988). Functional expression of a Drosophila gene in yeast: 
genetic complementation of DNA topoisomerase II. Proc. Natl. Acad. Sci. USA, 85, 6272-6276. 
XU, H., BOONE, C., BROWN, G.W. (2007). Genetic dissection of parallel sister-chromatid 
cohesion pathways. Genetics 176, 1417-1429. 
XU, Z. & BROWN, W.R. (2016). Comparison and optimization of ten phage encoded serine 
integrases for genome engineering in Saccharomyces cerevisiae. BMC biotechnology 16, 1. 
YAN, J., MAGNASCO, M.O., MARKO, J.F. (1999). A kinetic proofreading mechanism for 
disentanglement of DNA by topoisomerases. Nature 401, 932-935. 
YAN, J., MAGNASCO, M.O., MARKO, J.F. (2001). Kinetic proofreading can explain the 
suppression of supercoiling of circular DNA molecules by type-II topoisomerases. Proc. Natl. 
Acad. Sci. USA 71, 4135-4139. 
YANAGIDA, M. (2009). Clearing the way for mitosis: is cohesion a target? Nature Rev. Mol. 
Cell. Biol. 10, 489-496. 
YANG, X., LI, W., PRESCOTT, E.D., BURDEN, S.J. & WANG, J.C. (2000) DNA topoisomerase 





YOGO, K., OGAWA, T., HAYASHI, M., HARADA, Y., NISHIZAKA, T., KINOSITA, K. (2012). 
Direct observation of strand passage by DNA-Topoisomerase and its limited processivity. PLoS 
ONE 7, e34920. Doi:10.1371/ournal.pone.0034920. 
YOSHIDA, M.M., TING, L., GYGI, S.P., AZUMA, Y. (2016). Sumoylation of DNA topoisomerase 
IIα regulates histone H3 kinase Haspin and H3 phosphorylation in mitosis. J. Cell Biol. 213, 
665-678. 
ZECHIEDRICH, E.L., CHRISTIANSEN, K., ANDERSEN, A.H., WESTERGAARD, O., 
OSHEROFF, N. (1989) Double-stranded DNA cleavage/religation reaction of eukaryotic 
topoisomerase II: evidence for a nicked DNA intermediate. Biochemistry, 28, 6229–6236.  
ZECHIEDRICH, E.L., KHODURSKY, A.B., & COZZARELLI, N.R. (1997). Topoisomerase IV, 
not gyrase, decatenates products of site-specific recombination in Escherichia coli. Genes & 
Dev. 11, 2580-2592. 
ZECHIEDRICH, E.L. & OSHEROFF, N. (1990). Eukaryotic topoisomerases recognize nucleic 
acid topology by preferentially interacting with DNA crossovers. EMBO J. 9, 4555-4562. 
 
 
